# ::snt RMCE-ASAP : a gene targeting method for ES and somatic cells to accelerate phenotype analyses .
# ::tok RMCE-ASAP : a gene targeting method for ES and somatic cells to accelerate phenotype analyses .
# ::alignments 14-15|0.1 13-14|0.1.0 12-13|0 10-11|0.0 9-10|0.0.0 8-9|0.2 7-8|0.2.0.0.0 5-6|0.2.0 4-5|0.2.0.0 3-4|0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:46.784
(a2 / accelerate-01 
      :ARG0 (c / cell 
            :mod (s / somatic)) 
      :ARG1 (a / analysis 
            :mod (p / phenotype)) 
      :purpose-of (a3 / and 
            :op1 (m / method 
                  :ARG1-of (t / target-01 
                        :ARG0 (e / e)) 
                  :mod (g / gene))))

# ::snt In recent years , tremendous insight has been gained on p53 regulation by targeting mutations at the p53 locus using homologous recombination in ES cells to generate mutant mice .
# ::tok In recent years , tremendous insight has been gained on p53 regulation by targeting mutations at the p53 locus using homologous recombination in ES cells to generate mutant mice .
# ::alignments 28-29|0.0.1.1 27-28|0.0.1.1.0 26-27|0.0.1 24-25|0.1 23-24|0.1.0 21-22|0 20-21|0.0.0.0.0.1.0 19-20|0.0 18-19|0.0.0 14-15|0.0.0.0 13-14|0.0.0.0.0 11-12|0.0.0.0.0.0 10-11|0.0.0.0.0.0.0 8-9|0.0.0.0.0.1 5-6|0.0.0.0.0.1.1 4-5|0.0.1.0 2-3|0.0.0.1.1+0.0.0.1 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:47.437
(r / recombination 
      :ARG1-of (u / use-01 
            :ARG0 (l / locu 
                  :ARG1-of (m3 / mutate-01 
                        :ARG1-of (t / target-01 
                              :ARG1-of (r2 / regulate-01 
                                    :ARG0 (p / p53)) 
                              :manner-of (g2 / gain-02 
                                    :ARG0 (h / homologou) 
                                    :ARG1 (i / insight)))) 
                  :name (t3 / temporal-quantity 
                        :time (r3 / recent) 
                        :unit (y / year))) 
            :ARG2 (g / generate-01 
                  :ARG0 (t2 / tremendous) 
                  :ARG1 (m / mouse 
                        :mod (m2 / mutant)))) 
      :location (c / cell 
            :mod (e / e)))

# ::snt Although informative , this approach is inefficient , slow and expensive .
# ::tok Although informative , this approach is inefficient , slow and expensive .
# ::alignments 10-11|0.1 9-10|0 8-9|0.0.0.1 6-7|0.0.1+0.0 4-5|0.0.0 3-4|0.0.0.2 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:47.539
(a / and 
      :op1 (e2 / efficient-01 
            :ARG1 (a2 / approach-02 
                  :ARG1 (i / informative) 
                  :domain-of (s / slow) 
                  :mod (t / this)) 
            :polarity -) 
      :op2 (e / expensive))

# ::snt To facilitate targeting at the p53 locus , we developed an improved Recombinase-Mediated Cassette Exchange ( RMCE ) method .
# ::tok To facilitate targeting at the p53 locus , we developed an improved Recombinase-Mediated Cassette Exchange ( RMCE ) method .
# ::alignments 18-19|0.0.0.1.0.1 16-17|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 12-15|0.0.0.1.0.1.1.0.2+0.0.0.1.0.1.1.0.1+0.0.0.1.0.1.1.0.0+0.0.0.1.0.1.1.0+0.0.0.1.0.1.1 11-12|0.0.0.1.0.1.0 9-10|0.0.0.1.0 8-9|0.0.0.1.0.0 6-7|0.0 5-6|0 2-3|0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:47.708
(p / p53 
      :mod-of (l / locu 
            :ARG1-of (t / target-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "RMCE")) 
                  :ARG1-of (f / facilitate-01 
                        :purpose-of (d / develop-02 
                              :ARG0 (w / we) 
                              :ARG1 (m / method 
                                    :ARG1-of (i / improve-01) 
                                    :mod (o2 / organization 
                                          :name (n2 / name 
                                                :op1 "Recombinase-Mediated" 
                                                :op2 "Cassette" 
                                                :op3 "Exchange"))))))))

# ::snt Our approach enables efficient targeting in ES cells to facilitate the production of mutant mice .
# ::tok Our approach enables efficient targeting in ES cells to facilitate the production of mutant mice .
# ::alignments 14-15|0.0 13-14|0 11-12|0.0.0 9-10|0.0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.1 4-5|0.0.0.0.0.0 3-4|0.0.0.0.0.0.0.0.1 2-3|0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:48.087
(m2 / mutant 
      :mod-of (m / mouse 
            :ARG1-of (p / produce-01 
                  :ARG1-of (f / facilitate-01 
                        :purpose-of (c / cell 
                              :ARG1-of (t / target-01 
                                    :ARG1-of (e3 / enable-01 
                                          :ARG0 (a / approach-02 
                                                :ARG1 (w / we) 
                                                :ARG1-of (e2 / efficient-01)))) 
                              :mod (e / e))))))

# ::snt But more importantly , the approach was Adapted for targeting in Somatic cells to Accelerate Phenotyping ( RMCE-ASAP ) .
# ::tok But more importantly , the approach was Adapted for targeting in Somatic cells to Accelerate Phenotyping ( RMCE-ASAP ) .
# ::alignments 14-16|0.0.0.0.1.0.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 12-13|0.0.0.0.0 11-12|0.0.0.0.0.0 9-10|0.0.0.0 7-8|0.0 5-6|0.0.0 2-3|0.1 1-2|0.1.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:48.279
(c2 / contrast-01 
      :ARG2 (a2 / adapt-01 
            :ARG1 (a3 / approach-02 
                  :ARG0-of (t2 / target-01 
                        :ARG1 (c / cell 
                              :mod (s / somatic)) 
                        :purpose (t / thing 
                              :name (n / name 
                                    :op1 (a / Accelerate) 
                                    :op2 (p / Phenotyping)))))) 
      :mod (i / important 
            :degree (m / more)))

# ::snt We provide proof-of-concept for this at the p53 locus , by showing efficient targeting in fibroblasts , and rapid phenotypic read-out of a recessive mutation after a single exchange .
# ::tok We provide proof-of-concept for this at the p53 locus , by showing efficient targeting in fibroblasts , and rapid phenotypic read-out of a recessive mutation after a single exchange .
# ::alignments 28-29|0.1.1.2.0 27-28|0.1.1.2.0.1 25-26|0.1.1.2 24-25|0.1.1.1.0 23-24|0.1.1.1.0.0 20-21|0.1.1.1 19-20|0.2 18-19|0.1.1.0.0.1 17-18|0 15-16|0.1.0 13-14|0.1 12-13|0.0 11-12|0.1.1 8-9|0.1.1.0.0.0 7-8|0.1.1.0.0.0.0 4-5|0.1.1.2.0.0 1-2|0.1.1.0.0 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:49.280
(a2 / and 
      :ARG1-of (e2 / efficient-01) 
      :op1 (t / target-01 
            :ARG1 (f / fibroblast) 
            :ARG2-of (s2 / show-01 
                  :ARG0 (w / we 
                        :ARG0-of (p3 / provide-01 
                              :ARG1 (l / locu 
                                    :mod (p2 / p53)) 
                              :ARG2 (r3 / rapid))) 
                  :ARG1 (r2 / read-out 
                        :poss (m / mutation 
                              :mod (r / recessive))) 
                  :time (a / after 
                        :op1 (e / exchange-01 
                              :ARG0 (t2 / this) 
                              :ARG1-of (s / single-02))))) 
      :op2 (p / phenotypic))

# ::snt RMCE-ASAP combines inverted heterologous recombinase target sites , a positive/negative selection marker that preserves the germline capacity of ES cells , and the power of mouse genetics .
# ::tok RMCE-ASAP combines inverted heterologous recombinase target sites , a positive/negative selection marker that preserves the germline capacity of ES cells , and the power of mouse genetics .
# ::alignments 26-27|0.0.0.0.1.1.0 25-26|0.0.0.0.1.1.0.0 23-24|0.0.0.0.1.1 21-22|0.0.0.0.1 19-20|0.0 18-19|0 16-17|0.0.0 13-14|0.0.0.0 11-12|0.0.0.0.0 10-11|0.0.0.0.0.0 6-7|0.0.0.0.1.0 5-6|0.0.0.0.1.0.2 3-4|0.0.0.0.1.0.3 2-3|0.0.0.0.1.0.0 1-2|0.0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:50.249
(e / e 
      :mod-of (c / cell 
            :poss-of (c2 / capacity 
                  :ARG1-of (p2 / preserve-01 
                        :ARG0 (m2 / mark-01 
                              :ARG1-of (s / select-01)) 
                        :op2-of (a / and 
                              :op1 (s2 / site 
                                    :ARG1-of (i / invert-01) 
                                    :ARG1-of (c3 / combine-01) 
                                    :ARG1-of (t / target-01) 
                                    :mod (h / heterologou)) 
                              :op3 (p / power 
                                    :poss (g / genetic 
                                          :mod (m / mouse))))))))

# ::snt These general principles should make RMCE-ASAP applicable to any locus .
# ::tok These general principles should make RMCE-ASAP applicable to any locus .
# ::alignments 9-10|0.0.0.0 8-9|0.0.0.0.0 6-7|0.0.0 3-4|0 2-3|0.0 1-2|0.0.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:50.307
(r / recommend-01 
      :ARG2 (p / principle 
            :ARG1-of (a2 / apply-02 
                  :ARG2 (l / locu 
                        :mod (a / any))) 
            :mod (g / general-02) 
            :mod (t / this)))

# ::snt p53 is one of the most highly analyzed proteins for the past 25 years .
# ::tok p53 is one of the most highly analyzed proteins for the past 25 years .
# ::alignments 13-14|0.0.1.2+0.0.1 12-13|0.0.1.1 11-12|0.0.1.0 8-9|0.0.0 7-8|0.0 6-7|0.0.2 5-6|0.0.2.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:50.459
(p3 / p53 
      :ARG0-of (a / analyze-01 
            :ARG1 (p2 / protein) 
            :ARG3 (t / temporal-quantity 
                  :op1-of (p / past) 
                  :quant 25 
                  :unit (y / year)) 
            :degree (h / high 
                  :degree (m / most))))

# ::snt Studies in cultured cells , often relying on the transfection of plasmids expressing various p53 mutants , have established models to explain how p53 is regulated .
# ::tok Studies in cultured cells , often relying on the transfection of plasmids expressing various p53 mutants , have established models to explain how p53 is regulated .
# ::alignments 25-26|0.0.0.0 21-22|0.0.0 19-20|0.0 18-19|0 15-16|0.1.3.1 14-15|0.1.3.1.0 13-14|0.1.3.1.1 12-13|0.1.3 11-12|0.1.3.0 9-10|0.1.1 6-7|0.1 5-6|0.1.2 3-4|0.1.0.0 2-3|0.1.0.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:51.356
(e2 / establish-01 
      :ARG1 (m / model 
            :ARG0-of (e / explain-01 
                  :ARG1 (r / regulate-01))) 
      :purpose (r2 / rely-01 
            :ARG0 (s / study-01 
                  :ARG1 (c / cell 
                        :ARG1-of (c2 / culture-01))) 
            :ARG1 (t / transfection) 
            :frequency (o / often) 
            :purpose (e3 / express-01 
                  :ARG0 (p2 / plasmid) 
                  :ARG1 (m2 / mutant 
                        :mod (p / p53) 
                        :mod (v / various)))))

# ::snt In recent years , some of these models were tested in vivo by targeting subtle mutations at the p53 locus using homologous recombination in embryonic stem ( ES ) cells to generate mutant mice .
# ::tok In recent years , some of these models were tested in vivo by targeting subtle mutations at the p53 locus using homologous recombination in embryonic stem ( ES ) cells to generate mutant mice .
# ::alignments 33-34|0.0.2.0.0.2.1 32-33|0.0.2.0.0.2.1.0 31-32|0.0.2.0.0.2 29-30|0.0.2.0.0.2.0 27-28|0.0.2.1.0 25-26|0.0.2.0.0.1 24-25|0.0.2.0.0.1.0 22-23|0.0.2.0.0.0 21-22|0 20-21|0.0.2.0.0 19-20|0.0.2.0 18-19|0.0.2.0.1 15-16|0.0.2.1 14-15|0.0.2.1.1 13-14|0.0.2 11-12|0.0.1 9-10|0.0 7-8|0.0.0 6-7|0.0.0.0 4-5|0.0.0.1 2-3|0.0.2.2.1+0.0.2.2 1-2|0.0.2.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:52.171
(h / homologou 
      :ARG0-of (t2 / test-01 
            :ARG1 (m4 / model 
                  :mod (t3 / this) 
                  :quant (s3 / some)) 
            :ARG2 (v / vivo) 
            :manner (t / target-01 
                  :ARG0 (l / locu 
                        :ARG0-of (u / use-01 
                              :ARG1 (r / recombination) 
                              :ARG2 (s / stem 
                                    :mod (e2 / embryonic)) 
                              :purpose (g / generate-01 
                                    :ARG0 (c / cell) 
                                    :ARG1 (m / mouse 
                                          :mod (m2 / mutant)))) 
                        :mod (p / p53)) 
                  :ARG1 (m3 / mutate-01 
                        :ARG0 (e / e) 
                        :mod (s2 / subtle)) 
                  :time (t4 / temporal-quantity 
                        :time (r2 / recent) 
                        :unit (y / year)))))

# ::snt The strength of this approach is that mutations are tested in a genomic setting and expressed from the endogenous promoter , ensuring physiological expression levels and correct spatio-temporal profiles .
# ::tok The strength of this approach is that mutations are tested in a genomic setting and expressed from the endogenous promoter , ensuring physiological expression levels and correct spatio-temporal profiles .
# ::alignments 28-29|0.0.0.0.1.0 26-27|0.0.0.0.1 25-26|0.0.0.0 24-25|0.0 23-24|0 22-23|0.0.0.0.0.0.0.0 21-22|0.0.0 19-20|0.0.0.0.0.1 18-19|0.0.0.0.0.1.0 15-16|0.0.0.0.0 14-15|0.0.0.0.0.2 13-14|0.0.0.0.0.2.0.1 9-10|0.0.0.0.0.2.0 7-8|0.0.0.0.0.2.0.0 4-5|0.0.0.0.0.0.0 3-4|0.0.0.0.0.0.0.1 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:53.247
(e / express-01 
      :ARG1 (l / level 
            :ARG1-of (e2 / ensure-01 
                  :op1-of (a / and 
                        :ARG1-of (e4 / express-01 
                              :ARG0 (s2 / strength 
                                    :poss (a3 / approach-02 
                                          :ARG1 (p2 / physiological) 
                                          :mod (t2 / this))) 
                              :ARG2 (p3 / promote-01 
                                    :ARG1 (e3 / endogenou)) 
                              :op2-of (a2 / and 
                                    :op1 (t / test-01 
                                          :ARG1 (m / mutate-01) 
                                          :ARG2 (s / set-02)))) 
                        :op2 (c / correct-02 
                              :ARG1 (p / profile-01))))))

# ::snt As significant differences between phenotypes from targeted p53 mutants in vivo and transfection data were observed [ e.g. Refs ( 1 -- 5 ) ] , more targeted mutations need to be generated and analyzed in multiple tissues to formulate more accurate models of p53 regulation .
# ::tok As significant differences between phenotypes from targeted p53 mutants in vivo and transfection data were observed [ e.g. Refs ( 1 -- 5 ) ] , more targeted mutations need to be generated and analyzed in multiple tissues to formulate more accurate models of p53 regulation .
# ::alignments 45-46|0.0.1.0.0.0.0.0.1 42-43|0.0.1.0.0.0.0.0 41-42|0.0.1.0.0.0.0.0.0 40-41|0.0.1.0.0.0.0.0.0.0 39-40|0.0.1.0.0.0.0 37-38|0.0.1.0.0.0.0.1 36-37|0.0.1.0.0.0.0.1.0 34-35|0.0.1.0.0.1.0 33-34|0.0.1.0.0.1 32-33|0.0.1.0.0 29-30|0.0.1.0 28-29|0.0.1.0.0.0 27-28|0.0.1.0.0.0.2 26-27|0.0.1.0.0.0.2.0 22-23|0.0.2.0 20-21|0.0.1.0.0.1.0.0 17-19|0.0.1.0.0.0.0.0.1.0.0.1+0.0.1.0.0.0.0.0.1.0.0.0+0.0.1.0.0.0.0.0.1.0.0+0.0.1.0.0.0.0.0.1.0 15-16|0.0.1 13-14|0.3 12-13|0.2 11-12|0 10-11|0.1 8-9|0.0.1.0.0.0.1.0 7-8|0.0.1.0.0.0.1.0.0 6-7|0.0.1.0.0.0.1 4-5|0.0.0 2-3|0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:44:55.798
(a4 / and 
      :ARG1-of (d2 / differ-01 
            :ARG0 (p2 / phenotyp) 
            :ARG1-of (o / observe-01 
                  :condition-of (n / need-01 
                        :ARG1 (g / generate-01 
                              :ARG1 (m4 / mutate-01 
                                    :ARG0-of (f / formulate-01 
                                          :ARG1 (m / model 
                                                :mod (a / accurate 
                                                      :degree (m2 / more)) 
                                                :topic (r / regulate-01 
                                                      :ARG1 (t3 / thing 
                                                            :name (n2 / name 
                                                                  :op1 (e / e.g.) 
                                                                  :op2 (r2 / Refs))))) 
                                          :ARG2 (t / tissue 
                                                :quant (m3 / multiple))) 
                                    :ARG1 (t5 / target-01 
                                          :ARG0 (m6 / mutant 
                                                :mod (p / p53))) 
                                    :ARG1-of (t2 / target-01 
                                          :degree (m5 / more))) 
                              :op1-of (a3 / and 
                                    :op2 (a2 / analyze-01 
                                          :ARG1 1))))) 
            :ARG1-of (s / significant-02 
                  :ARG0 5)) 
      :op1 (v / vivo) 
      :op2 (t4 / transfection) 
      :op3 (d / data))

# ::snt However , using homologous recombination in ES cells to generate mutant mice is an inefficient , slow and expensive method because ( i ) homologous recombination typically occurs at low frequency in ES cells , requiring sophisticated selection schemes and screening of hundreds of clones to identify the desired mutant ; ( ii ) large ( 15 -- 20 kb ) plasmids , often difficult to clone , are required to increase targeting efficiency and ( iii ) breeding mice to homozygosity and housing a mouse colony generate further delays and costs .
# ::tok However , using homologous recombination in ES cells to generate mutant mice is an inefficient , slow and expensive method because ( i ) homologous recombination typically occurs at low frequency in ES cells , requiring sophisticated selection schemes and screening of hundreds of clones to identify the desired mutant ; ( ii ) large ( 15 -- 20 kb ) plasmids , often difficult to clone , are required to increase targeting efficiency and ( iii ) breeding mice to homozygosity and housing a mouse colony generate further delays and costs .
# ::alignments 91-92|0.2.0.0.0 90-91|0.2.0.1 89-90|0.2.0.0.1 88-89|0.2.0.0.1.1 87-88|0.2.0 86-87|0.2.0.0 85-86|0.2.0.0.2 83-84|0.3 82-83|0 81-82|0.2 79-80|0.1.1 78-79|0.1 76-77|0.2.0.0.1.0 74-75|0.0.0.0.0 73-74|0.0 72-73|0.0.1 71-72|0.0.0 69-70|0.0.0.0 66-67|0.2.0.2 64-65|0.2.0.2.0 63-64|0.0.0.0.0.0.0.1.2.0 61-62|0.0.0.0.0.0.2 59-60|0.3.0 58-59|0.0.0.0.0.0.0.1.1.0 56-57|0.1.0 54-55|0.0.0.0.0.0.0.1.0.4.0.0 52-53|0.0.0.0.0.0.1 50-51|0.0.0.0.0.0 49-50|0.0.0.0.0.0.0.1.2.1.0 48-49|0.0.0.0.0.0.0.1.2.1.0.0 46-47|0.0.0.0.0.0.0.1.2.1 44-45|0.0.0.0.0.0.0.1.2.1.1 42-43|0.0.0.0.0.0.0.1.1.1.0 40-41|0.0.0.0.0.0.0.1.2 39-40|0.0.0.0.0.0.0.1 38-39|0.0.0.0.0.0.0.1.1.1 37-38|0.0.0.0.0.0.0.1.1.1.1 36-37|0.0.0.0.0.0.0.1.1.1.2 35-36|0.0.0.0.0.0.0.1.1 33-34|0.0.0.0.0.0.0.1.0.3 30-31|0.0.0.0.0.0.0.1.0.4 29-30|0.0.0.0.0.0.0.1.0.4.0 27-28|0.0.0.0.0.0.0.1.0 26-27|0.0.0.0.0.0.0.1.0.2 25-26|0.0.0.0.0.0.0.1.0.0 22-23|0.0.0.0.0.0.0.1.0.1.1 20-21|0.0.0.0.0.0.0.1.0.1 19-20|0.0.0.0.0.0.0.3 18-19|0.0.0.0.0.0.0.2 17-18|0.0.0.0.0.0.0 16-17|0.0.0.0.0.0.0.1.1.1.1.0 14-15|0.0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0 11-12|0.0.0.0.0.0.0.1.0.1.0.0 10-11|0.0.0.0.0.0.0.1.0.1.0.0.0 9-10|0.0.0.0.0.0.0.1.0.1.0 7-8|0.0.0.0.0.0.0.1.0.1.0.1.0.0 6-7|0.0.0.0.0.0.0.1.0.1.0.1.0.0.0 4-5|0.0.0.0.0.0.0.1.0.1.0.1.0 3-4|0.0.0.0.0.0.0.0.0 2-3|0.0.0.0.0.0.0.1.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:08.515
(a2 / and 
      :ARG2-of (e / efficient-01 
            :ARG1-of (i2 / increase-01 
                  :ARG1-of (r / require-01 
                        :ARG2 (a3 / and 
                              :op4-of (a4 / and 
                                    :op1 (a6 / and 
                                          :op1 (e3 / efficient-01 
                                                :ARG1 (h4 / homologou) 
                                                :polarity -) 
                                          :op1-of (a5 / and 
                                                :ARG1-of (o2 / occur-01 
                                                      :ARG0 (r3 / recombination) 
                                                      :ARG0-of (c6 / cause-01 
                                                            :ARG1 (g2 / generate-01 
                                                                  :ARG1 (m5 / mouse 
                                                                        :mod (m6 / mutant)) 
                                                                  :ARG2-of (u / use-01 
                                                                        :ARG1 (r4 / recombination 
                                                                              :location (c7 / cell 
                                                                                    :mod (e4 / e))))) 
                                                            :ARG2 (i5 / i)) 
                                                      :ARG1-of (t2 / typical-02) 
                                                      :ARG2 (c5 / cell) 
                                                      :time (f2 / frequency 
                                                            :ARG1-of (l2 / low-04 
                                                                  :ARG0 (l / large)))) 
                                                :op2 (r2 / require-01 
                                                      :ARG0 20 
                                                      :ARG1 (s2 / scheme-01 
                                                            :ARG0 (h3 / hundred) 
                                                            :mod (s3 / select-01 
                                                                  :ARG0 (s5 / slow)) 
                                                            :mod (s4 / sophisticated))) 
                                                :op3 (s / screen-01 
                                                      :ARG0 (o / often) 
                                                      :ARG1 (i4 / identify-01 
                                                            :ARG1 (m3 / mutant 
                                                                  :ARG1-of (d3 / desire-01)) 
                                                            :ARG1-of (c4 / clone-01)))) 
                                          :op2 (e2 / expensive) 
                                          :op3 (m4 / method)) 
                                    :op2 (i3 / ii) 
                                    :op3 (p / plasmid))))) 
            :ARG1-of (t / target-01)) 
      :op1 (b / breed-01 
            :ARG0 15 
            :ARG1 (m2 / mouse)) 
      :op2 (h2 / homozygosity 
            :ARG2-of (g / generate-01 
                  :ARG0 (c2 / colony 
                        :ARG0-of (c / cost-01) 
                        :ARG0-of (d / delay-01 
                              :ARG1 (i / iii) 
                              :mod (f / further)) 
                        :mod (m / mouse)) 
                  :ARG1 (a / and) 
                  :ARG1-of (c3 / clone-01 
                        :domain-of (d2 / difficult)))) 
      :op3 (h / house-01 
            :ARG1 (k / kb)))

# ::snt Such limitations make the repeated targeting of a locus a technically daunting and economically impractical task .
# ::tok Such limitations make the repeated targeting of a locus a technically daunting and economically impractical task .
# ::alignments 15-16|0.1.0 14-15|0.2 13-14|0.2.1 12-13|0 11-12|0.1 10-11|0.2.0 8-9|0.0.2 5-6|0.0 4-5|0.0.1 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:08.712
(a / and 
      :ARG1-of (t3 / target-01 
            :ARG0 (l2 / limit-01 
                  :mod (s / such)) 
            :ARG1-of (r / repeat-01) 
            :ARG2 (l / locu)) 
      :op1 (d / daunt-01 
            :ARG1 (t / task)) 
      :op2 (i / impractical 
            :degree (t2 / technical) 
            :manner (e / economy)))

# ::snt Improvements in current technologies are needed to enable such analyses to be applied to the p53 or other genes .
# ::tok Improvements in current technologies are needed to enable such analyses to be applied to the p53 or other genes .
# ::alignments 18-19|0.2 17-18|0.0.1.0.1.0 16-17|0 15-16|0.1 12-13|0.0 9-10|0.0.1 8-9|0.0.1.1 7-8|0.0.1.0 5-6|0.0.1.0.1 3-4|0.0.0 2-3|0.0.0.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:09.079
(o2 / or 
      :ARG2-of (a / apply-01 
            :ARG0 (t / technology 
                  :time (c / current)) 
            :ARG1 (a2 / analysis 
                  :ARG1-of (e / enable-01 
                        :ARG0 (i / improvement) 
                        :ARG1-of (n / need-01 
                              :ARG0 (o / other))) 
                  :mod (s / such))) 
      :op1 (p / p53) 
      :op2 (g / gene))

# ::snt Developing methods to increase targeting efficiency in ES cells is clearly an important goal .
# ::tok Developing methods to increase targeting efficiency in ES cells is clearly an important goal .
# ::alignments 13-14|0.0.0.1.0.0.0 12-13|0.0.0.1.0.0 10-11|0.0.0.1.0.0.0.0 8-9|0.0 7-8|0 5-6|0.0.0.1 4-5|0.0.0.1.0 3-4|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:09.277
(e / e 
      :mod-of (c2 / cell 
            :location-of (i2 / increase-01 
                  :ARG0 (m / method 
                        :ARG1-of (d / develop-02)) 
                  :ARG1 (e2 / efficient-01 
                        :ARG1-of (t / target-01 
                              :ARG0 (i / important 
                                    :mod-of (g / goal 
                                          :ARG1-of (c / clear-06))))))))

# ::snt In addition , efficient methods for gene targeting in fibroblasts could expedite phenotypic analyses .
# ::tok In addition , efficient methods for gene targeting in fibroblasts could expedite phenotypic analyses .
# ::alignments 13-14|0.0.1 12-13|0.0.1.0 11-12|0.0 10-11|0 9-10|0.1.1 7-8|0.1 6-7|0.1.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:09.435
(p2 / possible-01 
      :ARG1 (e / expedite-01 
            :ARG0 (m / method 
                  :ARG1-of (e2 / efficient-01)) 
            :ARG1 (a / analysis 
                  :mod (p / phenotypic)) 
            :ARG2 (a2 / addition)) 
      :ARG1-of (t / target-01 
            :ARG0 (g / gene) 
            :location (f / fibroblast)))

# ::snt Indeed , siRNAs in fibroblasts often provide a faster read-out than equivalent gene knock-outs in animals ( 6 ) .
# ::tok Indeed , siRNAs in fibroblasts often provide a faster read-out than equivalent gene knock-outs in animals ( 6 ) .
# ::alignments 17-18|0.3.0 15-16|0.0.0.0.0.0 13-14|0.0.0.0.0 12-13|0.0.0.0.0.1 11-12|0.0.0.0 9-10|0.1 8-9|0.1.0 6-7|0 5-6|0.2 4-5|0.0.0 2-3|0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:09.645
(p / provide-01 
      :ARG0 (s / sirna 
            :location (f2 / fibroblast 
                  :mod-of (e / equivalent 
                        :mod-of (k / knock-out 
                              :location (a / animal) 
                              :mod (g / gene))))) 
      :ARG1 (r / read-out 
            :mod (f / fast)) 
      :frequency (o / often) 
      :mod (i / indeed 
            :poss 6))

# ::snt However , modeling most disease-associated mutations requires generating subtle mutations , not knock-outs or reduced expression alleles .
# ::tok However , modeling most disease-associated mutations requires generating subtle mutations , not knock-outs or reduced expression alleles .
# ::alignments 16-17|0.1.0.2 15-16|0.1.0.1 14-15|0.1.0.2.0 13-14|0.1.0 12-13|0.1.0.0.0 11-12|0.0.0 9-10|0.1.0.0 8-9|0.1.0.0.1 7-8|0.1 6-7|0 5-6|0.0 4-5|0.0.1 3-4|0.0.1.0 2-3|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:09.947
(r2 / require-01 
      :ARG0 (m2 / mutate-01 
            :ARG1 - 
            :mod (d / disease-associat 
                  :degree (m3 / most 
                        :ARG1-of (m4 / model-01)))) 
      :ARG1 (g / generate-01 
            :ARG1 (o / or 
                  :op1 (m / mutate-01 
                        :ARG1 (k / knock-out) 
                        :mod (s / subtle)) 
                  :op2 (e / express-01) 
                  :op3 (a / allel 
                        :ARG1-of (r / reduce-01)))))

# ::snt Targeting point mutations in fibroblasts by homologous recombination is extremely inefficient , and targeting both alleles is required to reveal the phenotype of recessive autosomal mutations .
# ::tok Targeting point mutations in fibroblasts by homologous recombination is extremely inefficient , and targeting both alleles is required to reveal the phenotype of recessive autosomal mutations .
# ::alignments 25-26|0.2.0.0.0 24-25|0.2.0.0.0.1 23-24|0.2.0.0.0.2 21-22|0.2.0.0 19-20|0.2.0 17-18|0.2 15-16|0.1.0 14-15|0.1.0.0 13-14|0.1 12-13|0 10-11|0.0.2+0.0 9-10|0.0.1 7-8|0.0.0.0 6-7|0.2.0.0.0.0 4-5|0.0.0.3 2-3|0.0.0 1-2|0.0.0.1 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:10.265
(a3 / and 
      :op1 (e / efficient-01 
            :ARG1 (m2 / mutate-01 
                  :ARG0 (r4 / recombination) 
                  :ARG1 (p2 / point) 
                  :ARG1-of (t2 / target-01) 
                  :location (f / fibroblast)) 
            :degree (e2 / extreme) 
            :polarity -) 
      :op2 (t / target-01 
            :ARG1 (a2 / allel 
                  :mod (b / both))) 
      :op3 (r3 / require-01 
            :ARG1 (r2 / reveal-01 
                  :ARG1 (p / phenotype 
                        :poss (m / mutate-01 
                              :ARG1 (h / homologou) 
                              :mod (a / autosomal) 
                              :mod (r / recessive))))))

# ::snt Here we report an approach that enables highly efficient targeting at the p53 locus in both ES cells and fibroblasts .
# ::tok Here we report an approach that enables highly efficient targeting at the p53 locus in both ES cells and fibroblasts .
# ::alignments 19-20|0.1 18-19|0 17-18|0.0.1 16-17|0.0.1.1 15-16|0.0.1.0 13-14|0.0 12-13|0.0.2 9-10|0.0.0 8-9|0.0.0.0.1 7-8|0.0.0.0.1.0 6-7|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:10.618
(a / and 
      :op1 (l / locu 
            :ARG1-of (t / target-01 
                  :ARG1-of (e3 / enable-01 
                        :ARG0 (a2 / approach-02 
                              :ARG1-of (r / report-01 
                                    :ARG0 (w / we) 
                                    :location (h2 / here))) 
                        :ARG2 (e2 / efficient-01 
                              :degree (h / high)))) 
            :location (c / cell 
                  :mod (b / both) 
                  :mod (e / e)) 
            :mod (p / p53)) 
      :op2 (f / fibroblast))

# ::snt Recombinase-Mediated Cassette Exchange ( RMCE ) approaches were developed to improve targeting efficiency using a two-step process : the gene of interest is first replaced by a selection cassette flanked by recombinase target sites ( e.g. loxP sites for Cre recombinase , to create a ` floxed ' locus ) .
# ::tok Recombinase-Mediated Cassette Exchange ( RMCE ) approaches were developed to improve targeting efficiency using a two-step process : the gene of interest is first replaced by a selection cassette flanked by recombinase target sites ( e.g. loxP sites for Cre recombinase , to create a ` floxed ' locus ) .
# ::alignments 48-49|0.0.1 46-47|0.0.1.0 43-44|0.0 37-38|0.0.0 36-37|0.0.0.0 35-36|0.2.0.0.0.0.0.0.1 33-34|0.2.0 32-33|0.2.0.0 29-30|0.2 28-29|0.2.1 27-28|0.2.1.0 24-25|0.2.1.1 21-22|0 19-20|0.1 16-17|0.2.0.0.0.0.0.0.0.0 15-16|0.2.0.0.0.0.0.0.0.0.0 13-14|0.2.0.0.0.0.0.0.0 12-13|0.2.0.0.0.0.0.0 11-12|0.2.0.0.0.0.0.0.2 10-11|0.2.0.0.0.0.0 8-9|0.2.0.0.0 6-7|0.2.0.0.0.0 1-3|0.2.0.0.0.0.1.1.1+0.2.0.0.0.0.1.1.0+0.2.0.0.0.0.1.1+0.2.0.0.0.0.1 0-1|0.2.0.0.0.0.1.0.0.0+0.2.0.0.0.0.1.0.0+0.2.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:11.580
(i / interest-01 
      :ARG1 (c / create-01 
            :ARG0 (s / site 
                  :location-of (l2 / loxP)) 
            :ARG1 (l / locu 
                  :mod (f / flox))) 
      :ARG2 (g / gene) 
      :ARG4-of (f2 / flank-01 
            :ARG0 (s2 / site 
                  :ARG1-of (t / target-01 
                        :ARG2 (d / develop-02 
                              :ARG1 (a / approach-02 
                                    :ARG0-of (i2 / improve-01 
                                          :ARG1 (e2 / efficient-01 
                                                :ARG0-of (u / use-01 
                                                      :ARG1 (p / process-02 
                                                            :mod (t2 / two-step))) 
                                                :ARG1 (e / e.g.) 
                                                :ARG1-of (t3 / target-01))) 
                                    :mod (t4 / thing 
                                          :mod (o / organization 
                                                :name (n2 / name 
                                                      :op1 "Recombinase-Mediated")) 
                                          :name (n / name 
                                                :op1 (c3 / Cassette) 
                                                :op2 (e3 / Exchange))))))) 
            :ARG1 (c2 / cassette 
                  :ARG1-of (s3 / select-01) 
                  :ARG1-of (r / replace-01))))

# ::snt Then , Cre-mediated recombination in the presence of a cassette containing a floxed mutant allele removes the resident sequence and inserts the mutant gene ( 7 ) .
# ::tok Then , Cre-mediated recombination in the presence of a cassette containing a floxed mutant allele removes the resident sequence and inserts the mutant gene ( 7 ) .
# ::alignments 25-26|0.2 23-24|0.1.0.2.0.1 22-23|0.1.0.2.0.1.0 20-21|0.1.0.2.0 19-20|0.1.0.2 18-19|0.1.0.0 17-18|0.1.0.1.0+0.1.0.1 15-16|0.1.0 14-15|0.1 13-14|0.1.1 12-13|0.1.2 10-11|0 9-10|0.0 6-7|0.0.0 3-4|0.1.0.2.0.0 2-3|0.1.0.2.0.0.0 0-1|0.1.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:12.294
(c / contain-01 
      :ARG0 (c2 / cassette 
            :poss-of (p2 / presence)) 
      :ARG1 (a2 / allele 
            :ARG0-of (r2 / remove-01 
                  :ARG1 (s / sequence) 
                  :ARG2 (p / person 
                        :ARG1-of (r / reside-01)) 
                  :op1-of (a / and 
                        :op2 (i / insert-01 
                              :ARG0 (r3 / recombination 
                                    :mod (c3 / cre-mediat)) 
                              :ARG1 (g / gene 
                                    :mod (m / mutant))) 
                        :time (t / then))) 
            :mod (m2 / mutant) 
            :mod (f / flox)) 
      :ARG2 7)

# ::snt Previously , technical difficulties have prevented RMCE from being applied routinely to generate mutant mice .
# ::tok Previously , technical difficulties have prevented RMCE from being applied routinely to generate mutant mice .
# ::alignments 14-15|0.0.1.0.0 13-14|0.0.1.0.0.0 12-13|0.0.1.0 10-11|0.0.1.1 9-10|0.0.1 6-7|0.0.0.0.0+0.0.0.0+0.0.0 5-6|0.0 3-4|0 2-3|0.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:12.816
(d / difficulty 
      :ARG0-of (p / prevent-01 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "RMCE")) 
            :ARG2 (a / apply-01 
                  :ARG1 (g / generate-01 
                        :ARG1 (m / mouse 
                              :mod (m2 / mutant))) 
                  :manner (r / routine)) 
            :frequency (p2 / previous)) 
      :mod (t / technical))

# ::snt For example , exchanges using cassettes with directly repeated loxP sites were inefficient because excisions dominated the intended exchanges ( 8 ) .
# ::tok For example , exchanges using cassettes with directly repeated loxP sites were inefficient because excisions dominated the intended exchanges ( 8 ) .
# ::alignments 20-21|0.1 18-19|0.0 17-18|0 15-16|0.0.0 14-15|0.0.0.0 13-14|0.0.0.1 12-13|0.0.0.1.0.1+0.0.0.1.0 10-11|0.0.0.1.0.0.0.0.0.0.1 9-10|0.0.0.1.0.0.0.0.0.0.1.0 8-9|0.0.0.1.0.0.0.0.0.0 7-8|0.0.0.1.0.0.0.0.0 5-6|0.0.0.1.0.0.0.0 4-5|0.0.0.1.0.0.0 3-4|0.0.0.1.0.0 1-2|0.0.0.1.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:13.199
(i / intend-01 
      :ARG0 (e / exchange-01 
            :ARG1-of (d / dominate-01 
                  :ARG0 (e2 / excision) 
                  :ARG0-of (c / cause-01 
                        :ARG1 (e3 / efficient-01 
                              :ARG1 (e4 / exchange-01 
                                    :ARG0-of (u / use-01 
                                          :ARG1 (c2 / cassett 
                                                :ARG1-of (d2 / direct-02 
                                                      :manner-of (r / repeat-01 
                                                            :ARG0 (e5 / example) 
                                                            :ARG1 (s / site 
                                                                  :location-of (l / loxP))))))) 
                              :polarity -)))) 
      :ARG1 8)

# ::snt loxP sites with different sequences were generated to overcome this problem , but these sites also underwent intramolecular recombination , making RMCE efficient only if the replacement cassette contained a marker enabling selection of the desired recombinant ( 7,9 -- 12 ) .
# ::tok loxP sites with different sequences were generated to overcome this problem , but these sites also underwent intramolecular recombination , making RMCE efficient only if the replacement cassette contained a marker enabling selection of the desired recombinant ( 7,9 -- 12 ) .
# ::alignments 40-41|0.1.0.0.0.0.0 36-37|0.1.0.0.1.1.1 35-36|0.1.0.0.1.1.1.0 32-33|0.1.0.0.1.1.0 31-32|0.1.0.0.1.1 30-31|0.1.0.0.1 28-29|0.1.0.0 27-28|0.1.0.0.1.1.0.0 26-27|0.1.0.0.1.1.0.0.0 23-24|0.1.0.0.1.1.1.0.0 22-23|0.1.0.0.0.0 21-22|0.1.0.0.0.1.0+0.1.0.0.0.1+0.1.0.0.0 18-19|0.1.1 17-18|0.1.1.1 16-17|0.1 15-16|0.1.1.0 14-15|0.1.0 13-14|0.1.0.0.1.0 12-13|0 10-11|0.0.0.1 9-10|0.0.0.1.0 8-9|0.0.0 6-7|0.0 4-5|0.1.0.0.1.1.0.0.0.0.0 3-4|0.1.0.0.1.1.0.0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:15.249
(c3 / contrast-01 
      :ARG1 (g / generate-01 
            :ARG1 (o3 / overcome-01 
                  :ARG0 (s4 / site 
                        :location-of (l / loxP)) 
                  :ARG1 (p / problem 
                        :mod (t2 / this)))) 
      :ARG2 (u / undergo-28 
            :ARG0 (s2 / site 
                  :ARG2-of (c / contain-01 
                        :ARG0 (o2 / organization 
                              :ARG0-of (e2 / efficient-01 
                                    :ARG1 12) 
                              :name (n / name 
                                    :op1 "RMCE")) 
                        :ARG1 (m / mark-01 
                              :ARG0 (t / this) 
                              :ARG0-of (e / enable-01 
                                    :ARG1 (s / select-01 
                                          :ARG1 (c2 / cassette 
                                                :ARG1-of (r2 / replace-01 
                                                      :ARG2-of (d2 / differ-02 
                                                            :ARG1 (s3 / sequence))))) 
                                    :ARG2 (r / recombinant 
                                          :ARG1-of (d / desire-01 
                                                :ARG0 (o / only))))))) 
            :ARG1 (r3 / recombination 
                  :mod (a / also) 
                  :mod (i / intramolecular))))

# ::snt However , interference resulting from expression of the selection marker and the endogenous gene ( 13 ) necessitates strategies to remove the selectable gene .
# ::tok However , interference resulting from expression of the selection marker and the endogenous gene ( 13 ) necessitates strategies to remove the selectable gene .
# ::alignments 23-24|0.1.0.0.0.1 20-21|0.1.0.0.0 18-19|0.1.0.0.0.0 17-18|0.1.0.0 15-16|0.1.0.1 13-14|0.2 12-13|0.2.0 10-11|0 9-10|0.1 8-9|0.1.1 5-6|0.0 3-4|0.1.0.2 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:15.637
(a / and 
      :ARG1-of (e2 / express-01) 
      :op1 (m / mark-01 
            :ARG1 (i / interfere-01 
                  :ARG0-of (n / necessitate-01 
                        :ARG1 (r / remove-01 
                              :ARG0 (s / strategy) 
                              :ARG1 (g / gene))) 
                  :ARG1 13 
                  :ARG2-of (r2 / result-01)) 
            :ARG1-of (s2 / select-01)) 
      :op2 (g2 / gene 
            :mod (e / endogenou)))

# ::snt Together , previous studies indicate that an optimal RMCE requires ( i ) inverted heterologous loxP sites diverging by at least 2 nt to maximize the efficiency of exchange and ( ii ) an expression cassette enabling both positive selection to identify the initial recombinant and then negative selection to obtain a ` marker-free ' mutant allele ( 14 ) .
# ::tok Together , previous studies indicate that an optimal RMCE requires ( i ) inverted heterologous loxP sites diverging by at least 2 nt to maximize the efficiency of exchange and ( ii ) an expression cassette enabling both positive selection to identify the initial recombinant and then negative selection to obtain a ` marker-free ' mutant allele ( 14 ) .
# ::alignments 58-59|0.1.1.1.1.1.1.1.1.0 56-57|0.1.1.1.1.1.1.1.2.0.1.1.0.0.0.0 55-56|0.1.1.1.1.1.1.1.2.0.1.1.0.0.0.0.0 50-51|0.1.1.1.1.1.1.1.2.0.1.1.0.0.0 48-49|0.1.1.1.1.1.1.1.2.0.1.1.0.0 47-48|0.1.1.1.1.1.1.1.2.0.1.1.0.0.1 46-47|0.1.1.1.1.1.1.1.2.0.1.1.0.0.2 45-46|0.1.1.1.1.1.1.1.2.0.1.1.0 44-45|0.1.1.1.1.0 43-44|0.1.1.1.1.1.1.0 41-42|0.1.1.1.1.1.1.1.2.0 39-40|0.1.1.1.1.1.1.1.2.0.1 38-39|0.1.1.1.1.1.1.1.2.0.1.3 37-38|0.1.1.1.1.1.1.1.2.0.1.2 36-37|0.1.1.1.1.1.1.1.2.0.1.1 35-36|0.1.1.1.1.1.1.1.2 34-35|0.1.1.1.1.1.1.1.1 31-32|0.1.1.1.1.1.0 29-30|0.1.1.1.1.1.1.1 28-29|0.1.1.1.1.1.1 26-27|0.1.1.1.1.1 24-25|0.1.1.1.1 22-23|0.1.1.1.0 21-22|0.1.1.1.0.0 17-18|0.1.1.1 16-17|0.1.1 15-16|0.1.1.2 14-15|0.1.1.1.1.1.1.1.2.0.1.0 13-14|0.1.1.0 11-12|0.1.1.1.1.1.1.1.2.0.0 9-10|0.1 8-9|0.1.0 7-8|0.1.0.0 4-5|0 3-4|0.0 2-3|0.0.0 0-1|0.1.1.1.1.1.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:17.886
(i6 / indicate-01 
      :ARG0 (s4 / study-01 
            :time (p2 / previous)) 
      :ARG1 (r2 / require-01 
            :ARG0 (r3 / RMCE 
                  :mod (o2 / optimal)) 
            :ARG1 (s3 / site 
                  :ARG1-of (i4 / invert-01) 
                  :ARG1-of (d / diverge-01 
                        :ARG0 (n2 / nt 
                              :quant 2) 
                        :purpose (m2 / maximize-01 
                              :ARG0 (r / recombinant) 
                              :ARG1 (e4 / efficient-01 
                                    :ARG0 (i3 / ii) 
                                    :ARG1 (e3 / exchange-01 
                                          :ARG1 (i / initial) 
                                          :op1-of (a3 / and 
                                                :mod (t2 / together) 
                                                :op2 (e2 / express-01 
                                                      :ARG0 14) 
                                                :op3 (c / cassette 
                                                      :ARG1-of (i2 / identify-01 
                                                            :ARG0 (i5 / i) 
                                                            :ARG1-of (s2 / select-01 
                                                                  :ARG0 (h / heterologou) 
                                                                  :ARG1-of (e / enable-01 
                                                                        :ARG0 (a2 / and 
                                                                              :op1 (s / select-01 
                                                                                    :ARG1 (o / obtain-01 
                                                                                          :ARG1 (a / allele 
                                                                                                :mod (m / mutant))) 
                                                                                    :mod (n / negative) 
                                                                                    :time (t / then)))) 
                                                                  :mod (b / both) 
                                                                  :mod (p / positive))))))))) 
                  :location-of (l / loxP))))

# ::snt Most RMCE experiments have been performed at random sites in somatic cell lines .
# ::tok Most RMCE experiments have been performed at random sites in somatic cell lines .
# ::alignments 12-13|0.1.0.0 11-12|0.1.0.0.0 10-11|0.0 8-9|0.1.0 7-8|0.1.0.1 5-6|0.1 2-3|0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:17.981
(e / experiment-01 
      :ARG1 (s / somatic) 
      :ARG1-of (p / perform-02 
            :ARG2 (s2 / site 
                  :location (l / line 
                        :mod (c / cell)) 
                  :mod (r / random))) 
      :mod (m / most))

# ::snt Only a few mutant mice generated by RMCE in ES cells have been reported , but the RMCE systematically introduced a selectable marker ( 15 -- 17 ) , or , when tested without an incoming marker , proved inefficient ( 12 ) .
# ::tok Only a few mutant mice generated by RMCE in ES cells have been reported , but the RMCE systematically introduced a selectable marker ( 15 -- 17 ) , or , when tested without an incoming marker , proved inefficient ( 12 ) .
# ::alignments 41-42|0.3.0.1.0.0 39-40|0.3.0.1.0.2+0.3.0.1.0 38-39|0.3.0.1.0.1 36-37|0.2.0 35-36|0.2.0.1 32-33|0.2 29-30|0.3.0.1 26-27|0.3.0.0 24-25|0.2.0.0 22-23|0.3.0 19-20|0.3 18-19|0.3.1 15-16|0 13-14|0.1 10-11|0.0 9-10|0.0.0 7-8|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 5-6|0.1.0.0 4-5|0.1.0 3-4|0.1.0.2 2-3|0.1.0.3 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:19.976
(c / contrast-01 
      :ARG0 (c2 / cell 
            :mod (e2 / e)) 
      :ARG1 (r / report-01 
            :ARG1 (m3 / mouse 
                  :ARG1-of (g / generate-01 
                        :ARG0 (o2 / organization 
                              :name (n / name 
                                    :op1 "RMCE"))) 
                  :mod (o3 / only) 
                  :mod (m4 / mutant) 
                  :op1-of (f / few))) 
      :ARG1-of (t / test-01 
            :manner (m / mark-01 
                  :ARG0 15 
                  :mod (i / incoming))) 
      :ARG2 (i2 / introduce-02 
            :ARG1 (m2 / mark-01 
                  :ARG1 17 
                  :op1-of (o / or 
                        :op2 (e / efficient-01 
                              :ARG1 12 
                              :ARG1-of (p / prove-01) 
                              :polarity -))) 
            :manner (s / systematical)))

# ::snt A recent report disclosed an additional problem : the Hygromycin -- Thymidine Kinase fusion gene used most frequently for positive/negative selection in RMCE , leads to mouse sterility , so that exchanges can only be performed in ES cells ( 16 ) .
# ::tok A recent report disclosed an additional problem : the Hygromycin -- Thymidine Kinase fusion gene used most frequently for positive/negative selection in RMCE , leads to mouse sterility , so that exchanges can only be performed in ES cells ( 16 ) .
# ::alignments 40-41|0.0.1.1.0 38-39|0.1.0.0 37-38|0.1.0.0.0 35-36|0.1.0 33-34|0.1.0.2 32-33|0.1 31-32|0.1.0.1 29-30|0 27-28|0.0.0.0 26-27|0.0.0 24-25|0.0 22-23|0.0.1.2.0.0.0+0.0.1.2.0.0+0.0.1.2.0 20-21|0.0.1.2 17-18|0.0.1.1 16-17|0.0.1.1.1 15-16|0.0.1 14-15|0.0.1.0 13-14|0.0.1.0.0 11-13|0.0.1.0.1.0.1+0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 6-7|0.0.1.3 5-6|0.0.1.3.1 3-4|0.0.1.3.0 2-3|0.0.1.3.0.0 1-2|0.0.1.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:21.441
(c2 / cause-01 
      :ARG1 (l / lead-03 
            :ARG1 (m / mouse 
                  :mod-of (s / sterility)) 
            :ARG1-of (u / use-01 
                  :ARG0 (g / gene 
                        :mod (f2 / fusion) 
                        :mod (t / thing 
                              :name (n2 / name 
                                    :op1 (t2 / Thymidine) 
                                    :op2 (k / Kinase)))) 
                  :ARG1-of (f / frequent-02 
                        :ARG0 16 
                        :degree (m2 / most)) 
                  :ARG2 (s2 / select-01 
                        :location (o2 / organization 
                              :name (n / name 
                                    :op1 "RMCE"))) 
                  :purpose-of (p3 / problem 
                        :ARG1-of (d / disclose-01 
                              :ARG0 (r / report 
                                    :time (r2 / recent))) 
                        :mod (a / additional)))) 
      :ARG2 (p2 / possible-01 
            :ARG1 (p / perform-02 
                  :ARG0 (c / cell 
                        :mod (e / e)) 
                  :ARG1 (e2 / exchange-01) 
                  :mod (o / only))))

# ::snt The RMCE strategy presented here relies on the integrated use of inverted heterologous loxP sites , a positive/negative selection marker that preserves the germline capacity of ES cells , and the power of mouse genetics to expedite phenotypic analyses .
# ::tok The RMCE strategy presented here relies on the integrated use of inverted heterologous loxP sites , a positive/negative selection marker that preserves the germline capacity of ES cells , and the power of mouse genetics to expedite phenotypic analyses .
# ::alignments 38-39|0.0.1.1 37-38|0.0.1.1.0 36-37|0.0.1 34-35|0.0.1.0 33-34|0.0.1.0.0 31-32|0.1.0.2.1 29-30|0.1.0.2 27-28|0.1.0.2.0.1.0 26-27|0.1.0.2.0.1.0.0 24-25|0.1.0.2.0.1 21-22|0.1.0.2.0 19-20|0.1.0.2.0.0 18-19|0.1.0.2.0.0.0 14-15|0.1.0 13-14|0.1.0.1 12-13|0.0.0.0 11-12|0.1.0.0 9-10|0.1 8-9|0.1.1 5-6|0 4-5|0.0.0.1 3-4|0.0.0 2-3|0.0 1-2|0.0.2.0.0+0.0.2.0+0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:22.225
(r / rely-01 
      :ARG0 (s3 / strategy 
            :ARG1-of (p4 / present-01 
                  :ARG0 (h / heterologou) 
                  :location (h2 / here)) 
            :domain (e / expedite-01 
                  :ARG0 (g / genetic 
                        :mod (m / mouse)) 
                  :ARG1 (a / analysis 
                        :mod (p / phenotypic))) 
            :mod (o / organization 
                  :name (n / name 
                        :op1 "RMCE"))) 
      :ARG1 (u / use-01 
            :ARG1 (s2 / site 
                  :ARG1-of (i / invert-01) 
                  :location-of (l / loxP) 
                  :op1-of (a2 / and 
                        :op2 (p3 / preserve-01 
                              :ARG0 (m2 / mark-01 
                                    :ARG1-of (s / select-01)) 
                              :ARG1 (c2 / capacity 
                                    :poss (c / cell 
                                          :mod (e2 / e)))) 
                        :op3 (p2 / power))) 
            :ARG1-of (i2 / integrate-01)))

# ::snt We show that our approach enables efficient targeting of marker-free mutations at the p53 locus in ES cells to generate mutant mice , but more importantly , it is Adapted for targeting in Somatic cells to Accelerate Phenotyping ( ASAP ) .
# ::tok We show that our approach enables efficient targeting of marker-free mutations at the p53 locus in ES cells to generate mutant mice , but more importantly , it is Adapted for targeting in Somatic cells to Accelerate Phenotyping ( ASAP ) .
# ::alignments 39-40|0.0 36-38|0.1.1.1.0.1+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 34-35|0.1.1.0 33-34|0.1.1.0.0 31-32|0.1.1 29-30|0.1 25-26|0.1.0.0.0.0.0.0 24-25|0.1.0.0.0.0.0.0.0 23-24|0 21-22|0.1.0.0.0.0.1.0.0.0 20-21|0.1.0.0.0.0.1.0.0.0.0 19-20|0.1.0.0.0.0.1.0.0 17-18|0.1.0.0.0.0.1.0 16-17|0.1.0.0.0.0.1.0.2 14-15|0.1.0.0.0.0.1.0.1 13-14|0.1.0.0.0.0.1.0.1.0 10-11|0.1.0.0.0.0.1 7-8|0.1.0.0.0.0.0 6-7|0.1.0.0.0.0 5-6|0.1.0.0.0 4-5|0.1.0.0 3-4|0.1.0 1-2|0.1.0.0.0.1 0-1|0.1.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:23.677
(c2 / contrast-01 
      :ARG1 (a / asap) 
      :ARG2 (a3 / adapt-01 
            :ARG0 (w / we 
                  :ARG1-of (a4 / approach-02 
                        :ARG0-of (e3 / enable-01 
                              :ARG1 (e2 / efficient-01 
                                    :ARG1 (t3 / target-01 
                                          :ARG1 (i / important 
                                                :degree (m / more))) 
                                    :ARG2 (m4 / mutate-01 
                                          :ARG2 (c3 / cell 
                                                :ARG0-of (g / generate-01 
                                                      :ARG1 (m2 / mouse 
                                                            :mod (m3 / mutant))) 
                                                :location-of (l / locu 
                                                      :mod (p2 / p53)) 
                                                :mod (e / e)))) 
                              :ARG1-of (s2 / show-01 
                                    :ARG0 (w2 / we))))) 
            :ARG1 (t2 / target-01 
                  :ARG1 (c / cell 
                        :mod (s / somatic)) 
                  :ARG2 (t / thing 
                        :name (n / name 
                              :op1 (a2 / Accelerate) 
                              :op2 (p / Phenotyping))))))

# ::snt Because it relies on very general principles , RMCE-ASAP could be applied to any locus of interest .
# ::tok Because it relies on very general principles , RMCE-ASAP could be applied to any locus of interest .
# ::alignments 16-17|0.0.1.0 14-15|0.0.1 13-14|0.0.1.1 11-12|0.0 9-10|0 6-7|0.1.0.0 5-6|0.1.0.0.0 4-5|0.0.0 2-3|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:23.750
(p / possible-01 
      :ARG1 (a2 / apply-01 
            :ARG1 (v / very) 
            :ARG2 (l / locu 
                  :ARG2-of (i / interest-01) 
                  :mod (a / any))) 
      :ARG1-of (c / cause-01 
            :ARG0 (r / rely-01 
                  :ARG1 (p2 / principle 
                        :mod (g / general-02)))))

# ::snt Targeting construct for a p53 RMCE-ready locus .
# ::tok Targeting construct for a p53 RMCE-ready locus .
# ::alignments 6-7|0.0.0 5-6|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 4-5|0.0.0.0 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:23.818
(t2 / target-01 
      :ARG1-of (c / construct-01 
            :ARG2 (l / locu 
                  :mod (p / p53 
                        :mod-of (t / thing 
                              :name (n / name 
                                    :op1 "RMCE-ready"))))))

# ::snt Details for plasmid construction are available upon request owing to space limitations mandating a brief outline .
# ::tok Details for plasmid construction are available upon request owing to space limitations mandating a brief outline .
# ::alignments 15-16|0 14-15|0.1 12-13|0.0 11-12|0.0.0 10-11|0.0.0.0 8-9|0.0.0.1 7-8|0.0.0.1.0 5-6|0.0.0.1.0.0.0.0 3-4|0.0.0.1.0.0 2-3|0.0.0.1.0.0.1 0-1|0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:24.075
(o / outline-01 
      :ARG1-of (m / mandate-01 
            :ARG0 (l / limit-01 
                  :ARG1 (s / space) 
                  :ARG2-of (o2 / owe-01 
                        :ARG1 (r / request-01 
                              :ARG1 (c / construct-01 
                                    :ARG1-of (d / detail-01 
                                          :ARG2-of (a / available-02)) 
                                    :mod (p / plasmid)))))) 
      :duration (b / brief))

# ::snt We started from a plasmid L3-1L containing heterologous loxP sites ( L3 is the mutant loxP257 recently described ( 14 ) , 1L is an inverted WT loxP ) .
# ::tok We started from a plasmid L3-1L containing heterologous loxP sites ( L3 is the mutant loxP257 recently described ( 14 ) , 1L is an inverted WT loxP ) .
# ::alignments 25-26|0 19-20|0.1.2.0 17-18|0.1.2 16-17|0.1.2.2 15-16|0.1.2.1 14-15|0.1.2.1.0 9-10|0.1.1 8-9|0.1.1.0 7-8|0.0 6-7|0.1 5-6|0.1.0.2.0+0.1.0.2+0.1.0 4-5|0.1.0.1 1-2|0.1.0.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:24.328
(i / invert-01 
      :ARG0 (h / heterologou) 
      :ARG2 (c / contain-01 
            :ARG0 (t / thing 
                  :ARG1-of (s2 / start-01 
                        :ARG0 (w / we)) 
                  :mod (p / plasmid) 
                  :name (n / name 
                        :op1 "L3-1L")) 
            :ARG1 (s / site 
                  :location-of (l2 / loxP)) 
            :purpose-of (d / describe-01 
                  :ARG0 14 
                  :ARG1 (l / loxP257 
                        :mod (m / mutant)) 
                  :time (r / recent))))

# ::snt The WT loxP and loxP257 differ in their spacer sequences : the spacer sequence is 5  - ATGTATGC-3  for WT loxP and 5  - AAGTCTCC-3  for loxP257 .
# ::tok The WT loxP and loxP257 differ in their spacer sequences : the spacer sequence is 5  - ATGTATGC-3  for WT loxP and 5  - AAGTCTCC-3  for loxP257 .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:24.330
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The three mutations in the loxP257 spacer sequence prevent it to recombine with WT loxP , ensuring efficient RMCE in several cell lines : accurate RMCE with these loxP sites occurred with an average frequency of 81 % at two loci in CHO cells and an average frequency of 69 % at four loci in Hela cells ( 14 ) .
# ::tok The three mutations in the loxP257 spacer sequence prevent it to recombine with WT loxP , ensuring efficient RMCE in several cell lines : accurate RMCE with these loxP sites occurred with an average frequency of 81 % at two loci in CHO cells and an average frequency of 69 % at four loci in Hela cells ( 14 ) .
# ::alignments 58-59|0.1.0.0.2.0.0 56-57|0.2.1.0.0.0 55-56|0.2.1.0.0.0.0.0.0+0.2.1.0.0.0.0.0+0.2.1.0.0.0.0 53-54|0.2.1.0.0 52-53|0.1.0.0.1 50-51|0.2.1 49-50|0.2.1.1 47-48|0.2 46-47|0.2.0 44-45|0 43-44|0.1 40-41|0.1.0 39-40|0.1.0.1 37-38|0.1.0.0.2.1 36-37|0.1.0.0.2.1.0 34-35|0.1.0.0.2 33-34|0.1.0.0.2.0 30-31|0.1.0.0 29-30|0.2.1.0 27-28|0.0.0.0.0.1.0.0 24-26|0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 22-23|0.0.0.0.1 21-22|0.0.0.0.1.0 20-21|0.0.0.0.1.1 18-19|0.0.0.1.0+0.0.0.1+0.0.0 17-18|0.0 16-17|0.0.0.0 14-15|0.0.0.0.0.0.0.0 11-12|0.0.0.0.0.0.0 8-9|0.0.0.0.0.0 7-8|0.0.0.0.0.1 6-7|0.0.0.0.0.1.0 2-3|0.0.0.0.0 1-2|0.0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:25.654
(a2 / and 
      :op1 (e / efficient-01 
            :ARG1 (o2 / organization 
                  :ARG1-of (e2 / ensure-01 
                        :ARG0 (m / mutate-01 
                              :ARG0-of (p3 / prevent-01 
                                    :ARG1 (r2 / recombine-01 
                                          :ARG1 (l4 / loxP))) 
                              :ARG1 (s3 / sequence 
                                    :ARG1-of (s4 / space-01 
                                          :ARG0 (t / this))) 
                              :quant 3) 
                        :manner (l3 / line 
                              :mod (c4 / cell) 
                              :quant (s2 / several))) 
                  :name (n3 / name 
                        :op1 "RMCE"))) 
      :op2 (c3 / cell 
            :location-of (l2 / locus 
                  :manner-of (o / occur-01 
                        :ARG0 (t2 / thing 
                              :name (n2 / name 
                                    :op1 (a4 / accurate) 
                                    :op2 (r / RMCE))) 
                        :ARG1 4 
                        :ARG2 (f2 / frequency 
                              :ARG1-of (a3 / average-01 
                                    :ARG0 14) 
                              :poss (p2 / percentage-entity 
                                    :value 81))) 
                  :quant 2)) 
      :op3 (f / frequency 
            :ARG1-of (a / average-01) 
            :poss (p / percentage-entity 
                  :poss (s / site 
                        :poss-of (l / locus 
                              :location (c / cell 
                                    :location (c2 / country 
                                          :name (n / name 
                                                :op1 "Hela"))))) 
                  :value 69)))

# ::snt The L3-1L plasmid was first modified to include a ClaI and a FseI site between the LoxP sites , leading to plasmid L3-CF-1L .
# ::tok The L3-1L plasmid was first modified to include a ClaI and a FseI site between the LoxP sites , leading to plasmid L3-CF-1L .
# ::alignments 22-23|0.0.1.0+0.0.1+0.0 21-22|0 19-20|0.0.0 17-18|0.0.0.0.1.1 16-17|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 13-14|0.0.0.0.0.1 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 7-8|0.0.0.0 5-6|0.0.0.0.2 2-3|0.0.0.0.2.0 1-2|0.0.0.0.2.0.0.0.0+0.0.0.0.2.0.0.0+0.0.0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:26.376
(p / plasmid 
      :mod-of (o / organization 
            :ARG2-of (l / lead-01 
                  :purpose-of (i / include-01 
                        :ARG1 (a / and 
                              :op1 (t2 / thing 
                                    :name (n3 / name 
                                          :op1 "ClaI")) 
                              :op2 (s2 / site)) 
                        :ARG2 (t / thing 
                              :name (n2 / name 
                                    :op1 "LoxP") 
                              :poss-of (s / site)) 
                        :ARG2-of (m / modify-01 
                              :ARG1 (p2 / plasmid 
                                    :mod (t3 / thing 
                                          :name (n4 / name 
                                                :op1 "L3-1L")))))) 
            :name (n / name 
                  :op1 "L3-CF-1L")))

# ::snt We next modified a puroTK plasmid ( YTC37 , a kind gift from A. Bradley ) by using oligonucleotides to destroy a NotI site downstream of the puroTK gene and introduce a NotI site upstream , and a FseI site downstream of the gene ( leading to plasmid CN-PuroTK-F ) .
# ::tok We next modified a puroTK plasmid ( YTC37 , a kind gift from A. Bradley ) by using oligonucleotides to destroy a NotI site downstream of the puroTK gene and introduce a NotI site upstream , and a FseI site downstream of the gene ( leading to plasmid CN-PuroTK-F ) .
# ::alignments 47-48|0.0.1.0.0 45-46|0.1.0 43-44|0.3.0 40-41|0.3 39-40|0.0.1.0.2.2 36-37|0 34-35|0.2 33-34|0.1.0.0 30-31|0.0 29-30|0.0.1 28-29|0.0.1.0.1 24-25|0.0.0 23-24|0.0.0.0.0 22-23|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 20-21|0.0.1.0 18-19|0.0.1.0.2.1 17-18|0.0.1.0.2 14-15|0.1.3+0.1.2.0+0.1.2+0.1 11-12|0.1.1+0.1.1.0 10-11|0.1.1.0.0 5-6|0.0.1.0.2.0.0.0 4-5|0.0.1.0.2.0.0.0.0 2-3|0.0.1.0.2.0.0 1-2|0.0.1.0.2.0.0.1 0-1|0.0.1.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:28.912
(a / and 
      :ARG1-of (i / introduce-02 
            :ARG0 (d2 / downstream 
                  :mod (c / country 
                        :mod-of (s3 / site) 
                        :name (n / name 
                              :op1 "NotI"))) 
            :op2-of (a2 / and 
                  :op1 (d3 / destroy-01 
                        :ARG0 (p / plasmid) 
                        :ARG1 (g2 / gene) 
                        :ARG2-of (u2 / use-01 
                              :ARG0 (w / we 
                                    :ARG0-of (m / modify-01 
                                          :ARG1 (p3 / plasmid 
                                                :mod (p4 / puroTK)) 
                                          :manner (n3 / next))) 
                              :ARG1 (o / oligonucleotid) 
                              :op1-of (s / site))))) 
      :op1 (p2 / person 
            :ARG0-of (l / lead-01 
                  :ARG1 (s2 / site)) 
            :ARG0-of (g3 / gift-01 
                  :ARG1 (t / thing 
                        :mod (k / kind))) 
            :name (n2 / name 
                  :op1 "Bradley") 
            :wiki -) 
      :op2 (u / upstream) 
      :op3 (d / downstream 
            :poss (g / gene)))

# ::snt Next , a PmlI-MfeI 6.3 kb fragment from Trp53 was subcloned in a modified pBluescript KSII + ( pBS , Stratagene ) , and the resulting plasmid was digested with SwaI to introduce an EagI site , leading to p53PmlEag , a plasmid containing exons 2 -- 11 of p53 .
# ::tok Next , a PmlI-MfeI 6.3 kb fragment from Trp53 was subcloned in a modified pBluescript KSII + ( pBS , Stratagene ) , and the resulting plasmid was digested with SwaI to introduce an EagI site , leading to p53PmlEag , a plasmid containing exons 2 -- 11 of p53 .
# ::alignments 49-50|0.1 47-48|0.0.0.1.1.1.0.1.0 45-46|0.0.0.1.0.2 43-44|0 42-43|0.0 37-38|0.0.0 35-36|0.0.0.1.1.1.0.0 32-33|0.0.0.1.1.1.0 30-31|0.0.0.1.1.2.0.0+0.0.0.1.1.2.0+0.0.0.1.1.2 28-29|0.0.0.1.1 26-27|0.0.0.1.1.1 25-26|0.0.0.1.0 23-24|0.0.0.1 18-19|0.0.0.1.1.0 15-16|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 14-15|0.0.0.1.1.1.0.1.2.0 13-14|0.0.0.1.1.1.0.1.2 8-9|0.0.0.1.1.1.0.1.4.0.0+0.0.0.1.1.1.0.1.4.0+0.0.0.1.1.1.0.1.4 6-7|0.0.0.1.1.1.0.1 5-6|0.0.0.1.1.1.0.1.1 4-5|0.0.0.1.0.1 3-4|0.0.0.1.1.1.0.1.3.0.0+0.0.0.1.1.1.0.1.3.0+0.0.0.1.1.1.0.1.3 0-1|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:31.375
(c / contain-01 
      :ARG0 (p2 / plasmid 
            :ARG0-of (l / lead-01 
                  :ARG1 (o / organization 
                        :name (n2 / name 
                              :op1 "KSII")) 
                  :ARG2 (a / and 
                        :op1 (r / result-01 
                              :ARG0 (n5 / next) 
                              :ARG2 6.3 
                              :op1-of 2) 
                        :op2 (d / digest-01 
                              :ARG0 (p4 / pb) 
                              :ARG1 (p3 / plasmid 
                                    :ARG0-of (i / introduce-02 
                                          :ARG1 (s / site) 
                                          :ARG2 (f / fragment-01 
                                                :ARG0 11 
                                                :ARG1 (k / kb) 
                                                :ARG2 (m / modify-01 
                                                      :ARG1 (p5 / pBluescript)) 
                                                :instrument (t2 / thing 
                                                      :name (n4 / name 
                                                            :op1 "PmlI-MfeI")) 
                                                :source (c2 / country 
                                                      :name (n3 / name 
                                                            :op1 "Trp53"))))) 
                              :ARG2 (t / thing 
                                    :name (n / name 
                                          :op1 "SwaI")))))) 
      :ARG1 (p / p53))

# ::snt We then inserted a 5.5 kb ClaI-EagI fragment from p53PmlEag in plasmid CN-PuroTK-F digested by ClaI and NotI , and inserted the resulting fragment between the loxP sites of L3-CF-1L by ClaI and FseI digestion , leading to L3-p53PmlEagPuroTK-1L .
# ::tok We then inserted a 5.5 kb ClaI-EagI fragment from p53PmlEag in plasmid CN-PuroTK-F digested by ClaI and NotI , and inserted the resulting fragment between the loxP sites of L3-CF-1L by ClaI and FseI digestion , leading to L3-p53PmlEagPuroTK-1L .
# ::alignments 38-39|0.0.0.1.1.0.1.0.0+0.0.0.1.1.0.1.0+0.0.0.1.1.0.1 36-37|0.0.0.1.1.0 34-35|0.0.0.1.2.0.0 32-33|0 29-30|0.0.0.1.0.0.0.0.0.0+0.0.0.1.0.0.0.0.0+0.0.0.1.0.0.0.0 27-28|0.0.0.0 26-27|0.0.0.0.0 23-24|0.0.0 22-23|0.0 20-21|0.0.0.1 19-20|0.0.0.1.1 17-18|0.0.0.1.2.2.0.0+0.0.0.1.2.2.0+0.0.0.1.2.2 16-17|0.0.0.1.2 15-16|0.0.0.1.2.1.0.0+0.0.0.1.2.1.0+0.0.0.1.2.1 13-14|0.0.0.1.2.0 11-12|0.0.0.1.1.0.0 7-8|0.0.0.1.0.0.0 6-7|0.0.0.1.0.0.0.1.0.0+0.0.0.1.0.0.0.1.0+0.0.0.1.0.0.0.1 5-6|0.0.0.1.0.0.0.2 4-5|0.0.0.1.0.0.0.2.0 2-3|0.0.0.1.0.0 1-2|0.0.0.1.0.0.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:32.069
(a / and 
      :ARG2-of (r / result-01 
            :ARG1 (f / fragment-01 
                  :ARG1 (s / site 
                        :location-of (l2 / loxP)) 
                  :ARG1-of (i / insert-01 
                        :ARG0 (w / we 
                              :ARG0-of (i2 / insert-01 
                                    :ARG1 (f2 / fragment-01 
                                          :ARG0 (o / organization 
                                                :name (n2 / name 
                                                      :op1 "L3-CF-1L")) 
                                          :ARG1 (t4 / thing 
                                                :name (n5 / name 
                                                      :op1 "ClaI-EagI")) 
                                          :mod (k / kb 
                                                :quant 5.5)) 
                                    :time (t5 / then))) 
                        :op1-of (a2 / and 
                              :ARG0-of (l / lead-01 
                                    :ARG1 (p / plasmid) 
                                    :ARG2 (t / thing 
                                          :name (n / name 
                                                :op1 "L3-p53PmlEagPuroTK-1L")))) 
                        :op3-of (a3 / and 
                              :ARG0-of (d2 / digest-01 
                                    :ARG1 (d / digestion)) 
                              :op1 (t3 / thing 
                                    :name (n4 / name 
                                          :op1 "ClaI")) 
                              :op2 (t2 / thing 
                                    :name (n3 / name 
                                          :op1 "NotI")))))))

# ::snt We next engineered a plasmid containing the region for 3  - homology downstream of the p53 gene and the DTA gene in two steps : ( i ) we performed a three-way ligation between a modified pBS digested by HindIII and NotI , a HindIII-EcoRI fragment from Trp53 for 3  homology and an EcoRI-NotI fragment containing the DTA gene , from plasmid pgkdtabpa ( kind gift of P. Soriano ) , leading to plasmid 3  + DTA and ( ii ) because the Bsu36I-EcoRI region downstream of p53 contains repetitive sequences ( F. Toledo and G. M. Wahl , unpublished data ) , we later deleted this region , to obtain plasmid 3  + DTA .
# ::tok We next engineered a plasmid containing the region for 3  - homology downstream of the p53 gene and the DTA gene in two steps : ( i ) we performed a three-way ligation between a modified pBS digested by HindIII and NotI , a HindIII-EcoRI fragment from Trp53 for 3  homology and an EcoRI-NotI fragment containing the DTA gene , from plasmid pgkdtabpa ( kind gift of P. Soriano ) , leading to plasmid 3  + DTA and ( ii ) because the Bsu36I-EcoRI region downstream of p53 contains repetitive sequences ( F. Toledo and G. M. Wahl , unpublished data ) , we later deleted this region , to obtain plasmid 3  + DTA .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:32.071
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The 5  homology consists of a 3.4 kb-long BamHI-PmlI fragment from intron 1 of p53 cloned in a modified pBS ( plasmid p5  ) .
# ::tok The 5  homology consists of a 3.4 kb-long BamHI-PmlI fragment from intron 1 of p53 cloned in a modified pBS ( plasmid p5  ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:32.075
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Finally , appropriate fragments from plasmids p5  , L3-p53PmlEagPuroTK-1L , and 3  + DTA were assembled in a modified pSP72 plasmid ( Promega ) .
# ::tok Finally , appropriate fragments from plasmids p5  , L3-p53PmlEagPuroTK-1L , and 3  + DTA were assembled in a modified pSP72 plasmid ( Promega ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:32.078
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Plasmid Flox , the resulting targeting construct , was verified by restriction analysis , then sequenced using 30 primers chosen to precisely verify all p53 coding sequences , all exon -- intron junctions and the sequences at and around the loxP sites .
# ::tok Plasmid Flox , the resulting targeting construct , was verified by restriction analysis , then sequenced using 30 primers chosen to precisely verify all p53 coding sequences , all exon -- intron junctions and the sequences at and around the loxP sites .
# ::alignments 41-42|0.0.0.0.0.0.0.1.0.0 40-41|0.0.0.0.0.0.0.1.0 38-39|0.0.0.0.0.0.0.2.1 37-38|0.0.0.0.0.0.0.2 35-36|0.0.0.0.0.0.0.1 33-34|0.0.0.0.0.0.0 32-33|0.0.0.0.0.0.0.2.0 31-32|0.0.0.0.0.0.0.2.0.0 29-30|0.0.0.0.0.0.0.0 28-29|0.0.0.0.0.0.0.0.0 26-27|0.0.0.0.0.0.1 25-26|0.0.0.0.0.0 24-25|0.0.0.0.0 23-24|0.0.0.0.0.1 22-23|0.0.0.0 21-22|0.0.0.0.2 19-20|0.0.0.0.1 18-19|0.0.0.0.1.0 17-18|0.0.0.0.1.0.1 16-17|0.0.0.0.1.0.0 14-15|0.0.1 12-13|0.0.0.1.0 11-12|0.0.0.1.0.0 9-10|0.0.0.1 6-7|0.0 5-6|0.0.2 4-5|0 0-2|0.0.0.2.1+0.0.0.2.0+0.0.0.2+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:34.139
(r2 / result-01 
      :ARG1 (c3 / construct-01 
            :ARG0 (p4 / person 
                  :ARG0-of (v / verify-01 
                        :ARG1 (p / p53 
                              :ARG0-of (c / code-01 
                                    :ARG1 (a3 / and 
                                          :op1 (e / exon 
                                                :quant (a4 / all)) 
                                          :op2 (s2 / sequence 
                                                :time (l / loxP 
                                                      :location (s / site))) 
                                          :op3 (a2 / and 
                                                :mod (j / junction 
                                                      :mod (i / intron)) 
                                                :op1 (a / around))) 
                                    :ARG2 (s3 / sequence)) 
                              :quant (a5 / all)) 
                        :ARG1-of (c2 / choose-01 
                              :ARG0 (p3 / primer 
                                    :ARG1-of (u / use-01) 
                                    :quant 30)) 
                        :manner (p2 / precise)) 
                  :ARG1-of (v2 / verify-01 
                        :ARG0 (a6 / analyze-01 
                              :ARG1 (r / restrict-01))) 
                  :name (n / name 
                        :op1 "Plasmid" 
                        :op2 "Flox")) 
            :ARG1 (t / then) 
            :ARG1-of (t2 / target-01)))

# ::snt Exchange constructs : making the p53GFP and p53PGFP plasmids .
# ::tok Exchange constructs : making the p53GFP and p53PGFP plasmids .
# ::alignments 8-9|0.0.0.1 6-7|0.0.0 5-6|0.0.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:34.163
(c / construct 
      :ARG1-of (e / exchange-01 
            :ARG0 (a / and 
                  :op1 (p2 / p53GFP) 
                  :op2 (p / plasmid))))

# ::snt To make a p53-GFP fusion protein , we first subcloned a SacII-HindIII fragment of the p53 locus ( corresponding to part of exon 10 to sequences downstream of the gene ) into pBS , then mutated the HindIII site into a FseI site .
# ::tok To make a p53-GFP fusion protein , we first subcloned a SacII-HindIII fragment of the p53 locus ( corresponding to part of exon 10 to sequences downstream of the gene ) into pBS , then mutated the HindIII site into a FseI site .
# ::alignments 42-43|0.1.0.0.3 38-39|0.1.0.0.0 35-36|0.1.0.0 34-35|0.1.0.0.5 32-33|0.1.0.1 29-30|0.2 26-27|0 25-26|0.0 23-24|0.1.3 22-23|0.1.0.0.4 18-19|0.1.0.0.2 16-17|0.1.2 15-16|0.1.2.0 12-13|0.1 11-12|0.1.1.0.0+0.1.1.0+0.1.1 7-8|0.1.0 5-6|0.1.0.0.1 4-5|0.1.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:34.862
(d / downstream 
      :mod (s3 / sequence) 
      :op1 (f / fragment-01 
            :ARG0 (w / we 
                  :ARG0-of (m / mutate-01 
                        :ARG1 (s2 / site) 
                        :ARG2 (p3 / protein 
                              :mod (f2 / fusion)) 
                        :ARG2-of (c / correspond-01) 
                        :location (s / site) 
                        :op1-of (e / exon) 
                        :time (t / then)) 
                  :poss-of (p / pb)) 
            :ARG1 (t2 / thing 
                  :name (n / name 
                        :op1 "SacII-HindIII")) 
            :ARG2 (l / locu 
                  :mod (p2 / p53)) 
            :op1-of 10) 
      :poss (g / gene))

# ::snt We next mutated the C-terminal part of the p53 gene in two rounds of PCR mutagenesis , first with primers 5  - GGGCCTGACTCAGACGGATCCCCTCTGCATCCCGTC-3  and 5  - GACGGGATGCAGAGGGGATCCGTCTGAGTCAGGCCC-3  , which removed the stop codon and introduced a BamHI site , then with primers 5  - GACGGATCCCCTCTGAATTCCGTCCCCATCACCA-3  and 5  - TGGTGATGGGGACGGAATACAGAGGGGATCCGTC-3  , which introduced an EcoRI site .
# ::tok We next mutated the C-terminal part of the p53 gene in two rounds of PCR mutagenesis , first with primers 5  - GGGCCTGACTCAGACGGATCCCCTCTGCATCCCGTC-3  and 5  - GACGGGATGCAGAGGGGATCCGTCTGAGTCAGGCCC-3  , which removed the stop codon and introduced a BamHI site , then with primers 5  - GACGGATCCCCTCTGAATTCCGTCCCCATCACCA-3  and 5  - TGGTGATGGGGACGGAATACAGAGGGGATCCGTC-3  , which introduced an EcoRI site .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:34.865
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt We verified the sequence from the mutated plasmid , then digested it with BamHI and EcoRI , to insert in frame GFP sequences from a Bam HI-EcoRI fragment of plasmid phr-GFP-1 ( Stratagene ) .
# ::tok We verified the sequence from the mutated plasmid , then digested it with BamHI and EcoRI , to insert in frame GFP sequences from a Bam HI-EcoRI fragment of plasmid phr-GFP-1 ( Stratagene ) .
# ::alignments 29-30|0.1.0.1.0.0.1.0.0 27-28|0.1.0.0 25-27|0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 22-23|0.1 21-22|0 20-21|0.0 18-19|0.1.0 14-15|0.1.0.1.1 10-11|0.1.0.1 9-10|0.1.0.1.2 7-8|0.1.0.1.0.0.1 6-7|0.1.0.1.0.0.1.0 3-4|0.1.0.1.0.0.0 1-2|0.1.0.1.0.0 0-1|0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:35.058
(g / GFP 
      :mod (f2 / frame) 
      :mod-of (s / sequence 
            :ARG0-of (i / insert-01 
                  :ARG1 (f / fragment-01 
                        :ARG0 (p2 / person 
                              :name (n / name 
                                    :op1 "Bam" 
                                    :op2 "HI-EcoRI"))) 
                  :purpose-of (d / digest-01 
                        :ARG0 (w / we 
                              :ARG0-of (v / verify-01 
                                    :ARG1 (s2 / sequence) 
                                    :ARG2 (p3 / plasmid 
                                          :ARG1-of (m / mutate-01 
                                                :ARG0 (p / plasmid))))) 
                        :ARG2 (a / and) 
                        :time (t / then)))))

# ::snt We verified the sequence of this p53-GFP fusion fragment , then swapped it in the L3-p53PmlEagPuroTK-1L plasmid ( see above ) by HindIII and FseI digestion , resulting in the p53GFP exchange construct , the sequence which was verified before use .
# ::tok We verified the sequence of this p53-GFP fusion fragment , then swapped it in the L3-p53PmlEagPuroTK-1L plasmid ( see above ) by HindIII and FseI digestion , resulting in the p53GFP exchange construct , the sequence which was verified before use .
# ::alignments 40-41|0.0.1.0.0.0.1.0 39-40|0.0.1.0.0.0.1 38-39|0.0.1.0.0.0 35-36|0.0.1.0.0.0.0 32-33|0.0.0 31-32|0.0.0.1 27-28|0.0 25-26|0.0.0.0 23-24|0 19-20|0.0.0.0.0.1 18-19|0.0.0.0.0 16-17|0.0.0.0.0.0 15-16|0.0.1.0.0.0.1.0.0.0.0+0.0.1.0.0.0.1.0.0.0+0.0.1.0.0.0.1.0.0 11-12|0.0.1 10-11|0.0.1.1 8-9|0.0.1.0.0.1 7-8|0.0.1.0.0.1.0 5-6|0.0.1.0.0.1.1 3-4|0.0.1.0.1 1-2|0.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:35.665
(a / and 
      :ARG1-of (r / result-01 
            :ARG2 (c / construct-01 
                  :ARG0 (d / digestion 
                        :ARG1-of (s2 / see-01 
                              :ARG2 (p / plasmid) 
                              :location (a2 / above))) 
                  :ARG1 (e / exchange-01)) 
            :manner-of (s3 / swap-01 
                  :ARG1 (v2 / verify-01 
                        :ARG0 (w / we 
                              :ARG0-of (v / verify-01 
                                    :ARG1 (s / sequence) 
                                    :time (b / before 
                                          :op1 (u / use-01 
                                                :ARG1 (t / thing 
                                                      :name (n / name 
                                                            :op1 "L3-p53PmlEagPuroTK-1L"))))) 
                              :ARG1-of (f / fragment-01 
                                    :ARG0 (f2 / fusion) 
                                    :mod (t3 / this))) 
                        :ARG1 (s4 / sequence)) 
                  :time (t2 / then))))

# ::snt The p53PGFP exchange construct was engineered by combining sequences from the p53GFP exchange plasmid and sequences from the p53P targeting construct described recently ( 5 ) .
# ::tok The p53PGFP exchange construct was engineered by combining sequences from the p53GFP exchange plasmid and sequences from the p53P targeting construct described recently ( 5 ) .
# ::alignments 24-25|0.0.0.0.0.0 22-23|0.0.0.1 21-22|0.0.0 20-21|0.0 19-20|0 15-16|0.0.0.0.1.0.0.1 14-15|0.0.0.0.1.0.0 13-14|0.0.0.0.1.0.0.0 12-13|0.0.0.0.1.0.0.0.0 8-9|0.0.0.0.1.0.1 7-8|0.0.0.0.1.0 5-6|0.0.0.0.1 3-4|0.0.0.0 2-3|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:35.924
(t / target-01 
      :ARG1 (c / construct-01 
            :ARG1-of (d / describe-01 
                  :ARG0 (c3 / construct-01 
                        :ARG1 (e3 / exchange-01 
                              :ARG1 5) 
                        :ARG1-of (e2 / engineer-01 
                              :ARG2 (c2 / combine-01 
                                    :ARG1 (a / and 
                                          :op1 (p / plasmid 
                                                :ARG1-of (e / exchange-01)) 
                                          :op2 (s / sequence)) 
                                    :ARG2 (s2 / sequence)))) 
                  :time (r / recent))))

# ::snt Its sequence was also verified before use .
# ::tok Its sequence was also verified before use .
# ::alignments 6-7|0.2.0 5-6|0.2 4-5|0 3-4|0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:35.950
(v / verify-01 
      :ARG1 (s / sequence 
            :poss (i / it)) 
      :mod (a / also) 
      :time (b / before 
            :op1 (u / use-01)))

# ::snt Sequences and use of PCR primers .
# ::tok Sequences and use of PCR primers .
# ::alignments 5-6|0.1.0 4-5|0.1.0.0 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:35.970
(a / and 
      :op1 (s / sequence) 
      :op2 (u / use-01 
            :ARG1 (p / primer 
                  :mod (p2 / PCR))))

# ::snt a : 5  - CCCCGGCCCTCACCCTCATCTTCG-3  , from the PuTK gene , assays targeting of Flox plasmid ; b : 5  - AACAAAACAAAACAGCAGCAACAA-3  , from sequences downstream of the p53 gene and outside Flox sequences , assays targeting of Flox and RMCE with p53GFP or p53PGFP plasmids ; c : 5  - TGAAGAGCAAGGGCGTGGTGAAGGA-3  , from GFP sequences , assays RMCE with p53GFP orp53PGFP plasmids ; d : 5  - CAAAAAATGGAAGGAAATCAGGAACTAA-3  , from p53 intron 3 , and e : 5  - TCTAGACAGAGAAAAAAGAGGCATT-3  , from p53 intron 4 , assay RMCE with p53PGFP plasmid ; f : 5  - ATGGGAGGCTGCCAGTCCTAACCC and g : 5  - GTGTTTCATTAGTTCCCCACCTTGAC-3  amplify the WT p53 allele according to Taconic 's procedures , h : 5  - TTTACGGAGCCCTGGCGCTCGATGT-3  and i : 5  - GTGGGAGGGACAAAAGTTCGAGGCC-3  amplify the Neo marker in the p53 KO allele according to Taconic 's procedures .
# ::tok a : 5  - CCCCGGCCCTCACCCTCATCTTCG-3  , from the PuTK gene , assays targeting of Flox plasmid ; b : 5  - AACAAAACAAAACAGCAGCAACAA-3  , from sequences downstream of the p53 gene and outside Flox sequences , assays targeting of Flox and RMCE with p53GFP or p53PGFP plasmids ; c : 5  - TGAAGAGCAAGGGCGTGGTGAAGGA-3  , from GFP sequences , assays RMCE with p53GFP orp53PGFP plasmids ; d : 5  - CAAAAAATGGAAGGAAATCAGGAACTAA-3  , from p53 intron 3 , and e : 5  - TCTAGACAGAGAAAAAAGAGGCATT-3  , from p53 intron 4 , assay RMCE with p53PGFP plasmid ; f : 5  - ATGGGAGGCTGCCAGTCCTAACCC and g : 5  - GTGTTTCATTAGTTCCCCACCTTGAC-3  amplify the WT p53 allele according to Taconic 's procedures , h : 5  - TTTACGGAGCCCTGGCGCTCGATGT-3  and i : 5  - GTGGGAGGGACAAAAGTTCGAGGCC-3  amplify the Neo marker in the p53 KO allele according to Taconic 's procedures .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:35.972
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Primary MEFs , isolated from 13.5 day embryos , were cultured in DMEM with 15 % FBS , 100 mM BME , 2 mM l-glutamine and antibiotics .
# ::tok Primary MEFs , isolated from 13.5 day embryos , were cultured in DMEM with 15 % FBS , 100 mM BME , 2 mM l-glutamine and antibiotics .
# ::alignments 26-27|0.0.1.0.0.2 25-26|0.0.1.0.0 22-23|0.0.0 20-21|0.0.1.0.0.1.1.0+0.0.1.0.0.1.1+0.0.1.0.0.1 19-20|0.0.1.0.0.1.0 18-19|0.0.1.0.0.1.2 16-17|0.0.1.0.0.0 15-16|0.0.1.0.0.0.0 14-15|0.0.1.0.0.0.0.0 10-11|0.0.1.0 7-8|0 6-7|0.1 5-6|0.1.0 3-4|0.0 1-2|0.0.1 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:36.212
(e / embryo 
      :ARG2-of (i / isolate-01 
            :ARG0 2 
            :ARG1 (m2 / mef 
                  :ARG1-of (c / culture-01 
                        :ARG0 (a2 / and 
                              :op1 (f / fb 
                                    :mod (p / percentage-entity 
                                          :value 15)) 
                              :op2 (o / organization 
                                    :mod (m / mm) 
                                    :name (n / name 
                                          :op1 "BME") 
                                    :quant 100) 
                              :op3 (a / antibiotic))) 
                  :mod (p2 / primary))) 
      :mod (d / day 
            :quant 13.5))

# ::snt 129/SvJae ES cells were grown in the same medium supplemented with 1000 U/ml ESGRO ( Chemicon ) , on a layer of mitomycin C-treated SNLPuro-7 / 4 feeders ( kind gift of A. Bradley ) .
# ::tok 129/SvJae ES cells were grown in the same medium supplemented with 1000 U/ml ESGRO ( Chemicon ) , on a layer of mitomycin C-treated SNLPuro-7 / 4 feeders ( kind gift of A. Bradley ) .
# ::alignments 33-34|0.0.0.0.2+0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 30-31|0.0.0.0.0+0.0.0.0.0.0 29-30|0.0.0.0.0.0.0 27-28|0 26-27|0.0 25-26|0.0.0.2.1.0.2 23-24|0.0.0.2.1.1 22-23|0.0.0.2.0.1 20-21|0.0.0.2.0.0 12-14|0.0.0.2.1.0.1.1+0.0.0.2.1.0.1.0+0.0.0.2.1.0.1+0.0.0.2.1.0 11-12|0.0.0.2.1.0.0 9-10|0.0.0.2.1 8-9|0.0.0.2 7-8|0.0.0.2.0 4-5|0.0.0 2-3|0.0.0.1 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:36.750
(f / feeder 
      :quant (4 / 4 
            :op1 (g2 / grow-03 
                  :ARG0 (p / person 
                        :ARG0-of (g / gift-01 
                              :ARG1 (t / thing 
                                    :mod (k / kind))) 
                        :name (n / name 
                              :op1 "Bradley") 
                        :wiki -) 
                  :ARG1 (c2 / cell 
                        :mod (e / e)) 
                  :location (m2 / medium 
                        :ARG1-of (s3 / same-01 
                              :ARG0 (l / layer) 
                              :ARG2 (m / mitomycin)) 
                        :ARG1-of (s2 / supplement-01 
                              :ARG2 (p2 / person 
                                    :mod 1000 
                                    :name (n2 / name 
                                          :op1 "U/ml" 
                                          :op2 "ESGRO") 
                                    :op1-of (s / slash)) 
                              :op1-of (c / c-treat))))))

# ::snt Selections were performed with 2 g/ml puromycin , 0.2 M FIAU or 2 M ganciclovir .
# ::tok Selections were performed with 2 g/ml puromycin , 0.2 M FIAU or 2 M ganciclovir .
# ::alignments 13-15|0.3.0.1+0.3.0.0+0.3.0+0.3 12-13|0.3.1 11-12|0 9-11|0.2.0.1+0.2.0.0+0.2.0+0.2 8-9|0.2.1 6-7|0.1 4-5|0.1.0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:36.969
(o / or 
      :ARG2-of (p2 / perform-02 
            :ARG1 (s / selection)) 
      :op1 (p / puromycin 
            :quant 2) 
      :op2 (t2 / thing 
            :name (n2 / name 
                  :op1 (m2 / M) 
                  :op2 (f / FIAU)) 
            :quant 0.2) 
      :op3 (t / thing 
            :name (n / name 
                  :op1 (m / M) 
                  :op2 (g / ganciclovir)) 
            :quant 2))

# ::snt Targeting/genotyping of the RMCE-ready locus .
# ::tok Targeting/genotyping of the RMCE-ready locus .
# ::alignments 4-5|0.0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:36.983
(t2 / targeting/genotyp 
      :poss (l / locu 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "RMCE-ready"))))

# ::snt 29/SvJae ES cells were electroporated with the Flox construct linearized with PmeI , and puromycin resistant clones were analyzed as described ( Figure 2 ) .
# ::tok 29/SvJae ES cells were electroporated with the Flox construct linearized with PmeI , and puromycin resistant clones were analyzed as described ( Figure 2 ) .
# ::alignments 23-24|0.1.1.0 22-23|0.0.1.0.0 20-21|0.1.2 18-19|0.1 16-17|0.1.1 15-16|0.1.1.1 13-14|0 11-12|0.0.0.0+0.0.0+0.0 9-10|0.0.1 8-9|0.0.1.0 2-3|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:37.241
(a2 / and 
      :op1 (t / thing 
            :name (n / name 
                  :op1 "PmeI") 
            :prep-with-of (l / linearize 
                  :mod (c2 / construct-01 
                        :ARG0 (f / figure)))) 
      :op2 (a / analyze-01 
            :ARG0 (c3 / cell 
                  :mod (e / e)) 
            :ARG1 (c / clone-01 
                  :ARG1 2 
                  :ARG1-of (r / resist-01)) 
            :ARG2 (d / describe-01)))

# ::snt Two clones were injected into blastocysts and transmitted through the germline .
# ::tok Two clones were injected into blastocysts and transmitted through the germline .
# ::alignments 10-11|0.1.1 7-8|0.1 6-7|0 5-6|0.0.0 3-4|0.0 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:37.289
(a / and 
      :op1 (i / inject-01 
            :ARG2 (b / blastocyst)) 
      :op2 (t / transmit-01 
            :ARG1 (c / clone-01 
                  :quant 2) 
            :path (g / germline)))

# ::snt Performing RMCE in ES cells .
# ::tok Performing RMCE in ES cells .
# ::alignments 4-5|0.0.0 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:37.300
(p / perform-01 
      :ARG1 (e / e 
            :mod-of (c / cell)))

# ::snt A total of 8  105 p53RMCE / + ES cells were grown without puromycin for 12 h , electroporated with 15 g CMV-Cre plasmid ( pOG231 ) and 200 g of the exchange construct , and plated in T25 flasks at 105 cells per flask .
# ::tok A total of 8  105 p53RMCE / + ES cells were grown without puromycin for 12 h , electroporated with 15 g CMV-Cre plasmid ( pOG231 ) and 200 g of the exchange construct , and plated in T25 flasks at 105 cells per flask .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:37.301
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt FIAU was added to the medium 3 -- 4 days after electroporation .
# ::tok FIAU was added to the medium 3 -- 4 days after electroporation .
# ::alignments 11-12|0.0 10-11|0.0.0 9-10|0.0.0.0.1+0.0.0.0 8-9|0.0.0.0.0 6-7|0.1.0 5-6|0.1 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:37.361
(a2 / add-01 
      :ARG1 (e / electroporation 
            :op1-of (a / after 
                  :quant (t / temporal-quantity 
                        :quant 4 
                        :unit (d / day)))) 
      :ARG3 (m / medium 
            :mod-of 3))

# ::snt Individual clones , picked 10 days after electroporation , were grown in 96-well plates and expanded to generate duplicate plates for freezing and DNA analysis by PCR and Southern .
# ::tok Individual clones , picked 10 days after electroporation , were grown in 96-well plates and expanded to generate duplicate plates for freezing and DNA analysis by PCR and Southern .
# ::alignments 28-29|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 27-28|0.0.0 24-25|0.2 23-24|0.1 22-23|0 21-22|0.0 19-20|0.2.0.0 18-19|0.2.0.0.0 17-18|0.2.0 15-16|0.2.0.1 14-15|0.2.0.1.1 13-14|0.2.0.1.1.0.0 10-11|0.2.0.1.1.0 7-8|0.2.0.1.0.0.0.0 6-7|0.2.0.1.0.0.0 5-6|0.2.0.1.0.0.0.0.0.1+0.2.0.1.0.0.0.0.0 4-5|0.2.0.1.0.0.0.0.0.0 3-4|0.2.0.1.0.0 1-2|0.2.0.1.0 0-1|0.2.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:38.231
(a3 / and 
      :op1 (f / freeze-02 
            :op1-of (a / and 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 "Southern")))) 
      :op2 (d / DNA) 
      :op3 (a2 / analyze-01 
            :ARG3-of (g / generate-01 
                  :ARG1 (p / plate 
                        :ARG1-of (d2 / duplicate-01)) 
                  :ARG2-of (e / expand-01 
                        :ARG1 (c / clone-01 
                              :ARG1-of (p3 / pick-up-04 
                                    :time (a5 / after 
                                          :op1 (e2 / electroporation 
                                                :location-of (t2 / temporal-quantity 
                                                      :quant 10 
                                                      :unit (d3 / day))))) 
                              :mod (i / individual)) 
                        :op2-of (a4 / and 
                              :op1 (g2 / grow-03 
                                    :ARG1 (p2 / plate)))))))

# ::snt Performing RMCE in MEFs .
# ::tok Performing RMCE in MEFs .
# ::alignments 3-4|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:38.239
(m / mef 
      :ARG1-of (p / perform-01))

# ::snt A total of 106 p53RMCE /  MEFs cells were grown without puromycin for 12 h , electroporated with 3 g pOG231 and 30 g exchange construct , and plated in a single 10 cm-dish , grown for 3 days then split in several dishes at 105 cells per dish .
# ::tok A total of 106 p53RMCE /  MEFs cells were grown without puromycin for 12 h , electroporated with 3 g pOG231 and 30 g exchange construct , and plated in a single 10 cm-dish , grown for 3 days then split in several dishes at 105 cells per dish .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:38.241
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt FIAU or ganciclovir was added to the medium 4 days after electroporation , for 3 -- 4 days .
# ::tok FIAU or ganciclovir was added to the medium 4 days after electroporation , for 3 -- 4 days .
# ::alignments 17-18|0.0.0.0+0.0.0 16-17|0.0 14-15|0.2.0.0.0 11-12|0.3.0 10-11|0.3 9-10|0.2+0.2.0 8-9|0.2.0.1 7-8|0.2.0.0 4-5|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:38.357
(a2 / add-01 
      :ARG0 (4 / 4 
            :quant-of (t / temporal-quantity 
                  :unit (d / day))) 
      :ARG1 (o / or) 
      :ARG2 (d2 / day 
            :unit-of (t2 / temporal-quantity 
                  :op1-of (m / medium 
                        :mod 3) 
                  :quant 4)) 
      :time (a / after 
            :op1 (e / electroporation)))

# ::snt Clones , picked 10 days after electroporation , were grown in 24-well plates and expanded for freezing and DNA analysis .
# ::tok Clones , picked 10 days after electroporation , were grown in 24-well plates and expanded for freezing and DNA analysis .
# ::alignments 19-20|0.3 18-19|0.2 17-18|0 16-17|0.1 14-15|0.0.1 13-14|0.0 12-13|0.0.0.1 9-10|0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.0.0.1+0.0.0.0.0.0 3-4|0.0.0.0.0.0.0 2-3|0.0.0.0.1 0-1|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:38.586
(a2 / and 
      :op1 (a3 / and 
            :op1 (g / grow-03 
                  :ARG1 (a4 / after 
                        :op1 (e2 / electroporation 
                              :location-of (t / temporal-quantity 
                                    :quant 10 
                                    :unit (d2 / day))) 
                        :time-of (p2 / pick-up-04)) 
                  :location (p / plate)) 
            :op2 (e / expand-01 
                  :ARG1 (c / country 
                        :name (n / name 
                              :op1 "Clones")))) 
      :op2 (f / freeze-02) 
      :op3 (d / DNA) 
      :op4 (a / analyze-01))

# ::snt Cells , untreated or treated for 24 h with 0.5 g/ml adriamycin , were lysed on the dish in a buffer consisting of 50 mM Tris ( pH 8.0 ) , 5 mM EDTA , 150 mM NaCl , 0.5 % Nonidet P-40 , 1 mM PMSF , 1 mM sodium vanadate , 10 mM NaF and Complete Mini Protease Inhibitors ( Roche Diagnostics ) at 4 C for 30 min .
# ::tok Cells , untreated or treated for 24 h with 0.5 g/ml adriamycin , were lysed on the dish in a buffer consisting of 50 mM Tris ( pH 8.0 ) , 5 mM EDTA , 150 mM NaCl , 0.5 % Nonidet P-40 , 1 mM PMSF , 1 mM sodium vanadate , 10 mM NaF and Complete Mini Protease Inhibitors ( Roche Diagnostics ) at 4 C for 30 min .
# ::alignments 70-71|0.0.0.0.0.0.0 69-70|0.0.0.0.0.0 67-68|0.0.0.0.1.0.0.1.0.1 66-67|0.0.0.0.1.0.0.1.0.1.0 62-64|0.0.0.0.1.1.1.0.1+0.0.0.0.1.1.1.0.0+0.0.0.0.1.1.1.0+0.0.0.0.1.1.1 60-61|0.0.0.0 58-60|0+0.0.1+0.0+0.0.0 57-58|0.0.0.0.0 56-57|0.0.0.0.1 55-56|0.0.0.0.1.5.0.0+0.0.0.0.1.5.0+0.0.0.0.1.5 53-54|0.0.0.0.1.0.0.1.2 51-52|0.0.0.0.1.4 50-51|0.0.0.0.1.4.0 48-49|0.0.0.0.1.0.0.1.3 46-47|0.0.0.0.1.3.0.0+0.0.0.0.1.3.0+0.0.0.0.1.3 44-45|0.0.0.0.1.0.0.1.1 41-43|0.0.0.0.1.2.0.1+0.0.0.0.1.2.0.0+0.0.0.0.1.2.0+0.0.0.0.1.2 40-41|0.0.0.0.1.2.0.1.0 39-40|0.0.0.0.1.2.0.1.0.0 35-36|0.0.0.0.1.0.0.1.0.0 33-34|0.0.0.0.1.1.0.0+0.0.0.0.1.1.0+0.0.0.0.1.1 31-32|0.0.0.0.1.0.3.3 28-29|0.0.0.0.1.0.3.2.2 27-28|0.0.0.0.1.0.3.2.3 25-26|0.0.0.0.1.0.2.0+0.0.0.0.1.0.2+0.0.0.0.1.0 24-25|0.0.0.0.1.0.1 23-24|0.0.0.0.1.0.4 21-22|0.0.0.0.1.0.0 20-21|0.0.0.0.1.0.0.1 17-18|0.0.0.0.1.0.0.1.0 11-12|0.0.0.0.1.0.3.2.1 9-10|0.0.0.0.1.0.0.0 7-8|0.0.0.0.1.0.3.2.0 6-7|0.0.0.0.1.0.3.2.0.0 4-5|0.0.0.0.1.0.3.2 3-4|0.0.0.0.1.0.3 2-3|0.0.0.0.1.0.3.1 0-1|0.0.0.0.1.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:41.806
(p / Protease 
      :op2-of (n2 / name 
            :name-of (t / thing 
                  :mod-of (i / inhibitor 
                        :ARG1-of (c2 / complete-02 
                              :ARG0 (3 / 30 
                                    :quant-of (m / min))) 
                        :op7-of (a / and 
                              :op1 (p5 / person 
                                    :ARG2-of (c5 / consist-01 
                                          :ARG0 0.5 
                                          :ARG1 (b / buffer-01 
                                                :ARG1-of (d / dish-01 
                                                      :ARG2 150 
                                                      :time (c / C 
                                                            :quant 4)) 
                                                :ARG2 1 
                                                :op1-of 10 
                                                :op1-of 1)) 
                                    :mod (m3 / mm) 
                                    :name (n8 / name 
                                          :op1 "Tris") 
                                    :op4-of (o3 / or 
                                          :op1 (c6 / cell) 
                                          :op2 (u / untreat) 
                                          :op3 (t3 / treat-01 
                                                :ARG1 (h / h 
                                                      :quant 24) 
                                                :ARG2 (a2 / adriamycin) 
                                                :op1-of 8.0 
                                                :op1-of (p4 / ph)) 
                                          :op5 5) 
                                    :quant 50) 
                              :op2 (o2 / organization 
                                    :name (n7 / name 
                                          :op1 "EDTA") 
                                    :part-of (o / organization 
                                          :name (n / name 
                                                :op1 "Roche" 
                                                :op2 "Diagnostics"))) 
                              :op3 (t2 / thing 
                                    :name (n5 / name 
                                          :op1 (n6 / Nonidet) 
                                          :op2 (p2 / P-40 
                                                :ARG2 (p3 / percentage-entity 
                                                      :value 0.5)))) 
                              :op4 (c4 / country 
                                    :name (n4 / name 
                                          :op1 "PMSF")) 
                              :op5 (v / vanadate 
                                    :mod (s / sodium)) 
                              :op6 (c3 / country 
                                    :name (n3 / name 
                                          :op1 "NaF"))))) 
            :op1 (m2 / Mini)))

# ::snt Lysates were scraped , then spun at 6000  g at 4 C for 10 min .
# ::tok Lysates were scraped , then spun at 6000  g at 4 C for 10 min .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:41.808
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Protein concentration in the supernatant was determined using the Bio-Rad DC protein assay .
# ::tok Protein concentration in the supernatant was determined using the Bio-Rad DC protein assay .
# ::alignments 12-13|0.0.0 11-12|0.0.0.0 9-11|0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 7-8|0.0 6-7|0 4-5|0.1 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:41.912
(d / determined-02 
      :ARG1 (u / use-01 
            :ARG1 (a / assay 
                  :mod (p / protein) 
                  :poss (o / organization 
                        :name (n / name 
                              :op1 "Bio-Rad" 
                              :op2 "DC"))) 
            :ARG2 (c / concentrate-02 
                  :ARG1 (p2 / protein))) 
      :manner (s / supernatant))

# ::snt Lysates were separated on single percentage SDS/PAGE gels , then electrophoretically transferred to poly ( vinylidene difluoride ) , using standard procedures.Blots were incubated in 5 % non-fat dried milk in TBST ( 0.02 M Tris , pH 7.6 / 0.35 M NaCl/0 .1 % Tween-20 ) for 1 h at room temperature before probing with primary antibodies against p53 ( CM-5 , Novacastra ) and - actin ( Sigma ) .
# ::tok Lysates were separated on single percentage SDS/PAGE gels , then electrophoretically transferred to poly ( vinylidene difluoride ) , using standard procedures.Blots were incubated in 5 % non-fat dried milk in TBST ( 0.02 M Tris , pH 7.6 / 0.35 M NaCl/0 .1 % Tween-20 ) for 1 h at room temperature before probing with primary antibodies against p53 ( CM-5 , Novacastra ) and - actin ( Sigma ) .
# ::alignments 69-70|0.1.2.1.0.1.3 65-66|0 63-64|0.1.2.0.2.0+0.1.2.0.2+0.1.2.0 59-60|0.1.3.0.0.2 57-58|0.1.3.0.1 56-57|0.1.3.0.1.0 54-55|0.1.3.0 53-54|0.1.3 52-53|0.1.3.0.0 51-52|0.1.3.0.0.0 49-50|0.1.3.0.0.1 48-49|0.1.2.1.0.0 44-45|0.1.1 41-42|0.1.2.0.1.1+0.1.2.0.1.0.0+0.1.2.0.1.0+0.1.2.0.1 39-40|0.2 38-39|0.1.2.2.2 37-38|0.1.2.2.0 35-36|0.1.2.0.0.0 34-35|0.1.2.0.0.2+0.1.2.0.0.1.0+0.1.2.0.0.1+0.1.2.0.0 29-30|0.1.2.1.0.1.2 28-29|0.1.2.1.0.1 26-27|0.1.2.1.0.1.1 25-26|0.0.0.0.0 23-24|0.1 21-22|0.1.2.1 20-21|0.1.2.1.0 19-20|0.1.2 16-17|0.1.2.1.0.1.0 13-14|0.1.2.2.1 11-12|0.1.2.2 9-10|0.1.0 7-8|0.0.0 5-6|0.0.0.1 4-5|0.0.0.0 2-3|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:44.044
(a / and 
      :condition (s5 / separate-01 
            :ARG0 (g / gel 
                  :ARG1-of (s4 / single-02 
                        :ARG2 5) 
                  :mod-of (p9 / percentage)) 
            :ARG1 (l / lysat)) 
      :op1 (i / incubate-01 
            :ARG1 (t4 / then) 
            :ARG2 (p4 / percentage-entity) 
            :ARG2-of (u / use-01 
                  :ARG0 (c / country 
                        :mod-of (v2 / vehicle 
                              :mod-of (t2 / tri) 
                              :name (n3 / name 
                                    :op1 "M1") 
                              :wiki "M1_Abrams") 
                        :mod-of (v / vehicle 
                              :name (n2 / name 
                                    :op1 "M1") 
                              :wiki "M1_Abrams") 
                        :name (n / name 
                              :op1 "Novacastra")) 
                  :ARG1 (p7 / procedures.blot 
                        :ARG1-of (s3 / standard-02 
                              :op1-of 1 
                              :purpose (d / dry-02 
                                    :ARG0 (d2 / difluoride) 
                                    :ARG1 (p6 / percentage-entity) 
                                    :ARG2 (m / milk) 
                                    :op1-of (s / sigma)))) 
                  :purpose-of (t3 / transfer-01 
                        :ARG1 (p5 / ph) 
                        :ARG2 (p8 / poly) 
                        :op1-of 7.6)) 
            :time (b / before 
                  :op1 (p3 / probe-01 
                        :ARG0 (t / temperature 
                              :consist-of (r / room) 
                              :location-of (h / h) 
                              :mod-of (p / p53)) 
                        :ARG1 (a2 / antibodi 
                              :mod (p2 / primary))))) 
      :op2 (s2 / slash))

# ::snt Secondary antibodies used include peroxidase-conjugated goat anti-mouse IgG and anti-rabbit IgG ( Pierce ) .
# ::tok Secondary antibodies used include peroxidase-conjugated goat anti-mouse IgG and anti-rabbit IgG ( Pierce ) .
# ::alignments 12-13|0.0.2.0.0+0.0.2.0+0.0.2 10-11|0.0.1 8-9|0.0 7-8|0.0.0 5-6|0.0.1.0 4-5|0.0.0.0 3-4|0 2-3|0.1.0 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:44.263
(i3 / include-01 
      :ARG1 (a / and 
            :op1 (i2 / igg 
                  :mod (p2 / peroxidase-conjugat)) 
            :op2 (i / igg 
                  :mod (g / goat)) 
            :op3 (p / person 
                  :name (n / name 
                        :op1 "Pierce"))) 
      :ARG2 (a2 / antibodi 
            :ARG1-of (u / use-01) 
            :mod (s / secondary)))

# ::snt Probed blots were incubated with Pierce Supersignal West Pico chemiluminescent substrate and exposed to X-ray films .
# ::tok Probed blots were incubated with Pierce Supersignal West Pico chemiluminescent substrate and exposed to X-ray films .
# ::alignments 15-16|0.0.0.0.0 14-15|0.0.0.0 12-13|0.2 11-12|0 10-11|0.1 9-10|0.2.0 7-9|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 5-7|0.0.1.0.0.0.0.1+0.0.1.0.0.0.0.0+0.0.1.0.0.0.0+0.0.1.0.0.0 3-4|0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:44.610
(a / and 
      :op1 (i / incubate-01 
            :ARG1 (b / blot-01 
                  :ARG1 (x / x-ray-01 
                        :ARG1 (f / film)) 
                  :ARG1-of (p3 / probe-01)) 
            :ARG2 (t / thing 
                  :name (n / name 
                        :op1 (w / West 
                              :mod (t2 / thing 
                                    :name (n2 / name 
                                          :op1 (p2 / Pierce) 
                                          :op2 (s2 / Supersignal)))) 
                        :op2 (p / Pico)))) 
      :op2 (s / substrate) 
      :op3 (e / expose-01 
            :ARG1 (c / chemiluminescent)))

# ::snt Log phase cells were irradiated at RT with a 60 Co -irradiator at doses of 6 or 12 Gy and incubated for 24 h. Cells were then pulse-labeled for 1 h with BrdU ( 10 M ) , fixed in 70 % ethanol , double-stained with FITC anti-BrdU and propidium iodide , then sorted by using a Becton Dickinson FACScan machine .
# ::tok Log phase cells were irradiated at RT with a 60 Co -irradiator at doses of 6 or 12 Gy and incubated for 24 h. Cells were then pulse-labeled for 1 h with BrdU ( 10 M ) , fixed in 70 % ethanol , double-stained with FITC anti-BrdU and propidium iodide , then sorted by using a Becton Dickinson FACScan machine .
# ::alignments 60-61|0.5.1.1 57-60|0.5.1.1.0.0.2+0.5.1.1.0.0.1+0.5.1.1.0.0.0+0.5.1.1.0.0+0.5.1.1.0 55-56|0.5.1 53-54|0.5 52-53|0.5.2 50-51|0.4 49-50|0.4.0 48-49|0 46-48|0.1.0.1+0.1.0.0+0.1.0+0.1 42-43|0.0 41-42|0.0.1 40-41|0.0.1.0 38-39|0.0.0 35-36|0.5.0.1+0.5.0.0.0+0.5.0.0+0.5.0 34-35|0.2.0.0 30-31|0.5.1.0 29-30|0.0.0.0.0.0.0.0 26-27|0.2.0.1 24-25|0.2.0.3 22-23|0.2.0.3.0 20-21|0.2.0 19-20|0.2 17-18|0.3.0 16-17|0.3 15-16|0.0.0.1 13-14|0.2.0.2 9-11|0.0.0.0.1.1+0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0.0.1 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:47.448
(a / and 
      :op1 (e / ethanol 
            :ARG2-of (f3 / fix-03 
                  :ARG0 (t5 / thing 
                        :ARG2-of (i3 / irradiate-01 
                              :ARG1 (c3 / cell 
                                    :ARG1-of (l / log-01 
                                          :ARG0 1) 
                                    :mod (p3 / phase))) 
                        :name (n4 / name 
                              :op1 60 
                              :op2 (c2 / Co))) 
                  :ARG1 6) 
            :mod (p2 / percentage-entity 
                  :value 70)) 
      :op2 (t3 / thing 
            :name (n2 / name 
                  :op1 (f2 / FITC) 
                  :op2 (a2 / anti-BrdU))) 
      :op2-of (a3 / and 
            :op1 (i2 / incubate-01 
                  :ARG0 10 
                  :ARG1 (t4 / then) 
                  :ARG1-of (d2 / dose-01) 
                  :ARG3 (c / cell 
                        :quant 24))) 
      :op2-of (o / or 
            :op1 12) 
      :op3 (i / iodide 
            :mod (p / propidium)) 
      :op4 (s / sort-out-02 
            :ARG0 (v / vehicle 
                  :name (n3 / name 
                        :op1 "M1") 
                  :wiki "M1_Abrams") 
            :manner (u / use-01 
                  :ARG0 (h / h) 
                  :ARG1 (m / machine 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 (b / Becton) 
                                    :op2 (d / Dickinson) 
                                    :op3 (f / FACScan))))) 
            :time (t2 / then)))

# ::snt Data were analyzed using Becton Dickinson Cellquest Pro .
# ::tok Data were analyzed using Becton Dickinson Cellquest Pro .
# ::alignments 6-8|0.0.1.1.1+0.0.1.1.0+0.0.1.1+0.0.1 4-6|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 3-4|0.0 2-3|0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:47.733
(a / analyze-01 
      :ARG1 (u / use-01 
            :ARG0 (d / data) 
            :ARG1 (t / thing 
                  :mod (o / organization 
                        :name (n2 / name 
                              :op1 "Becton" 
                              :op2 "Dickinson")) 
                  :name (n / name 
                        :op1 (c / Cellquest) 
                        :op2 (p / Pro)))))

# ::snt The rationale for RMCE-ASAP is detailed in Figure 1 .
# ::tok The rationale for RMCE-ASAP is detailed in Figure 1 .
# ::alignments 8-9|0.0.0.1 7-8|0.1 5-6|0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:47.758
(d / detail-01 
      :ARG1 (r / rationale 
            :prep-for (p / person 
                  :name (n / name 
                        :op1 "RMCE-ASAP") 
                  :quant 1)) 
      :ARG2 (f / figure))

# ::snt The first step requires generating a floxed allele in ES cells that will serve as the substrate for subsequent exchanges ( RMCE-ready ES cell , Figure 1 ) .
# ::tok The first step requires generating a floxed allele in ES cells that will serve as the substrate for subsequent exchanges ( RMCE-ready ES cell , Figure 1 ) .
# ::alignments 26-27|0.1.0.0.2.0 25-26|0.2 23-24|0.3 21-22|0.1.1.0.0+0.1.1.0+0.1.1 19-20|0.1.0.0.2 18-19|0.1.0.0.1 16-17|0.1.0.0.0 13-14|0.1.0.0 10-11|0.1.0.1 9-10|0.1.0.1.0 7-8|0.1.0 6-7|0.1.0.2 4-5|0.1 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:48.170
(r / require-01 
      :ARG0 (s4 / step) 
      :ARG1 (g / generate-01 
            :ARG1 (a / allele 
                  :ARG0-of (s3 / serve-01 
                        :ARG1 (s2 / substrate) 
                        :duration (s / subsequent) 
                        :purpose (e / exchange-01 
                              :ARG1 1)) 
                  :location (c2 / cell 
                        :mod (e2 / e)) 
                  :mod (f2 / flox)) 
            :op1-of (t / thing 
                  :name (n / name 
                        :op1 "RMCE-ready"))) 
      :ARG2 (f / figure) 
      :op1-of (c / cell))

# ::snt The targeting strategy is detailed in Figure 2 .
# ::tok The targeting strategy is detailed in Figure 2 .
# ::alignments 7-8|0.0.0.0 6-7|0.1 4-5|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:48.197
(d / detail-01 
      :ARG1 (s / strategy 
            :ARG1-of (t / target-01 
                  :time 2)) 
      :ARG2 (f / figure))

# ::snt The frequency of targeting was 4 % ( 12/300 puromycin-resistant clones , analyzed by Southern blot and long-range PCR , Figure 2 ) .
# ::tok The frequency of targeting was 4 % ( 12/300 puromycin-resistant clones , analyzed by Southern blot and long-range PCR , Figure 2 ) .
# ::alignments 21-22|0.1.0 20-21|0.0.0.0.0.0 17-18|0.0.0.1 16-17|0 15-16|0.1 14-15|0.1.1.0.0+0.1.1.0+0.1.1 12-13|0.0 10-11|0.0.0 6-7|0.0.1 5-6|0.0.1.0 3-4|0.0.0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:48.479
(a / and 
      :ARG0-of (a2 / analyze-01 
            :ARG1 (c / clone-01 
                  :ARG0 (f2 / frequency 
                        :compared-to (t2 / target-01 
                              :ARG0 (f / figure))) 
                  :ARG1 (l / long-range)) 
            :time (p / percentage-entity 
                  :value 4)) 
      :op1 (b / blot-01 
            :ARG0 2 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "Southern"))))

# ::snt We next tested the efficiency of RMCE in ES cells , using a replacement construct encoding p53 fused to GFP ( p53GFP ) to enable tracking p53 in individual live cells .
# ::tok We next tested the efficiency of RMCE in ES cells , using a replacement construct encoding p53 fused to GFP ( p53GFP ) to enable tracking p53 in individual live cells .
# ::alignments 30-31|0.0.1.1.0.0.0.0.0 29-30|0.0.1.1.0.0.0.0 28-29|0.0.1.1.0.0.0.0.0.0 25-26|0.1.0 24-25|0.1 17-18|0 16-17|0.0 15-16|0.0.0 14-15|0.0.1 13-14|0.0.1.0 11-12|0.0.1.1 9-10|0.0.1.1.0.0.0.1 8-9|0.0.1.1.0.0.0.1.0 4-5|0.0.1.1.0.0.0 2-3|0.0.1.1.0.0 1-2|0.0.1.1.0.0.1 0-1|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:48.769
(f / fuse-01 
      :ARG1 (p / p53 
            :ARG1-of (e2 / encode-01) 
            :ARG1-of (c2 / construct-01 
                  :ARG0 (r / replace-01) 
                  :ARG1-of (u / use-01 
                        :ARG0 (w / we 
                              :ARG0-of (t2 / test-01 
                                    :ARG1 (e4 / efficient-01 
                                          :ARG1 (l / live-01 
                                                :ARG1 (c / cell 
                                                      :mod (i / individual))) 
                                          :location (c3 / cell 
                                                :mod (e3 / e))) 
                                    :manner (n / next)))))) 
      :purpose (e / enable-01 
            :ARG1 (t / track-01)))

# ::snt Importantly however , GFP fluorescence was not used to screen cells with targeted events , as we wanted to develop a general method to isolate marker-free recombinants .
# ::tok Importantly however , GFP fluorescence was not used to screen cells with targeted events , as we wanted to develop a general method to isolate marker-free recombinants .
# ::alignments 26-27|0 24-25|0.0 22-23|0.0.0.1 21-22|0.0.0.1.0 19-20|0.0.0 17-18|0.0.0.0.0 16-17|0.0.0.0 13-14|0.0.0.2.0 12-13|0.0.0.2 10-11|0.0.0.0.0.0.1.0 9-10|0.0.0.0.0.0.1 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.0.3 4-5|0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:49.267
(r / recombinant 
      :ARG1-of (i / isolate-01 
            :purpose-of (d / develop-02 
                  :ARG0 (w2 / we 
                        :ARG0-of (w / want-01 
                              :ARG1 (u / use-01 
                                    :ARG1 (f / fluorescence) 
                                    :ARG2 (s / screen 
                                          :ARG1 (c / cell)) 
                                    :manner (i2 / importantly) 
                                    :polarity -))) 
                  :ARG1 (m / method 
                        :ARG1-of (g / general-02)) 
                  :ARG1-of (t / target-01 
                        :ARG0 (e / event)))))

# ::snt The exchange strategy is detailed in Figure 3A .
# ::tok The exchange strategy is detailed in Figure 3A .
# ::alignments 6-8|0.0.0.1+0.0.0.0+0.0.0+0.0 4-5|0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:49.294
(d / detail-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 (f / Figure) 
                  :op2 3A)) 
      :ARG1 (s / strategy 
            :mod (e / exchange-01)))

# ::snt We picked 65 ES cell clones resistant to 1 - ( -2-deoxy-2-fluoro-1-b-d-arabino-furanosyl ) -5-iodouracil ( FIAU ) due to TK loss and analyzed their DNA by PCR and Southern blot .
# ::tok We picked 65 ES cell clones resistant to 1 - ( -2-deoxy-2-fluoro-1-b-d-arabino-furanosyl ) -5-iodouracil ( FIAU ) due to TK loss and analyzed their DNA by PCR and Southern blot .
# ::alignments 29-30|0.2.1.0.0.0 28-29|0.2.1.0.0.1.0+0.2.1.0.0.1+0.2.1.0.0 27-28|0.2.1.0 24-25|0.2.1.1 22-23|0.2.1 21-22|0.2 20-21|0.2.1.1.0 19-20|0.2.0.1+0.2.0.0.0+0.2.0.0+0.2.0 8-9|0.1.1.0 6-7|0.1.1 5-6|0.1 4-5|0.1.0 3-4|0.1.0.0 2-3|0.2.1.0.0.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:49.713
(p / pick-up-04 
      :ARG0 (w / we) 
      :ARG1 (c / clone-01 
            :ARG1 (c2 / cell 
                  :mod (e / e)) 
            :ARG1-of (r / resist-01 
                  :ARG2 1)) 
      :op1-of (a3 / and 
            :op2 (o / organization 
                  :name (n2 / name 
                        :op1 "TK") 
                  :wiki -) 
            :op3 (a2 / analyze-01 
                  :ARG0 (a / and 
                        :op1 (t / thing 
                              :location (b / blot-01 
                                    :ARG1 65) 
                              :name (n / name 
                                    :op1 "Southern"))) 
                  :ARG1 (d / DNA 
                        :domain-of (l / loss)))))

# ::snt Strikingly , 54 proper recombinants were identified , indicating very high RMCE efficiency ( 83 % ) .
# ::tok Strikingly , 54 proper recombinants were identified , indicating very high RMCE efficiency ( 83 % ) .
# ::alignments 15-16|0.0.0 14-15|0.0 12-13|0.1.0 10-11|0.1.0.0 9-10|0.1.0.0.1 8-9|0.1 6-7|0 4-5|0.2 3-4|0.2.0 2-3|0.1.0.0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:49.853
(i2 / identify-01 
      :ARG0 (8 / 83 
            :value-of (p / percentage-entity)) 
      :ARG0-of (i / indicate-01 
            :ARG1 (e / efficient-01 
                  :ARG1-of (h / high-02 
                        :ARG0 54 
                        :degree (v / very)))) 
      :ARG1 (r / recombinant 
            :mod (p2 / proper)) 
      :ARG2 (s / strikingly))

# ::snt RMCE also proved to be precise , as no aberrant bands were detected in PCR and Southern blots ( Figure 3A ) .
# ::tok RMCE also proved to be precise , as no aberrant bands were detected in PCR and Southern blots ( Figure 3A ) .
# ::alignments 19-20|0.2.0 17-18|0.2.2.0 16-17|0.2.2.0.1.0.0+0.2.2.0.1.0+0.2.2.0.1 15-16|0.2.2 12-13|0.2 10-11|0.2.1 9-10|0.2.2.0.0 8-9|0.2.3 5-6|0.0 2-3|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:50.013
(p2 / prove-01 
      :ARG1 (p / precise) 
      :mod (a3 / also) 
      :purpose (d / detect-01 
            :ARG0 (f / figure) 
            :ARG1 (b2 / band) 
            :location (a / and 
                  :op1 (b / blot-01 
                        :ARG0 (a2 / aberrant) 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Southern")))) 
            :polarity -))

# ::snt p53 + / GFP ES clones were analyzed by western blot with an antibody against p53 , and found to express an additional band at the expected size ( ca. 80 kDa ) .
# ::tok p53 + / GFP ES clones were analyzed by western blot with an antibody against p53 , and found to express an additional band at the expected size ( ca. 80 kDa ) .
# ::alignments 31-32|0.1.0.0.0.0 30-31|0.1.0.0.1.0 27-28|0.2 26-27|0.2.0 23-24|0.0 22-23|0.0.0 20-21|0 18-19|0.1 17-18|0.1.0 13-14|0.1.0.1 10-11|0.1.0.0.0 9-10|0.1.0.0.0.1.1+0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 7-8|0.1.0.0 5-6|0.1.0.0.1 3-5|0.1.0.0.1.1.0.1+0.1.0.0.1.1.0.0+0.1.0.0.1.1.0+0.1.0.0.1.1 2-3|0.1.0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:50.340
(e2 / express-01 
      :ARG1 (b / band 
            :mod (a / additional)) 
      :ARG1-of (f / find-01 
            :op3-of (a2 / and 
                  :op1 (a4 / analyze-01 
                        :ARG0 (b2 / blot-01 
                              :ARG0 (k / kDa) 
                              :ARG1 (w / world-region 
                                    :name (n / name 
                                          :op1 "West") 
                                    :wiki "Western_world")) 
                        :ARG1 (c / clone-01 
                              :ARG0 80 
                              :ARG1 (t / thing 
                                    :name (n2 / name 
                                          :op1 (g / GFP) 
                                          :op2 (e3 / ES)) 
                                    :op1-of (s2 / slash)))) 
                  :op2 (a3 / antibody))) 
      :manner (s / size 
            :ARG1-of (e / expect-01)))

# ::snt Surprisingly , the fusion of GFP to p53 apparently altered p53 stability : steady-state levels of p53GFP were much higher than those of wild-type p53 ( p53WT ) in unstressed cells , and did not vary significantly after DNA damage , so that the levels for both p53WT and p53GFP were similar after adriamycin treatment ( Figure 3A ) .
# ::tok Surprisingly , the fusion of GFP to p53 apparently altered p53 stability : steady-state levels of p53GFP were much higher than those of wild-type p53 ( p53WT ) in unstressed cells , and did not vary significantly after DNA damage , so that the levels for both p53WT and p53GFP were similar after adriamycin treatment ( Figure 3A ) .
# ::alignments 56-57|0.0.1.4.1.3.0 54-55|0.0.1.4.1 53-54|0.0.1.4.1.2 52-53|0.0.1.4.1.3 51-52|0.0.1.4.1.1 48-49|0 46-47|0.0.1.1 44-45|0.0.1.4.1.1.0 39-40|0.0.1.4.0 38-39|0.0.1.4.0.0 37-38|0.0.1.4 36-37|0.0.1.2 35-36|0.0.1 34-35|0.0.1.3 32-33|0.0 30-31|0.0.1.4.1.0 29-30|0.0.1.4.1.0.0 19-20|0.0.0 18-19|0.0.1.2.0 14-15|0.0.0.0 11-12|0.0.1.2.1.1 9-10|0.0.1.2.1 8-9|0.0.1.2.1.2 7-8|0.0.1.0 3-4|0.0.1.2.1.0 0-1|0.0.1.4.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:51.362
(a3 / and 
      :op3-of (a5 / and 
            :op1 (h / high-02 
                  :ARG1 (l2 / level)) 
            :op2 (v / vary-01 
                  :ARG0 (p / p53) 
                  :ARG1 (b / both) 
                  :ARG2 (s / significant-02 
                        :ARG0 (m / much) 
                        :ARG1 (a6 / alter-01 
                              :ARG0 (f2 / fusion) 
                              :ARG1 (s2 / stability) 
                              :manner (a7 / apparent))) 
                  :polarity - 
                  :time (a4 / after 
                        :op1 (d / damage-01 
                              :ARG1 (d2 / DNA) 
                              :op1-of (s3 / surprisingly)) 
                        :op2 (t / treat-03 
                              :ARG1 (c / cell 
                                    :mod (u / unstress)) 
                              :ARG1-of (r / resemble-01 
                                    :ARG2 (l / level)) 
                              :ARG2 (a / adriamycin) 
                              :op1-of (a2 / after 
                                    :op2 (f / figure)))))))

# ::snt Six independent p53 + / GFP clones were injected into blastocysts and transferred to pseudo-pregnant females using standard procedures .
# ::tok Six independent p53 + / GFP clones were injected into blastocysts and transferred to pseudo-pregnant females using standard procedures .
# ::alignments 18-19|0.2.1.0.0 17-18|0.2.1.0.0.0 16-17|0.2.1.0 15-16|0.2.1 12-13|0.2 11-12|0 10-11|0.1.0 8-9|0.1 6-7|0.2.0 4-5|0.2.0.1 2-3|0.2.0.0 1-2|0.0.0+0.0 0-1|0.2.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:51.588
(a / and 
      :ARG1-of (d / depend-01 
            :polarity -) 
      :op1 (i / inject-01 
            :ARG2 (b / blastocyst)) 
      :op2 (t / transfer-01 
            :ARG1 (c / clone-01 
                  :ARG1 (p2 / p53) 
                  :op1-of (s2 / slash)) 
            :ARG2 (f / female 
                  :ARG0-of (u / use-01 
                        :ARG1 (p / procedure 
                              :instrument-of (s / standard)) 
                        :ARG2 6))))

# ::snt Strikingly , no pregnancies were obtained .
# ::tok Strikingly , no pregnancies were obtained .
# ::alignments 5-6|0 3-4|0.0 2-3|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:51.683
(o / obtain-01 
      :ARG1 (p / pregnanci 
            :mod-of (s / strikingly) 
            :polarity -))

# ::snt It has been shown that the p53 pathway is regulated very differently in ES and somatic cells : ES cells contain relatively high p53 levels and lack the p53-mediated DNA damage responses found in somatic cells ( 18 ) .
# ::tok It has been shown that the p53 pathway is regulated very differently in ES and somatic cells : ES cells contain relatively high p53 levels and lack the p53-mediated DNA damage responses found in somatic cells ( 18 ) .
# ::alignments 37-38|0.0.1.0.0.1.0.0.0.1 35-36|0.0.1.0.0.0.0 34-35|0.0.1.0.0.0.0.0 32-33|0.0.1.0.0.0 31-32|0.0.1.0.0.1.0.0+0.0.1.0.0.1.0 30-31|0.0.1.0.0.1.0.0.0 29-30|0.0.1.0.0.1.0.0.0.0 28-29|0.1.0.1.0 26-27|0.0.1.0.0.1 25-26|0.0.1.0.0.1.1 24-25|0.0.1.0.0.2.0 22-23|0.0.1.0.0.2.0.0 21-22|0.0.1.0.0.2.0.0.0 20-21|0.0.1.0.0.2 19-20|0.0.1.0.0 16-17|0.0.1 15-16|0.0.1.0 14-15|0.0 13-14|0.0.0 11-12|0.1.0.1 10-11|0.1.0.1.1 9-10|0.1.0 7-8|0.1.0.0 6-7|0.1.0.0.0 3-4|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:53.914
(s3 / show-01 
      :ARG0 (a2 / and 
            :op1 (e / e) 
            :op2 (c4 / cell 
                  :mod (s2 / somatic 
                        :mod-of (c3 / cell 
                              :ARG0-of (f / find-01 
                                    :ARG1 (c / cell 
                                          :mod (s / somatic))) 
                              :ARG0-of (l / lack-01 
                                    :ARG1 (t / thing 
                                          :ARG2-of (r / respond-01 
                                                :ARG1 (d / damage-01 
                                                      :ARG0 (d2 / DNA) 
                                                      :ARG1 18))) 
                                    :op1-of (a / and)) 
                              :ARG0-of (c2 / contain-01 
                                    :ARG1 (l2 / level 
                                          :ARG1-of (h / high-02 
                                                :degree (r2 / relative)))))))) 
      :ARG1 (i / it 
            :ARG0-of (r3 / regulate-01 
                  :ARG1 (p2 / pathway 
                        :mod (p3 / p53)) 
                  :manner (d3 / differ-02 
                        :ARG1 (p / p53-mediat) 
                        :degree (v / very)))))

# ::snt This , together with the observation that p53 levels decrease during mouse embryogenesis ( 19 ) , suggested an explanation for the observed lack of pregnancies : we speculate that the high levels of p53GFP in the ES cells injected into blastocysts might have prevented normal embryonic development once these cells began to differentiate and the p53 pathway became functional .
# ::tok This , together with the observation that p53 levels decrease during mouse embryogenesis ( 19 ) , suggested an explanation for the observed lack of pregnancies : we speculate that the high levels of p53GFP in the ES cells injected into blastocysts might have prevented normal embryonic development once these cells began to differentiate and the p53 pathway became functional .
# ::alignments 59-60|0.2.2.2.0.2.0.1 58-59|0.2.2.2.0.2.0 57-58|0.2.2.2.0.2.0.0 54-55|0.2.2.2.0.2 53-54|0.2.2.2.0.1 51-52|0.2.2.2.0 50-51|0.2.2.2.0.1.0 49-50|0.2.2.2.0.1.0.0 48-49|0.2.2.2 47-48|0.2.2.0 46-47|0.2.2.0.0 45-46|0.2.2.0.1 44-45|0.2.2 42-43|0.2.2.1 41-42|0.2.2.1.0.0.0.1 39-40|0.2.2.1.0.0.0 38-39|0.2.2.1.0.0.0.0 37-38|0.2.2.1.0.0.0.0.1 34-35|0.2.2.1.0.0.0.0.0 32-33|0.2.2.2.0.0 31-32|0.2.2.2.0.0.0 28-29|0.2.2.1.0 27-28|0.2.2.1.0.0 25-26|0.2.0 23-24|0.2 22-23|0.2.1 19-20|0.1 17-18|0 14-15|0.1.1 12-13|0.2.2.2.0.0.0.0.2 11-12|0.2.2.2.0.0.0.0.2.0 9-10|0.2.2.2.0.0.0.0 8-9|0.2.2.2.0.0.0.0.1 7-8|0.2.2.2.0.0.0.0.1.0 5-6|0.2.2.2.0.0.0.0.0 2-3|0.1.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:56.486
(s2 / suggest-01 
      :ARG0 (t3 / this) 
      :ARG1 (e3 / explain-01 
            :ARG0 (t2 / together) 
            :ARG1 19) 
      :ARG2 (l2 / lack-01 
            :ARG1 (p5 / pregnanci) 
            :ARG1-of (o2 / observe-01) 
            :ARG2-of (p2 / prevent-01 
                  :ARG1 (d2 / develop-02 
                        :ARG1 (e / embryonic) 
                        :ARG1-of (n / normal-02)) 
                  :ARG1-of (p3 / possible-01 
                        :ARG1-of (s / speculate-01 
                              :ARG0 (w / we 
                                    :ARG0-of (i / inject-01 
                                          :ARG1 (c2 / cell 
                                                :location-of (p4 / p53GFP) 
                                                :mod (e2 / e)) 
                                          :ARG2 (b3 / blastocyst))))) 
                  :time (o / once 
                        :op1 (b2 / begin-01 
                              :ARG0 (l / level 
                                    :ARG1-of (h / high-02 
                                          :ARG2-of (d3 / decrease-01 
                                                :ARG0 (o3 / observation) 
                                                :ARG1 (l3 / level 
                                                      :mod (p6 / p53)) 
                                                :time (e4 / embryogenesi 
                                                      :mod (m / mouse))))) 
                              :ARG1 (d / differentiate-01 
                                    :ARG0 (c / cell 
                                          :mod (t / this))) 
                              :op1-of (a / and 
                                    :op2 (b / become-01 
                                          :ARG1 (p / pathway) 
                                          :ARG2 (f / functional))))))))

# ::snt To test this possibility , we performed RMCE with a p53 fusion gene in which the p53 proline-rich domain ( PRD ) was deleted ( p53P ) , and the p53P was fused to GFP .
# ::tok To test this possibility , we performed RMCE with a p53 fusion gene in which the p53 proline-rich domain ( PRD ) was deleted ( p53P ) , and the p53P was fused to GFP .
# ::alignments 34-35|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 32-33|0.0.0.0 28-29|0 25-26|0.0.0.1.1 23-24|0.0.0.1 20-21|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 18-19|0.0.0.1.0 12-13|0.0.2 11-12|0.0.2.0 10-11|0.0.1.2 6-7|0.0 5-6|0.0.0 3-4|0.0.1 2-3|0.0.1.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:57.268
(a / and 
      :op1 (p3 / perform-02 
            :ARG0 (w / we 
                  :ARG0-of (f / fuse-01 
                        :ARG1 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "PRD")) 
                        :ARG2 (o / organization 
                              :name (n / name 
                                    :op1 "GFP"))) 
                  :ARG0-of (d / delete-01 
                        :ARG1 (d2 / domain) 
                        :ARG2 (p / p53P))) 
            :ARG1 (p4 / possible-01 
                  :ARG1-of (t2 / test-01) 
                  :mod (t / this) 
                  :op1-of (p2 / p53)) 
            :ARG2 (g / gene 
                  :mod (f2 / fusion))))

# ::snt We used this mutant because deleting the proline-rich domain decreases stability and compromises DNA-damage responses in vivo ( 5 ) .
# ::tok We used this mutant because deleting the proline-rich domain decreases stability and compromises DNA-damage responses in vivo ( 5 ) .
# ::alignments 18-19|0.2.0.0.0.0 16-17|0.2.0.1.0.0.0 14-15|0.2.0.1.0.0+0.2.0.1.0 12-13|0.2.0.1 11-12|0.2.0 10-11|0.2.0.0.1 9-10|0.2.0.0 8-9|0.2.0.0.0.1 5-6|0.2.0.0.0 4-5|0.2 3-4|0.1 2-3|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:57.707
(u / use-01 
      :ARG0 (w / we) 
      :ARG1 (m / mutant 
            :mod (t2 / this)) 
      :ARG1-of (c2 / cause-01 
            :ARG0 (a / and 
                  :op1 (d / decrease-01 
                        :ARG0 (d3 / delete-01 
                              :ARG0 5 
                              :ARG1 (d2 / domain)) 
                        :ARG1 (s / stability)) 
                  :op2 (c / compromise-01 
                        :ARG1 (t / thing 
                              :ARG2-of (r / respond-01 
                                    :ARG1 (v / vivo)))))))

# ::snt According to our hypothesis , this hypomorphic mutant should not prevent embryonic development .
# ::tok According to our hypothesis , this hypomorphic mutant should not prevent embryonic development .
# ::alignments 12-13|0.1.0.1 11-12|0.1.0.1.0 10-11|0.1.0 9-10|0.1.0.2 8-9|0.1 7-8|0.1.0.0 6-7|0.1.0.0.0 5-6|0.1.0.0.1 3-4|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:57.826
(s / say-01 
      :ARG0 (h2 / hypothesi 
            :poss (w / we)) 
      :ARG1 (r / recommend-01 
            :ARG1 (p / prevent-01 
                  :ARG0 (m / mutant 
                        :mod (h / hypomorphic) 
                        :mod (t / this)) 
                  :ARG1 (d / develop-02 
                        :ARG1 (e / embryonic)) 
                  :polarity -)))

# ::snt RMCE with a p53PGFP replacement plasmid was again very efficient and western blots revealed an additional band of the predicted molecular weight only in p53 + / PGFP ES cells ( Figure 3B ) .
# ::tok RMCE with a p53PGFP replacement plasmid was again very efficient and western blots revealed an additional band of the predicted molecular weight only in p53 + / PGFP ES cells ( Figure 3B ) .
# ::alignments 31-32|0.1.1.1.1.0 29-30|0.2 27-29|0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 26-27|0.2.1 22-23|0.1.0.0 21-22|0.1.1.1 20-21|0.1.1.1.0 19-20|0.1.1.1.1 16-17|0.1.1 15-16|0.1.1.0 13-14|0.1 12-13|0.1.0 11-12|0.1.0.1.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 10-11|0 9-10|0.0 8-9|0.0.1 7-8|0.0.2 5-6|0.0.0 4-5|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:58.198
(a2 / and 
      :op1 (e2 / efficient-01 
            :ARG1 (p3 / plasmid 
                  :ARG1-of (r2 / replace-01)) 
            :degree (v / very) 
            :mod (a3 / again)) 
      :op2 (r / reveal-01 
            :ARG0 (b2 / blot-01 
                  :ARG0 (o / only) 
                  :ARG1 (w2 / world-region 
                        :name (n2 / name 
                              :op1 "West") 
                        :wiki "Western_world")) 
            :ARG1 (b / band 
                  :mod (a / additional) 
                  :mod (w / weight 
                        :mod (m / molecule) 
                        :mod (p2 / predict-01 
                              :ARG1 (f / figure))))) 
      :op3 (c / cell 
            :mod (t / thing 
                  :name (n / name 
                        :op1 (p / PGFP) 
                        :op2 (e / ES))) 
            :op1-of (s / slash)))

# ::snt As expected , the PRD deletion correlated with lower expression levels : p53PGFP was much less abundant than p53WT in all p53 + / PGFP clones ( Figure 3B ) .
# ::tok As expected , the PRD deletion correlated with lower expression levels : p53PGFP was much less abundant than p53WT in all p53 + / PGFP clones ( Figure 3B ) .
# ::alignments 27-28|0.0.1 25-26|0 23-24|0.2 20-21|0.1 18-19|0.0.0.0.0.0.0.1 16-17|0.0.0.0.0.0.0.0 15-16|0.0.0.0.0.0.0.0.0 14-15|0.0.0.0.0.0.0.0.0.0 12-13|0.0.0.0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0 8-9|0.0.0.0.0.1 6-7|0.0.0.0 5-6|0.0.0 4-5|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:58.555
(c / clone-01 
      :ARG1 (e2 / expect-01 
            :ARG0 (d / deletion 
                  :ARG0-of (c2 / correlate-01 
                        :ARG1 (l2 / level 
                              :ARG1-of (e / express-01 
                                    :ARG2 (p2 / p53PGFP 
                                          :domain-of (a2 / abundance 
                                                :degree (l / less 
                                                      :quant (m / much))) 
                                          :topic (p / p53WT))) 
                              :ARG1-of (l3 / low-04))) 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "PRD"))) 
            :ARG1 (f / figure)) 
      :mod (a / all) 
      :op1-of (s / slash))

# ::snt We next determined whether p53 + / PGFP ES cells could generate chimeric mice and transmit the modified allele through the germline .
# ::tok We next determined whether p53 + / PGFP ES cells could generate chimeric mice and transmit the modified allele through the germline .
# ::alignments 21-22|0.1.0.1.1 18-19|0.1.1.0 17-18|0.1.1.0.0 15-16|0.1.1 14-15|0.1 13-14|0.1.0.1 12-13|0.1.0.1.0 11-12|0.1.0 10-11|0.1.0.2 9-10|0.1.0.0 7-9|0.1.0.0.1.0.1+0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 6-7|0.1.0.0.0 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:58.684
(d / determine-01 
      :ARG0 (w / we) 
      :ARG1 (a2 / and 
            :op1 (g2 / generate-01 
                  :ARG0 (c2 / cell 
                        :mod (s / slash) 
                        :mod (t2 / thing 
                              :name (n / name 
                                    :op1 (p2 / PGFP) 
                                    :op2 (e / ES)))) 
                  :ARG1 (m2 / mouse 
                        :mod (c / chimeric) 
                        :mod-of (g / germline)) 
                  :ARG1-of (p / possible-01)) 
            :op2 (t / transmit-01 
                  :ARG1 (a / allele 
                        :ARG1-of (m / modify-01)))) 
      :manner (n2 / next))

# ::snt Two p53 + / PGFP ES cell clones were injected into blastocysts and highly chimeric ( > 80 % ) mice were obtained .
# ::tok Two p53 + / PGFP ES cell clones were injected into blastocysts and highly chimeric ( > 80 % ) mice were obtained .
# ::alignments 22-23|0.1 20-21|0.1.0 18-19|0.0.1.0 17-18|0.0.0 14-15|0.0.2.0 13-14|0.0.2.0.0 12-13|0 11-12|0.0.2 9-10|0.0 7-8|0.0.1 6-7|0.0.1.2 4-6|0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 3-4|0.0.1.3 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:58.981
(a / and 
      :op1 (i / inject-01 
            :ARG0 80 
            :ARG1 (c2 / clone-01 
                  :ARG0 (p / percentage-entity 
                        :value 2) 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (p2 / PGFP) 
                              :op2 (e / ES))) 
                  :mod (c3 / cell) 
                  :op1-of (s / slash)) 
            :ARG2 (b / blastocyst 
                  :quant (c / chimeric 
                        :degree (h / high)))) 
      :op2 (o / obtain-01 
            :ARG1 (m / mouse)))

# ::snt Heterozygote pups were recovered from the mating the chimeras with WT mice ( Figure 3C ) .
# ::tok Heterozygote pups were recovered from the mating the chimeras with WT mice ( Figure 3C ) .
# ::alignments 13-14|0.2.0 11-12|0.3 8-9|0.0 6-7|0.2 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:59.028
(r / recover-02 
      :ARG0 (c / chimera) 
      :ARG1 (p / pup-01 
            :mod (h / heterozygote)) 
      :ARG2 (m2 / mate-01 
            :ARG1 (f / figure)) 
      :instrument (m / mouse))

# ::snt These data demonstrate that marker-free RMCE is very efficient in ES cells and allows germline transmission of a targeted mutation ( see Figure 1 , path A ) .
# ::tok These data demonstrate that marker-free RMCE is very efficient in ES cells and allows germline transmission of a targeted mutation ( see Figure 1 , path A ) .
# ::alignments 25-26|0.1.1.0.0.0.0 23-24|0.1.2 22-23|0.0 21-22|0 19-20|0.1.1.0.1.0 18-19|0.1.1.0.1.0.0 15-16|0.1.1.0.1 13-14|0.1.1.0 12-13|0.1.1 11-12|0.1.1.0.0.0.2 10-11|0.1.1.0.0.0.2.0 8-9|0.1.1.0.0.0 7-8|0.1.1.0.0.0.1 5-6|0.1.1.0.0 2-3|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:59.438
(s / see-01 
      :ARG1 (f / figure) 
      :ARG2 (d / demonstrate-01 
            :ARG0 (d2 / data 
                  :mod (t3 / this)) 
            :ARG1 (a2 / and 
                  :op1 (a / allow-01 
                        :ARG0 (r / RMCE 
                              :ARG1-of (e2 / efficient-01 
                                    :ARG0 (p / path) 
                                    :degree (v / very) 
                                    :manner (c / cell 
                                          :mod (e / e)))) 
                        :ARG1 (t2 / transmission 
                              :poss (m / mutation 
                                    :ARG1-of (t / target-01))))) 
            :ARG2 1))

# ::snt We next determined whether the RMCE approach could be used to target mutations at the p53 allele in somatic cells ( Figure 1 , path B ) .
# ::tok We next determined whether the RMCE approach could be used to target mutations at the p53 allele in somatic cells ( Figure 1 , path B ) .
# ::alignments 25-26|0.1.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 24-25|0.1.0 22-23|0.1.1.0.0 21-22|0.1.1.1.0.0 19-20|0.1.1.1.1.0 18-19|0.1.1.1.1.0.0 16-17|0.1.1.1.1 15-16|0.1.1.1.1.1 12-13|0.1.1.1.0 11-12|0.1.1.1 9-10|0.1.1 7-8|0.1 6-7|0.1.1.0 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:59.937
(d / determine-01 
      :ARG0 (w / we) 
      :ARG1 (p3 / possible-01 
            :ARG0 (p / path 
                  :mod-of (l / location 
                        :name (n / name 
                              :op1 "B") 
                        :wiki -)) 
            :ARG1 (u / use-01 
                  :ARG1 (a2 / approach-02 
                        :ARG0 1) 
                  :ARG2 (t / target-01 
                        :ARG1 (m / mutate-01 
                              :ARG1 (f / figure)) 
                        :location (a / allele 
                              :location (c / cell 
                                    :mod (s / somatic)) 
                              :mod (p2 / p53))))) 
      :manner (n2 / next))

# ::snt We first verified that the RMCE-ready p53 locus ( p53RMCE ) could be transmitted through the germline by mating p53RMCE / + chimeras with p53 + /  mice ( 20 ) ( Figure 4 ) .
# ::tok We first verified that the RMCE-ready p53 locus ( p53RMCE ) could be transmitted through the germline by mating p53RMCE / + chimeras with p53 + /  mice ( 20 ) ( Figure 4 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:59.943
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Importantly , this allowed us to generate p53RMCE /  MEFs , which were used to test RMCE at the p53 locus in somatic cells .
# ::tok Importantly , this allowed us to generate p53RMCE /  MEFs , which were used to test RMCE at the p53 locus in somatic cells .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:59.946
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt We first attempted RMCE in MEFs by electroporating p53RMCE /  MEFs with a Cre-expression plasmid and the p53GFP plasmid , followed by selection with FIAU or ganciclovir .
# ::tok We first attempted RMCE in MEFs by electroporating p53RMCE /  MEFs with a Cre-expression plasmid and the p53GFP plasmid , followed by selection with FIAU or ganciclovir .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:45:59.949
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Strikingly , no clones with an exchanged allele were identified ( data not shown ) .
# ::tok Strikingly , no clones with an exchanged allele were identified ( data not shown ) .
# ::alignments 13-14|0.1.0 12-13|0.1.0.0 11-12|0.1 9-10|0 7-8|0.0.0 6-7|0.0.0.0 3-4|0.0 2-3|0.0.1 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:00.073
(i / identify-01 
      :ARG1 (c / clone-01 
            :ARG2 (a / allele 
                  :ARG1-of (e / exchange-01 
                        :ARG0 (s2 / strikingly))) 
            :polarity -) 
      :ARG2 (d / data 
            :ARG1-of (s / show-01 
                  :polarity -)))

# ::snt RMCE with p53GFP in ES cells showed that p53GFP is expressed at high levels ( Figure 3A ) , and as mentioned before , the p53 pathway that can be activated in MEFs is not readily activated in ES cells ( 18 ) .
# ::tok RMCE with p53GFP in ES cells showed that p53GFP is expressed at high levels ( Figure 3A ) , and as mentioned before , the p53 pathway that can be activated in MEFs is not readily activated in ES cells ( 18 ) .
# ::alignments 41-42|0.2.1.1.0.0 39-40|0.2.1.0 36-37|0.2.1 35-36|0.2.1.2 34-35|0.2.1.3 32-33|0.2.1.1.0.2 30-31|0.2.1.1.0 28-29|0.2.1.1.0.1 26-27|0.2.1.1 25-26|0.2.1.1.1 22-23|0.2.1.1.0.1.0 21-22|0.2.0 19-20|0.2 15-16|0.2.1.2.0 13-14|0.1.0 12-13|0.1.0.0 10-11|0.1 6-7|0 5-6|0.0 4-5|0.0.1 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:00.832
(s / show-01 
      :ARG0 (c2 / cell 
            :location-of (p4 / p53GFP) 
            :mod (e2 / e)) 
      :ARG1 (e / express-01 
            :ARG1 (l / level 
                  :ARG1-of (h / high-02))) 
      :op1-of (a3 / and 
            :op2 (m2 / mention-01) 
            :op3 (a / activate-01 
                  :ARG0 (c / cell) 
                  :ARG1 (p2 / pathway 
                        :ARG1-of (a2 / activate-01 
                              :ARG0 18 
                              :ARG1-of (p / possible-01 
                                    :op1-of (b / before)) 
                              :location (m / mef)) 
                        :mod (p3 / p53)) 
                  :manner (r / ready-02 
                        :ARG1 (f / figure)) 
                  :polarity -)))

# ::snt The results above suggest that high levels of p53GFP could be tolerated by ES cells but toxic to MEFs , so that MEFs in which an RMCE had occurred failed to proliferate .
# ::tok The results above suggest that high levels of p53GFP could be tolerated by ES cells but toxic to MEFs , so that MEFs in which an RMCE had occurred failed to proliferate .
# ::alignments 31-32|0.1.3 29-30|0.1 28-29|0.1.2 22-23|0.1.1 20-21|0.0.1 18-19|0.1.0.1.0 16-17|0.1.0.1 15-16|0 14-15|0.0.0.0 13-14|0.0.0.0.0 11-12|0.0.0 9-10|0.0 8-9|0.1.0.2 6-7|0.1.0 5-6|0.1.0.0 3-4|0.0.0.1 2-3|0.0.0.1.1 1-2|0.0.0.1.0.0+0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:01.626
(c2 / contrast-01 
      :ARG1 (p2 / possible-01 
            :ARG1 (t2 / tolerate-01 
                  :ARG1 (c3 / cell 
                        :mod (e / e)) 
                  :ARG1-of (s / suggest-01 
                        :ARG0 (t3 / thing 
                              :ARG2-of (r / result-01)) 
                        :mod (a / above))) 
            :ARG1-of (c / cause-01)) 
      :ARG2 (f / fail-01 
            :ARG0 (l / level 
                  :ARG1-of (h / high-02) 
                  :domain-of (t / toxic 
                        :prep-to (m2 / mef)) 
                  :mod (p3 / p53GFP)) 
            :ARG1 (m / mef) 
            :ARG1-of (o / occur-01) 
            :ARG2 (p / proliferate-01)))

# ::snt To test this possibility , p53RMCE /  MEFs were electroporated with the p53GFP replacement construct with or without a Cre-expression plasmid , then analyzed by fluorescence microscopy 48 h after electroporation .
# ::tok To test this possibility , p53RMCE /  MEFs were electroporated with the p53GFP replacement construct with or without a Cre-expression plasmid , then analyzed by fluorescence microscopy 48 h after electroporation .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:01.627
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The experiment was done without selection to enable observation of cells under conditions where a failure to proliferate would not derive from FIAU or ganciclovir toxicity but rather solely from the effects of p53GFP .
# ::tok The experiment was done without selection to enable observation of cells under conditions where a failure to proliferate would not derive from FIAU or ganciclovir toxicity but rather solely from the effects of p53GFP .
# ::alignments 33-34|0.1.0.0 31-32|0.1.0.1.0 28-29|0.0 26-27|0 25-26|0.1.2 24-25|0.1.2.0 23-24|0.1.2.0.0 22-23|0.1.2.0.0.0 20-21|0.1 19-20|0.1.3 17-18|0.1.0.1 15-16|0.1.0 12-13|0.1.1 10-11|0.1.1.0.0.1.0.0 8-9|0.1.1.0.0.1.0 7-8|0.1.1.0.0.1 5-6|0.1.1.0 3-4|0.1.1.0.0 1-2|0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:02.123
(c / contrast-01 
      :ARG1 (s / sole) 
      :ARG2 (d / derive-01 
            :ARG0 (f2 / fail-01 
                  :ARG1 (p / p53GFP) 
                  :ARG2 (p2 / proliferate-01 
                        :ARG1 (e / effect))) 
            :ARG1 (c2 / condition 
                  :ARG1-of (s2 / select-01 
                        :manner-of (d2 / do-02 
                              :ARG1 (e3 / experiment-01) 
                              :ARG2 (e2 / enable-01 
                                    :ARG1 (o2 / observation 
                                          :domain (c3 / cell)))))) 
            :ARG2 (t / toxicity 
                  :mod (g / ganciclovir 
                        :op2-of (o / or 
                              :op1 (f / FIAU)))) 
            :polarity -))

# ::snt We observed a few fluorescent cells only when the Cre expression plasmid was co-electroporated , suggesting that such cells resulted from RMCE .
# ::tok We observed a few fluorescent cells only when the Cre expression plasmid was co-electroporated , suggesting that such cells resulted from RMCE .
# ::alignments 19-20|0.0.1.0.0 18-19|0.0.1.0 17-18|0.0.1 15-16|0.0.1.0.0.1 13-14|0.0.0 11-12|0.0 10-11|0 6-7|0.0.1.0.0.0 5-6|0.0.1.0.0.1.0.0.0 4-5|0.0.1.0.0.1.0.0.0.0 3-4|0.0.1.0.0.1.0.0.0.1 1-2|0.0.1.0.0.1.0.0 0-1|0.0.1.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:02.290
(e / express-01 
      :ARG1 (p / plasmid 
            :domain-of (c2 / co-electroporat) 
            :mod (s / such 
                  :mod-of (c / cell 
                        :ARG1-of (r / result-01 
                              :ARG0 (o / only) 
                              :ARG1-of (s2 / suggest-01 
                                    :ARG0 (w / we 
                                          :ARG0-of (o2 / observe-01 
                                                :ARG1 (c3 / cell 
                                                      :mod (f / fluorescent) 
                                                      :quant (f2 / few))))))))))

# ::snt Importantly , the rare fluorescent cells had a flat , ` fried-egg ' appearance typical of senescent cells ( Figure 5A ) , and when plates were observed 5 days later , the cells had detached .
# ::tok Importantly , the rare fluorescent cells had a flat , ` fried-egg ' appearance typical of senescent cells ( Figure 5A ) , and when plates were observed 5 days later , the cells had detached .
# ::alignments 35-36|0.0 33-34|0.0.1 30-31|0.0.2.2 29-30|0.0.2.2.0.1+0.0.2.2.0 28-29|0.0.2.2.0.0 27-28|0.0.2 25-26|0.0.2.1 23-24|0 19-20|0.0.2.0 17-18|0.0.0.0.0.0 16-17|0.0.0.0.0.0.0 14-15|0.0.0.0.0 13-14|0.0.0.0 8-9|0.0.0.0.1 5-6|0.0.0 4-5|0.0.0.2 3-4|0.0.0.1 0-1|0.0.2.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:02.998
(a / and 
      :op1 (d / detach-01 
            :ARG0 (c3 / cell 
                  :ARG1-of (a2 / appear-01 
                        :ARG1-of (t2 / typical-02 
                              :ARG2 (c2 / cell 
                                    :mod (s / senescent))) 
                        :mod (f2 / flat)) 
                  :ARG1-of (r / rare-02) 
                  :mod (f3 / fluorescent)) 
            :ARG1 (c / cell) 
            :time (o / observe-01 
                  :ARG0 (f / figure) 
                  :ARG1 (p / plate) 
                  :ARG3 (l / late 
                        :op1 (t / temporal-quantity 
                              :quant (5 / 5 
                                    :mod (i / importantly)) 
                              :unit (d2 / day))))))

# ::snt Altogether , the results suggest that RMCE can give rise to p53GFP-expressing MEFs , but they die rapidly owing to p53GFP toxicity .
# ::tok Altogether , the results suggest that RMCE can give rise to p53GFP-expressing MEFs , but they die rapidly owing to p53GFP toxicity .
# ::alignments 21-22|0.2.0.0.0 18-19|0.2.0.0 17-18|0.2.1 16-17|0.2 15-16|0.2.0 14-15|0 12-13|0.0.0.0.0 11-12|0.0.0.0.0.0 9-10|0.0.0.0 8-9|0.0.0 7-8|0.0 4-5|0.1 3-4|0.1.0.0+0.1.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:03.160
(c / contrast-01 
      :ARG1 (p2 / possible-01 
            :ARG1 (g / give-01 
                  :ARG1 (r2 / rise-01 
                        :ARG1 (m / mef 
                              :mod (p / p53gfp-express))))) 
      :ARG1-of (s / suggest-01 
            :ARG0 (t3 / thing 
                  :ARG2-of (r3 / result-01)) 
            :mod (a / altogeth)) 
      :ARG2 (d / die-01 
            :ARG1 (t2 / they 
                  :ARG0-of (o / owe-01 
                        :ARG2 (t / toxicity))) 
            :manner (r / rapid)))

# ::snt We also performed RMCE in p53RMCE /  MEFs with the p53PGFP construct .
# ::tok We also performed RMCE in p53RMCE /  MEFs with the p53PGFP construct .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:03.161
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt p53PGFP-expressing MEFs were viable , recovered with an efficiency of  40 % , and , as expected from ES cell experiments , expressed a p53PGFP protein at much lower levels than p53WT ( Figure 5B ) .
# ::tok p53PGFP-expressing MEFs were viable , recovered with an efficiency of  40 % , and , as expected from ES cell experiments , expressed a p53PGFP protein at much lower levels than p53WT ( Figure 5B ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:03.165
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Unlike WT MEFs , p53P/P MEFs are unable to arrest cycling after irradiation ( 5 ) .
# ::tok Unlike WT MEFs , p53P/P MEFs are unable to arrest cycling after irradiation ( 5 ) .
# ::alignments 14-15|0.0.0.0 12-13|0.0.1.0 11-12|0.0.1 10-11|0.0 9-10|0.0.0 1-3|0.1.0.1+0.1.0.0+0.1.0+0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:03.333
(u / unlike 
      :ARG0-of (c / cycle-01 
            :ARG1-of (a2 / arrest-01 
                  :ARG0 5) 
            :time (a / after 
                  :op1 (i / irradiation))) 
      :op1 (t / thing 
            :name (n / name 
                  :op1 (w / WT) 
                  :op2 (m / MEFs))))

# ::snt Likewise , we found that irradiation doses that arrested p53RMCE /  MEFs ( which express a wild-type p53 from the RMCE-ready locus , see Figure 2 ) did not arrest p53PGFP /  MEFs ( Figure 5C ) .
# ::tok Likewise , we found that irradiation doses that arrested p53RMCE /  MEFs ( which express a wild-type p53 from the RMCE-ready locus , see Figure 2 ) did not arrest p53PGFP /  MEFs ( Figure 5C ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:03.334
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt These data show that a single RMCE-ASAP reaction in heterozygous MEFs enables detection of a recessive phenotype .
# ::tok These data show that a single RMCE-ASAP reaction in heterozygous MEFs enables detection of a recessive phenotype .
# ::alignments 16-17|0.1.1.0 15-16|0.1.1.0.0 12-13|0.1.1 11-12|0.1 10-11|0.1.0.0 9-10|0.1.0.0.0 7-8|0.1.0 6-7|0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 5-6|0.1.0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:03.787
(s2 / show-01 
      :ARG0 (d2 / data 
            :mod (t2 / this)) 
      :ARG1 (e / enable-01 
            :ARG0 (r2 / react-01 
                  :ARG1 (m / mef 
                        :mod (h / heterozygou)) 
                  :ARG1-of (s / single-02) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "RMCE-ASAP"))) 
            :ARG1 (d / detect-01 
                  :ARG1 (p / phenotype 
                        :mod (r / recessive)))))

# ::snt The results confirm that deleting the proline rich domain leads to less active p53 with impaired cell cycle control , and also indicate that a GFP C-terminal fusion can dramatically alter p53 regulation .
# ::tok The results confirm that deleting the proline rich domain leads to less active p53 with impaired cell cycle control , and also indicate that a GFP C-terminal fusion can dramatically alter p53 regulation .
# ::alignments 32-33|0.0.1 30-31|0.0 29-30|0.0.3 28-29|0 27-28|0.0.0 22-23|0.0.2 21-22|0.0.2.0 20-21|0.0.2.1 18-19|0.0.2.1.1 17-18|0.0.2.1.1.1 16-17|0.0.2.1.0.1 15-16|0.0.2.1.1.2 13-14|0.0.2.1.1.0 12-13|0.0.2.1.1.0.0 11-12|0.0.2.1.1.0.0.0 9-10|0.0.2.1.0 8-9|0.0.2.1.0.0.0 7-8|0.0.2.1.0.0.0.0 6-7|0.0.2.1.0.0.0.1 4-5|0.0.2.1.0.0 2-3|0.0.2.1.0.2 1-2|0.0.2.1.0.2.0.0+0.0.2.1.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:04.496
(p / possible-01 
      :ARG1 (a / alter-01 
            :ARG0 (f / fusion) 
            :ARG1 (r / regulate-01) 
            :ARG1-of (i / indicate-01 
                  :mod (a2 / also) 
                  :op3-of (a3 / and 
                        :op1 (l2 / lead-03 
                              :ARG0 (d3 / delete-01 
                                    :ARG1 (d2 / domain 
                                          :mod (r2 / rich) 
                                          :mod (p3 / proline))) 
                              :ARG1 (c3 / cell) 
                              :ARG1-of (c4 / confirm-01 
                                    :ARG0 (t / thing 
                                          :ARG2-of (r3 / result-01)))) 
                        :op2 (c / control-01 
                              :ARG0 (p2 / p53 
                                    :ARG1-of (a4 / activity-06 
                                          :degree (l / less))) 
                              :ARG1 (c2 / cycle-02) 
                              :ARG1-of (i2 / impair-01)))) 
            :manner (d / dramatic)))

# ::snt A summary of our results is presented in Table 1 .
# ::tok A summary of our results is presented in Table 1 .
# ::alignments 9-10|0.0.0 8-9|0.0 6-7|0 4-5|0.1.0.0+0.1.0 3-4|0.1.0.0.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:04.525
(p / present-01 
      :ARG0 (t / table 
            :mod 1) 
      :ARG1 (s / summary 
            :poss (t2 / thing 
                  :ARG2-of (r / result-01 
                        :ARG1 (w / we)))))

# ::snt These data report the development and implementation of an improved RMCE approach that enables efficient allele modification in ES cells to generate mice and in heterozygous MEFs to accelerate phenotypic analyses .
# ::tok These data report the development and implementation of an improved RMCE approach that enables efficient allele modification in ES cells to generate mice and in heterozygous MEFs to accelerate phenotypic analyses .
# ::alignments 30-31|0.0.1.0.0 29-30|0.0.1.0.0.0 28-29|0.0.1.0 26-27|0.0.1.0.1 25-26|0.0.1.0.1.0 23-24|0 22-23|0.0.1.1.0.0 21-22|0.0.1.1.0 19-20|0.0.1.1 18-19|0.0.1.1.1 16-17|0.0.1 15-16|0.0.1.3 14-15|0.0.1.2 13-14|0.0 11-12|0.0.0.0 9-10|0.0.0.0.1 6-7|0.0.0.0.0 5-6|0.0.0.1 4-5|0.0.0 2-3|0.0.0.1.0 1-2|0.0.0.1.0.0 0-1|0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:05.312
(a3 / and 
      :ARG2-of (e3 / enable-01 
            :ARG0 (d / develop-02 
                  :ARG1 (a5 / approach-02 
                        :ARG1-of (i2 / implement-01) 
                        :ARG1-of (i / improve-01)) 
                  :op1-of (a6 / and 
                        :ARG1-of (r / report-01 
                              :ARG0 (d2 / data 
                                    :mod (t / this))))) 
            :ARG1 (m3 / modify-01 
                  :ARG0-of (a2 / accelerate-01 
                        :ARG1 (a / analysis 
                              :mod (p / phenotypic)) 
                        :ARG2 (m / mef 
                              :mod (h / heterozygou))) 
                  :ARG1 (c / cell 
                        :ARG0-of (g / generate-01 
                              :ARG1 (m2 / mouse)) 
                        :mod (e / e)) 
                  :ARG1-of (e2 / efficient-01) 
                  :mod (a4 / allele))))

# ::snt The success of RMCE-ASAP relied on the integrated use of inverted heterologous loxP sites , a positive/negative selection marker that preserves the germline capacity of ES cells , and , for somatic cells , the existence of a knock-out allele of the gene of interest .
# ::tok The success of RMCE-ASAP relied on the integrated use of inverted heterologous loxP sites , a positive/negative selection marker that preserves the germline capacity of ES cells , and , for somatic cells , the existence of a knock-out allele of the gene of interest .
# ::alignments 44-45|0.0.2.0.0.0.2 42-43|0.0.2.0.0.0.2.0 39-40|0.0.2.0.0.0.2.0.0 35-36|0.0.2.0.0.0 32-33|0.0.2.0.0.0.0 31-32|0.0.2.0.0.0.0.0 28-29|0.0.2.0.0.0.1 26-27|0.0.0.0.0.0 25-26|0.0.0.0.0.0.0 23-24|0.0.0.0.0 20-21|0.0.0.0 18-19|0.0.0 17-18|0.0.0.1 13-14|0.0.2.0.0.0.1.0 12-13|0.0.2.0.0.0.1.0.0 10-11|0.0.1 8-9|0.0 7-8|0 4-5|0.0.2 3-4|0.0.2.0.1.0+0.0.2.0.1+0.0.2.0 1-2|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:06.234
(i3 / integrate-01 
      :ARG1 (u / use-01 
            :ARG1-of (m / mark-01 
                  :ARG0-of (p / preserve-01 
                        :ARG1 (c3 / capacity 
                              :poss (c2 / cell 
                                    :mod (e2 / e)))) 
                  :ARG1-of (s2 / select-01)) 
            :ARG1-of (i2 / invert-01) 
            :time-of (r / rely-01 
                  :ARG1 (t / thing 
                        :ARG0-of (s4 / succeed-01 
                              :ARG0-of (e / exist-01 
                                    :ARG1 (c / cell 
                                          :mod (s / somatic)) 
                                    :op2-of (a2 / and 
                                          :op1 (s3 / site 
                                                :location-of (l / loxP))) 
                                    :purpose (i / interest-01 
                                          :ARG2 (g / gene 
                                                :poss-of (a / allele))))) 
                        :name (n / name 
                              :op1 "RMCE-ASAP")))))

# ::snt These characteristics should make RMCE-ASAP a robust and general technology for analysis of mammalian genes under conditions that preserve normal control mechanisms in different tissues .
# ::tok These characteristics should make RMCE-ASAP a robust and general technology for analysis of mammalian genes under conditions that preserve normal control mechanisms in different tissues .
# ::alignments 24-25|0.1.0 23-24|0.1 21-22|0.2.1.1.0.0.0 20-21|0.2.1.1.0.0.0.1 19-20|0.2.1.1.0.0.0.0 18-19|0.2.1.1.0.0 16-17|0.2.1.1.0 14-15|0.2.1.1.1 13-14|0.2.1.1.0.0.0.1.0 11-12|0.2.1.1 9-10|0.2.1 8-9|0.2.1.0 7-8|0.2 6-7|0.2.0 2-3|0 1-2|0.0.0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:06.535
(r2 / recommend-01 
      :ARG1 (t3 / thing 
            :ARG2-of (c3 / characteristic-02) 
            :mod (t4 / this)) 
      :ARG2-of (d / differ-02 
            :ARG1 (t / tissue)) 
      :op1-of (a2 / and 
            :op2 (r / robust) 
            :op3 (t2 / technology 
                  :ARG1-of (g2 / general-02) 
                  :purpose (a / analyze-01 
                        :ARG0 (c2 / condition 
                              :ARG0-of (p / preserve-01 
                                    :ARG1 (m / mechanism 
                                          :ARG1-of (n / normal-02) 
                                          :mod (c / control-01 
                                                :ARG1 (m2 / mammalian))))) 
                        :ARG1 (g / gene)))))

# ::snt In addition , RMCE-ASAP could be used to generate fibroblastic cell lines tailored for the repeated targeting of widely studied genes ( p53 , c-myc , NF-KB , etc. ) .
# ::tok In addition , RMCE-ASAP could be used to generate fibroblastic cell lines tailored for the repeated targeting of widely studied genes ( p53 , c-myc , NF-KB , etc. ) .
# ::alignments 22-23|0.0.1.0.0.0.0.1.0 20-21|0.0.1.0.0.0.0.0 19-20|0.0.1.0.0.0.0.0.0 18-19|0.0.1.0.0.0.0.0.0.0 16-17|0.0.1.0.0.0.0.1 15-16|0.0.1.0.0.0.0 12-13|0.0.1.0.0.0 11-12|0.0.1.0.0 10-11|0.0.1.0 8-9|0.0.1 6-7|0.0 4-5|0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:06.844
(p2 / possible-01 
      :ARG1 (u / use-01 
            :ARG1 (t3 / thing 
                  :name (n / name 
                        :op1 "RMCE-ASAP")) 
            :ARG2 (g2 / generate-01 
                  :ARG1 (c / cell 
                        :mod-of (l / line 
                              :ARG1-of (t2 / tailor-01 
                                    :ARG2 (r / repeat-01 
                                          :ARG0 (g / gene 
                                                :ARG1-of (s / study-01 
                                                      :manner (w / wide))) 
                                          :ARG1 (t / target-01 
                                                :ARG1 (p / p53))))))) 
            :time (a / addition)))

# ::snt The authors thank A. Bradley for the PuroTK gene and SNLPuro-7 / 4 cells , P Soriano for the DTA gene , G. Campbell for technical assistance and E. T. Wong for helpful discussions .
# ::tok The authors thank A. Bradley for the PuroTK gene and SNLPuro-7 / 4 cells , P Soriano for the DTA gene , G. Campbell for technical assistance and E. T. Wong for helpful discussions .
# ::alignments 33-34|0.0 32-33|0.0.0 29-31|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 28-29|0.0.1.1.1.0.0+0.0.1.1.1.0+0.0.1.1.1 27-28|0.0.1.1 26-27|0.0.1.1.0 25-26|0.0.1.1.0.1 22-24|0.4.0.1+0.4.0.0+0.4.0+0.4 20-21|0.0.1.1.0.0.0 19-20|0.0.1.1.0.0.1.0+0.0.1.1.0.0.1+0.0.1.1.0.0 15-17|0.1.0.1.0.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 13-14|0.0.1.1.2 12-13|0.1.0.0 11-12|0.3 9-10|0 8-9|0.2 7-8|0.2.0.0.0+0.2.0.0+0.2.0 4-5|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:08.002
(a3 / and 
      :ARG0-of (d / discuss-01 
            :ARG1-of (h / helpful-04) 
            :ARG2 (p / person 
                  :name (n / name 
                        :op1 "T." 
                        :op2 "Wong") 
                  :op3-of (a / and 
                        :op1 (a2 / assist-01 
                              :ARG0 (o / organization 
                                    :mod-of (g / gene) 
                                    :name (n4 / name 
                                          :op1 "DTA")) 
                              :ARG2 (t / technical)) 
                        :op2 (p2 / person 
                              :name (n2 / name 
                                    :op1 "E.")) 
                        :poss-of (c / cell)))) 
      :ARG2-of (t4 / thank-01 
            :ARG0 (a4 / author-01 
                  :ARG0 4 
                  :ARG1 (t2 / thing 
                        :name (n5 / name 
                              :op1 (p4 / P) 
                              :op2 (s / Soriano)))) 
            :ARG1 (p5 / person 
                  :name (n7 / name 
                        :op1 "Bradley") 
                  :wiki -)) 
      :op1 (g2 / gene 
            :mod (t3 / thing 
                  :name (n6 / name 
                        :op1 "PuroTK"))) 
      :op2 (s2 / slash) 
      :op3 (p3 / person 
            :name (n3 / name 
                  :op1 "G." 
                  :op2 "Campbell")))

# ::snt The work was supported by NIH grants CA100845 and CA061449 to G.M.W. F.T. was supported in part by the Institut Pasteur and a fellowship from Association pour la Recherche sur le Cancer .
# ::tok The work was supported by NIH grants CA100845 and CA061449 to G.M.W. F.T. was supported in part by the Institut Pasteur and a fellowship from Association pour la Recherche sur le Cancer .
# ::alignments 25-32|0.3.0.6+0.3.0.5+0.3.0.4+0.3.0.3+0.3.0.2+0.3.0.1+0.3.0.0+0.3.0+0.3 23-24|0.2 21-22|0 19-21|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 14-15|0.1 11-13|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 9-10|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 8-9|0.0.0 7-8|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 3-4|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:09.500
(a / and 
      :op1 (s2 / support-01 
            :ARG0 (a2 / and 
                  :op1 (o4 / organization 
                        :ARG0-of (g / grant-01 
                              :ARG1 (o5 / organization 
                                    :name (n6 / name 
                                          :op1 "NIH"))) 
                        :name (n5 / name 
                              :op1 "CA100845")) 
                  :op2 (o3 / organization 
                        :name (n4 / name 
                              :op1 "CA061449"))) 
            :ARG1 (w / work-01)) 
      :op2 (s / support-01 
            :ARG0 (o2 / organization 
                  :name (n2 / name 
                        :op1 "Institut" 
                        :op2 "Pasteur")) 
            :ARG1 (p / person 
                  :name (n3 / name 
                        :op1 "G.M.W." 
                        :op2 "F.T."))) 
      :op3 (f / fellowship) 
      :op4 (o / organization 
            :name (n / name 
                  :op1 "Association" 
                  :op2 "pour" 
                  :op3 "la" 
                  :op4 "Recherche" 
                  :op5 "sur" 
                  :op6 "le" 
                  :op7 "Cancer")))

# ::snt Funding to pay the Open Access publication charges for this article was provided by the Institut Pasteur .
# ::tok Funding to pay the Open Access publication charges for this article was provided by the Institut Pasteur .
# ::alignments 15-17|0.0.0.1+0.0.0.0+0.0.0+0.0 12-13|0 10-11|0.1.1 9-10|0.1.1.0 7-8|0.1 6-7|0.1.0.0+0.1.0 5-6|0.1.3 2-3|0.1.2 0-1|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:09.633
(p / provide-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "Institut" 
                  :op2 "Pasteur")) 
      :ARG1 (c / charge-05 
            :ARG0 (p2 / publication 
                  :wiki -) 
            :ARG1 (a / article 
                  :mod (t / this)) 
            :ARG1-of (p3 / pay-01 
                  :ARG1-of (f / fund-01)) 
            :ARG2 (a2 / access-01)))

# ::snt Conflict of interest statement .
# ::tok Conflict of interest statement .
# ::alignments 3-4|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:09.647
(c / conflict-01 
      :ARG1 (s / state-01 
            :ARG0 (i / interest-01)))

# ::snt None declared .
# ::tok None declared .
# ::alignments 1-2|0 0-1|0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:09.654
(d / declare-01 
      :ARG0 (p / person 
            :quant (n / none)))

# ::snt Rationale for a RMCE-ASAP .
# ::tok Rationale for a RMCE-ASAP .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:09.663
(a / amr-empty)

# ::snt Using homologous recombination , the gene of interest ( GOI , open boxes : exons ) , is targeted with a construct introducing upstream of coding regions one loxP ( blue arrowhead ) and downstream , a positive/negative selection cassette ( red box ) and a second inverted heterologous loxP ( purple arrowhead ) to create RMCE-ready ES cells .
# ::tok Using homologous recombination , the gene of interest ( GOI , open boxes : exons ) , is targeted with a construct introducing upstream of coding regions one loxP ( blue arrowhead ) and downstream , a positive/negative selection cassette ( red box ) and a second inverted heterologous loxP ( purple arrowhead ) to create RMCE-ready ES cells .
# ::alignments 58-59|0.0.0.2.1.0.0 56-58|0.0.0.2.1.0.0.0.0.1+0.0.0.2.1.0.0.0.0.0+0.0.0.2.1.0.0.0.0+0.0.0.2.1.0.0.0 55-56|0.0.0.2.1.0 52-53|0.0.0.0.1.3.1 51-52|0.0.0.0.1.3 48-49|0.0.0.0.1.2.0 47-48|0.0.0.0.1.2 44-45|0.0 42-43|0.0.0.2.0.0 41-42|0.0.0.2.0 39-40|0.0.0.0.0.1 38-39|0.0.0.0.0.1.0 34-35|0 33-34|0.0.0.0.0 31-32|0.0.0.0.1.3.0.0 30-31|0.0.0.0.1.3.0 28-29|0.0.0.0.0.0 26-27|0.0.0.0.1.1 25-26|0.0.0.0.1 23-24|0.0.0.0.2 22-23|0.0.0.0 21-22|0.0.0 18-19|0.0.0.2 14-15|0.0.0.0.0.1.0.0 12-13|0.0.0.1.0 11-12|0.0.0.1 9-10|0.0.0.2.2.0.0.0+0.0.0.2.2.0.0+0.0.0.2.2.0 7-8|0.0.0.2.1.1 5-6|0.0.0.2.1 2-3|0.0.0.2.2.1 1-2|0.0.0.0.1.0 0-1|0.0.0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:11.741
(d / downstream 
      :op2-of (a2 / and 
            :op1 (c5 / construct-01 
                  :ARG0-of (i2 / introduce-02 
                        :ARG1 (a3 / and 
                              :op1 (l / loxP) 
                              :op2 (c3 / cassette 
                                    :ARG1-of (s / select-01 
                                          :ARG0 (e2 / exon)))) 
                        :condition (c4 / code-01 
                              :ARG0 (h2 / homologou) 
                              :ARG1 (r3 / region) 
                              :ARG2-of (i / invert-01 
                                    :ARG1 (h / heterologou)) 
                              :ARG2-of (p / purple-02 
                                    :ARG0 (b2 / blue 
                                          :mod-of (a4 / arrowhead)) 
                                    :ARG1 (a / arrowhead))) 
                        :manner (u / upstream)) 
                  :ARG1 (o / open-04 
                        :ARG1 (b3 / box)) 
                  :ARG2-of (t2 / target-01 
                        :ARG0 (r2 / red 
                              :mod-of (b / box)) 
                        :ARG1 (g / gene 
                              :ARG0-of (c2 / create-01 
                                    :ARG1 (c / cell 
                                          :mod (t / thing 
                                                :name (n / name 
                                                      :op1 (r / RMCE-ready) 
                                                      :op2 (e / ES))))) 
                              :ARG2-of (i3 / interest-01)) 
                        :purpose (u2 / use-01 
                              :ARG0 (o2 / organization 
                                    :name (n2 / name 
                                          :op1 "GOI")) 
                              :ARG1 (r4 / recombination))))))

# ::snt An exchange is performed in these cells by co-transfecting a Cre expression plasmid and a marker-free plasmid with a floxed mutant GOI ( green box : mutated exon ) , to produce a mutant mouse ( path A ) .
# ::tok An exchange is performed in these cells by co-transfecting a Cre expression plasmid and a marker-free plasmid with a floxed mutant GOI ( green box : mutated exon ) , to produce a mutant mouse ( path A ) .
# ::alignments 36-37|0.0.0.0.1.0.0 34-35|0.0 33-34|0 31-32|0.0.0 27-28|0.0.0.0.0.0.0.0.0.0 26-27|0.0.0.0.0.0.0.0.0 24-25|0.0.0.0.0.0.0.0 23-24|0.0.0.0.0.0.0 21-22|0.0.0.0.0.0.1.2.0+0.0.0.0.0.0.1.2+0.0.0.0.0.0.1 20-21|0.0.0.0.0.0.1.0 19-20|0.0.0.0.0.0.1.1 16-17|0.0.0.0.2 13-14|0.0.0.0 12-13|0.0.0.0.1 11-12|0.0.0.0.1.0 6-7|0.0.0.0.0.1 5-6|0.0.0.0.0.1.0 3-4|0.0.0.0.0 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:12.161
(m2 / mutant 
      :mod-of (m / mouse 
            :ARG1-of (p2 / produce-01 
                  :op4-of (a / and 
                        :op1 (p5 / perform-02 
                              :ARG1 (e3 / exchange-01 
                                    :ARG1 (g / green-02 
                                          :ARG1 (b / box 
                                                :ARG0-of (m3 / mutate-01 
                                                      :ARG1 (e / exon)))) 
                                    :op1-of (o / organization 
                                          :mod (m4 / mutant) 
                                          :mod (f / flox) 
                                          :name (n / name 
                                                :op1 "GOI"))) 
                              :location (c / cell 
                                    :mod (t / this))) 
                        :op2 (p4 / plasmid 
                              :ARG1-of (e2 / express-01 
                                    :ARG0 (p / path))) 
                        :op3 (p3 / plasmid)))))

# ::snt Importantly RMCE-ASAP incorporates two major improvements over classical RMCE ( path B ) : ( i ) the positive/negative selection cassette does not prevent germline transmission , so that RMCE-ready mice can be obtained ; ( ii ) the selection cassette does not replace , but rather lies downstream of the GOI .
# ::tok Importantly RMCE-ASAP incorporates two major improvements over classical RMCE ( path B ) : ( i ) the positive/negative selection cassette does not prevent germline transmission , so that RMCE-ready mice can be obtained ; ( ii ) the selection cassette does not replace , but rather lies downstream of the GOI .
# ::alignments 51-52|0.0.1.0.0+0.0.1.0+0.0.1 48-49|0.0.2 47-48|0.0 45-46|0 43-44|0.0.0.0 42-43|0.0.0.0.0 40-41|0.0.0 39-40|0.0.0.1 36-37|0.0.0.0.1.3.0.2.1 34-35|0.0.0.0.1.3.0.2 33-34|0.0.0.0.1.3.0 31-32|0.0.0.0.1.3 30-31|0.0.0.0.1.3.0.1 29-30|0.0.0.0.1.3.0.2.0.0.0.0+0.0.0.0.1.3.0.2.0.0.0+0.0.0.0.1.3.0.2.0.0 25-26|0.0.0.0.1.1 23-24|0.0.0.0.1 22-23|0.0.0.0.1.2 20-21|0.0.0.0.1.0 19-20|0.0.0.0.1.0.0 15-16|0.0.0.0.1.0.1 11-12|0.0.0.0.1.3.0.0.2+0.0.0.0.1.3.0.0.1.0+0.0.0.0.1.3.0.0.1+0.0.0.0.1.3.0.0 10-11|0.0.0.0.1.3.0.0.0 7-8|0.0.0.0.1.0.0.0 5-6|0.0.0.0.1.3.0.2.0 4-5|0.0.0.0.1.3.0.2.0.1 3-4|0.0.0.0.1.3.0.2.0.3 2-3|0.0.0.0.1.3.0.2.0.2 0-2|0.0.0.0.1.3.0.2.0.2.0.0.1+0.0.0.0.1.3.0.2.0.2.0.0.0+0.0.0.0.1.3.0.2.0.2.0.0+0.0.0.0.1.3.0.2.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:14.079
(c / contrast-01 
      :ARG2 (l / lie-07 
            :ARG0 (c2 / cassette 
                  :ARG0-of (r / replace-01 
                        :polarity - 
                        :purpose (p2 / prevent-01 
                              :ARG0 (c3 / cassette 
                                    :ARG1-of (s2 / select-01 
                                          :ARG0 (c4 / classics)) 
                                    :op1-of (i2 / i)) 
                              :ARG1 (t2 / transmission) 
                              :polarity - 
                              :purpose (p / possible-01 
                                    :ARG1 (o2 / obtain-01 
                                          :ARG0 (l2 / location 
                                                :mod (p3 / path) 
                                                :name (n3 / name 
                                                      :op1 "B") 
                                                :wiki -) 
                                          :ARG1 (m / mouse) 
                                          :op2-of (a / and 
                                                :op1 (i3 / improve-01 
                                                      :ARG1 (t / thing 
                                                            :name (n2 / name 
                                                                  :op1 "RMCE-ready")) 
                                                      :ARG1-of (m2 / major-02) 
                                                      :ARG1-of (i4 / incorporate-01 
                                                            :ARG0 (t3 / thing 
                                                                  :name (n4 / name 
                                                                        :op1 (i5 / Importantly) 
                                                                        :op2 (r2 / RMCE-ASAP)))) 
                                                      :quant 2) 
                                                :op3 (i / ii)))))) 
                  :ARG1-of (s / select-01)) 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "GOI")) 
            :ARG3 (d / downstream)))

# ::snt This is a crucial requirement for accelerated phenotyping in somatic cells , as maintaining a functional GOI ensures that the RMCE-ready locus still behaves like a WT locus .
# ::tok This is a crucial requirement for accelerated phenotyping in somatic cells , as maintaining a functional GOI ensures that the RMCE-ready locus still behaves like a WT locus .
# ::alignments 27-28|0.1.0.1.1.0 24-25|0.1.0.1.1 23-24|0.1.0.1 22-23|0.1.0.1.2 21-22|0.1.0.1.0 20-21|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 17-18|0.1.0 16-17|0.1.0.0.2.0+0.1.0.0.2+0.1.0.0 15-16|0.1.0.0.1 13-14|0.1.0.0.0 10-11|0.0 9-10|0.0.0 6-7|0 4-5|0.1 3-4|0.1.2 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:14.748
(a / accelerate-01 
      :ARG1 (c / cell 
            :mod (s2 / somatic)) 
      :ARG1-of (r2 / require-01 
            :condition (e / ensure-01 
                  :ARG0 (o / organization 
                        :ARG1-of (m / maintain-01 
                              :ARG0 (t / thing 
                                    :name (n / name 
                                          :op1 "RMCE-ready"))) 
                        :mod (f / functional) 
                        :name (n2 / name 
                              :op1 "GOI")) 
                  :ARG1 (b / behave-01 
                        :ARG0 (l2 / locu) 
                        :ARG1-of (r / resemble-01 
                              :ARG2 (l / locu)) 
                        :mod (s / still))) 
            :domain (t2 / this) 
            :mod (c2 / crucial)))

# ::snt Hence , after breeding the RMCE-ready mouse with mice heterozygotes for the GOI , somatic cells with an RMCE-ready locus and a WT or KO allele can be recovered [ e.g. RMCE / + and RMCE /  mouse embryonic fibroblasts ( MEFs ) ] .
# ::tok Hence , after breeding the RMCE-ready mouse with mice heterozygotes for the GOI , somatic cells with an RMCE-ready locus and a WT or KO allele can be recovered [ e.g. RMCE / + and RMCE /  mouse embryonic fibroblasts ( MEFs ) ] .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:14.751
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Such cells , phenotypically similar to + / + and + /  cells , can then be used for phenotypic analyses of dominant or recessive mutations after a single exchange .
# ::tok Such cells , phenotypically similar to + / + and + /  cells , can then be used for phenotypic analyses of dominant or recessive mutations after a single exchange .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:14.754
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Generating ES cells with a p53 RMCE-ready locus .
# ::tok Generating ES cells with a p53 RMCE-ready locus .
# ::alignments 7-8|0.0.0.0.0 6-7|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 5-6|0.0.0.0.0.1 2-3|0.0.0.0 0-2|0.0.1+0+0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:14.793
(g / Generating 
      :op1-of (n2 / name 
            :name-of (t2 / thing 
                  :mod-of (c / cell 
                        :prep-with (l / locu 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 "RMCE-ready")) 
                              :mod (p / p53)))) 
            :op2 (e / ES)))

# ::snt The p53 gene is contained in a 17 kb-long EcoRI ( RI ) fragment ( black boxes : coding sequences , white boxes : UTRs ) .
# ::tok The p53 gene is contained in a 17 kb-long EcoRI ( RI ) fragment ( black boxes : coding sequences , white boxes : UTRs ) .
# ::alignments 24-25|0.0 22-23|0.1.0.0.0.0 21-22|0.1.0.0.0 19-20|0.2.1 18-19|0.2 16-17|0.1.1.0.0 15-16|0.1.1.0 13-14|0.1.0 11-12|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 9-10|0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 7-8|0.2.0 4-5|0 2-3|0.1 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:15.103
(c3 / contain-01 
      :ARG0 (u / utr) 
      :ARG1 (g / gene 
            :ARG1-of (f / fragment-01 
                  :ARG0 (p / person 
                        :mod (w / white 
                              :mod-of (b / box)) 
                        :name (n2 / name 
                              :op1 "EcoRI")) 
                  :location (c2 / country 
                        :name (n / name 
                              :op1 "RI"))) 
            :mod (p2 / p53 
                  :ARG0-of (b3 / black-04 
                        :ARG1 (b2 / box)))) 
      :purpose (c / code-01 
            :ARG0 17 
            :ARG1 (s / sequence)))

# ::snt The Flox targeting construct ( below ) , the sequence which was verified before use ( Materials and Methods ) , contains ( i ) a 3.4 kb-long 5  homology region ; ( ii ) 0.2 kb upstream of coding sequences , an EcoRI site and L3 , a mutant loxP [ loxP257 , ( 14 ) ] ; ( iii ) p53 exons ; ( iv ) 0.4 kb downstream , a puroTK fusion gene ( puDTK ) for positive/negative selection ( 21 ) and an inverted WT loxP ( 1L ) ; ( v ) a 1.2 kb-long 3  homology region and ( vi ) the diphteria -toxin ( DTA ) gene for targeting enrichment .
# ::tok The Flox targeting construct ( below ) , the sequence which was verified before use ( Materials and Methods ) , contains ( i ) a 3.4 kb-long 5  homology region ; ( ii ) 0.2 kb upstream of coding sequences , an EcoRI site and L3 , a mutant loxP [ loxP257 , ( 14 ) ] ; ( iii ) p53 exons ; ( iv ) 0.4 kb downstream , a puroTK fusion gene ( puDTK ) for positive/negative selection ( 21 ) and an inverted WT loxP ( 1L ) ; ( v ) a 1.2 kb-long 3  homology region and ( vi ) the diphteria -toxin ( DTA ) gene for targeting enrichment .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:15.107
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The recombinants resulting from the depicted crossing-overs are identified by a 6.5 kb band in Southern blot with probe A and a 3 kb band by PCR with primers a and b .
# ::tok The recombinants resulting from the depicted crossing-overs are identified by a 6.5 kb band in Southern blot with probe A and a 3 kb band by PCR with primers a and b .
# ::alignments 31-32|0.0.0.0 30-31|0 28-29|0.0.0.3.0 24-25|0.0.2 22-23|0.0.0.1.0.1.0.0 20-21|0.0 18-19|0.0.0.3.2 16-17|0.0.0.3 15-16|0.0.0.3.1.0.0+0.0.0.3.1.0+0.0.0.3.1 13-14|0.0.0.2 12-13|0.0.1 11-12|0.0.0.1.0.0 8-9|0.0.0 6-7|0.0.0.1.0.1 5-6|0.0.0.1.0.1.0 2-3|0.0.0.1.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:15.755
(a / and 
      :op1 (a2 / and 
            :op1 (i / identify-01 
                  :ARG0 (b / b) 
                  :ARG1 (r2 / recombinant 
                        :ARG1-of (r / result-01 
                              :ARG0 6.5 
                              :ARG2 (c / crossing-over 
                                    :ARG1-of (d / depict-01 
                                          :ARG0 3)))) 
                  :manner (b4 / band) 
                  :manner (b3 / blot-01 
                        :ARG0 (p / primer) 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Southern")) 
                        :ARG2 (p2 / probe-01))) 
            :op2 (k / kb) 
            :op3 (b2 / band)))

# ::snt A representative Southern , and PCR of one positive (  ) and two negative clones , are shown .
# ::tok A representative Southern , and PCR of one positive (  ) and two negative clones , are shown .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:15.757
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Performing RMCE in ES cells .
# ::tok Performing RMCE in ES cells .
# ::alignments 4-5|0.0.0 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:15.772
(p / perform-01 
      :ARG1 (e / e 
            :mod-of (c / cell)))

# ::snt ( A ) RMCE with a p53GFP plasmid .
# ::tok ( A ) RMCE with a p53GFP plasmid .
# ::alignments 7-8|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:15.779
(p / plasmid)

# ::snt The exchange plasmid , the sequence which was verified before use , contains p53GFP coding sequences flanked by L3 and 1L sites .
# ::tok The exchange plasmid , the sequence which was verified before use , contains p53GFP coding sequences flanked by L3 and 1L sites .
# ::alignments 21-22|0.1.0.0.2 19-20|0.1.0.0 18-19|0.1.0.0.1 16-17|0.1.0 15-16|0.1 14-15|0.1.1 12-13|0 10-11|0.1.0.0.0 9-10|0.1.0.0.0.0 8-9|0.1.0.0.0.0.0 5-6|0.1.0.0.0.0.0.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:16.231
(c2 / contain-01 
      :ARG0 (p / plasmid 
            :ARG1-of (e / exchange-01)) 
      :ARG1 (s2 / sequence 
            :ARG1-of (f / flank-01 
                  :ARG0 (a / and 
                        :ARG1-of (u / use-01 
                              :op1-of (b / before 
                                    :time-of (v / verify-01 
                                          :ARG1 (s3 / sequence)))) 
                        :op1 (l / L3) 
                        :op2 (s / site))) 
            :ARG1-of (c / code-01)))

# ::snt It was electroporated with a Cre expression plasmid .
# ::tok It was electroporated with a Cre expression plasmid .
# ::alignments 7-8|0 6-7|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:16.245
(p / plasmid 
      :ARG1-of (e / express-01 
            :ARG0 (i / it)))

# ::snt FIAU-resistant clones were analyzed by PCR with primers b and c and Southern blot with probe B. Both approaches led to identical results and identified 54/65 RMCE recombinants .
# ::tok FIAU-resistant clones were analyzed by PCR with primers b and c and Southern blot with probe B. Both approaches led to identical results and identified 54/65 RMCE recombinants .
# ::alignments 27-28|0.0.0.2.3.1 24-25|0.0.0.2.3 23-24|0.0.0.2 22-23|0+0.0 21-22|0.0.1 19-20|0.0.0 18-19|0.0.0.1 17-18|0.0.0.0 15-17|0.0.0.2.3.0.1.1+0.0.0.2.3.0.1.0+0.0.0.2.3.0.1+0.0.0.2.3.0 13-14|0.0.0.2.3.0.0 12-13|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 11-12|0.0.0.2.2 10-11|0.0.0.2.3.0.0.0 9-10|0.0.0.2.1 8-9|0.0.1.0 7-8|0.0.0.2.0.0.0 3-4|0.0.0.2.0.0 1-2|0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:16.858
(r2 / result-01 
      :ARG2 (t / thing 
            :ARG2-of (l / lead-02 
                  :ARG0 (b / both) 
                  :ARG1 (a2 / approach-02 
                        :ARG1 (t3 / thing 
                              :name (n2 / name 
                                    :op1 "Southern"))) 
                  :op2-of (a / and 
                        :ARG1-of (c2 / clone-01 
                              :ARG1-of (a5 / analyze-01 
                                    :ARG2 (p2 / primer))) 
                        :op1 (a4 / and) 
                        :op1-of (a3 / and) 
                        :op3 (i / identify-01 
                              :ARG0 (t2 / thing 
                                    :ARG2-of (b3 / blot-01 
                                          :ARG1 (c / c)) 
                                    :name (n / name 
                                          :op1 (p / probe) 
                                          :op2 (b2 / B.))) 
                              :ARG1 (r / recombinant)))) 
            :ARG2-of (i2 / identical-01 
                  :ARG1 (b4 / b))))

# ::snt Representative clones ( P -- Z ) are shown ( left ) , analyzed by PCR ( top ) and Southern ( bottom ) : all clones but Q and T are positive with both assays .
# ::tok Representative clones ( P -- Z ) are shown ( left ) , analyzed by PCR ( top ) and Southern ( bottom ) : all clones but Q and T are positive with both assays .
# ::alignments 35-36|0.1.2 34-35|0.1.2.0 32-33|0.1 30-31|0.1.0.1.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 29-30|0.1.0 28-29|0.1.1 27-28|0 26-27|0.1.0.0 25-26|0.1.0.0.1 22-23|0.2.0.1 20-21|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 19-20|0.2.0 17-18|0.2.1 13-14|0.2 10-11|0.0.1 8-9|0.0 5-6|0.1.0.0.0 3-4|0.0.1.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:17.955
(c / contrast-01 
      :ARG1 (s / show-01 
            :ARG1 (c3 / clone-01 
                  :ARG1 (r / represent-01)) 
            :ARG2 (l / leave-11 
                  :ARG1 (p2 / P60))) 
      :ARG2 (p / positive 
            :domain (a3 / and 
                  :op1 (c2 / clone-01 
                        :ARG1 (z / z) 
                        :quant (a4 / all)) 
                  :op2 (a2 / aircraft-type 
                        :name (n / name 
                              :op1 "T50") 
                        :wiki "Sukhoi_PAK_FA")) 
            :domain (q / q) 
            :time (a / assay 
                  :mod (b / both))) 
      :condition (a6 / analyze-01 
            :ARG0 (a5 / and 
                  :op1 (t / thing 
                        :name (n2 / name 
                              :op1 "Southern")) 
                  :op2 (b2 / bottom)) 
            :ARG1 (t2 / top)))

# ::snt All positive clones produced a band of the expected size by PCR , indicating correct recombination at 1L , and displayed only the expected 12 and 5 kb bands by Southern , indicating correct recombination at L3 .
# ::tok All positive clones produced a band of the expected size by PCR , indicating correct recombination at 1L , and displayed only the expected 12 and 5 kb bands by Southern , indicating correct recombination at L3 .
# ::alignments 34-35|0.1.0.0.0.0.1.1 33-34|0.1.0.0.0.0.1.1.0 32-33|0.1.0.0.0.0.1 30-31|0.1.0.0.0.0.1.0.0.0+0.1.0.0.0.0.1.0.0+0.1.0.0.0.0.1.0 28-29|0.1.0.0.0.0.0.0.0.1.1.0.0 27-28|0.1.0.0.0.0.0.0.0.1.0 26-27|0.1.0.0.0.0.0.0.1 25-26|0.1.0 24-25|0.0 23-24|0 21-22|0.1 20-21|0.1.0.0.0.0 19-20|0.1.0.0.0.0.0 15-16|0.1.0.0.0.0.0.0.0.1.1 14-15|0.1.0.0.0.0.0.0.0.1.1.0 13-14|0.1.0.0.0.0.0.0.0.1 9-10|0.1.0.0.0 8-9|0.1.0.0 5-6|0.1.0.0.0.0.0.0.0.0 3-4|0.1.0.0.0.0.0.0.0 2-3|0.1.0.0.0.0.0.0 1-2|0.1.0.0.0.0.0.0.2 0-1|0.1.0.0.0.0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:18.762
(e / expect-01 
      :ARG1 12 
      :mod (o / only 
            :mod-of (a / and 
                  :op1 (e2 / expect-01 
                        :ARG1 (s / size 
                              :ARG1-of (d / display-01 
                                    :op2-of (a2 / and 
                                          :op1 (c3 / clone-01 
                                                :ARG0-of (p / produce-01 
                                                      :ARG1 (b2 / band) 
                                                      :purpose (i2 / indicate-01 
                                                            :ARG0 (k / kb) 
                                                            :ARG1 (r2 / recombination 
                                                                  :ARG1-of (c2 / correct-02 
                                                                        :ARG0 (b / band))))) 
                                                :ARG1 5 
                                                :mod (p2 / positive) 
                                                :quant (a3 / all))) 
                                    :purpose (i / indicate-01 
                                          :ARG0 (t / thing 
                                                :name (n / name 
                                                      :op1 "Southern")) 
                                          :ARG1 (r / recombination 
                                                :ARG1-of (c / correct-02)))))))))

# ::snt The absence of bands of aberrant size in Southerns also indicated that the exchange plasmid was neither rearranged nor inserted at ectopic sites .
# ::tok The absence of bands of aberrant size in Southerns also indicated that the exchange plasmid was neither rearranged nor inserted at ectopic sites .
# ::alignments 22-23|0.1.0.0.0 21-22|0.1.0.0.0.0 19-20|0.1.0.0 17-18|0.1 14-15|0.1.0 13-14|0.1.0.1 10-11|0 9-10|0.2 8-9|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.1 3-4|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:19.038
(i2 / indicate-01 
      :ARG0 (a3 / absent-01 
            :ARG1 (b / band 
                  :consist-of (s2 / size 
                        :location (c / country 
                              :name (n / name 
                                    :op1 "Southerns")) 
                        :mod (a2 / aberrant)))) 
      :ARG1 (r / rearrange-01 
            :ARG1 (p / plasmid 
                  :ARG0-of (i / insert-01 
                        :ARG1 (s / site 
                              :mod (e / ectopic))) 
                  :ARG1-of (e2 / exchange-01))) 
      :mod (a / also))

# ::snt Thus RMCE was efficient and accurate .
# ::tok Thus RMCE was efficient and accurate .
# ::alignments 5-6|0.1 4-5|0 3-4|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:19.050
(a2 / and 
      :op1 (e / efficient-01) 
      :op2 (a / accurate) 
      :time (t / thu))

# ::snt Recombinant clones were analyzed by western blot with an antibody to p53 .
# ::tok Recombinant clones were analyzed by western blot with an antibody to p53 .
# ::alignments 11-12|0.1.0 9-10|0.2 6-7|0.0 5-6|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 3-4|0 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:19.120
(a2 / analyze-01 
      :ARG0 (b / blot-01 
            :ARG1 (w / world-region 
                  :name (n / name 
                        :op1 "West") 
                  :wiki "Western_world")) 
      :ARG1 (c / clone-01 
            :ARG0 (p / p53) 
            :ARG1 (r / recombinant)) 
      :ARG2 (a / antibody))

# ::snt In the representative western ( right ) , cells from two independent p53 + / GFP ES clones were left untreated or treated with adriamycin ( ADR ) at 0.5 g/ml for 24 h , and protein extracts were prepared .
# ::tok In the representative western ( right ) , cells from two independent p53 + / GFP ES clones were left untreated or treated with adriamycin ( ADR ) at 0.5 g/ml for 24 h , and protein extracts were prepared .
# ::alignments 39-40|0.0.0.0.2 37-38|0.0+0.0.0 36-37|0 35-36|0.0.0.0 32-33|0.0.0.0.0.0.0.0 29-30|0.0.0.0.1.2 24-25|0.0.0.0.0.0.0.1.1 22-23|0.0.0.0.0.0.0.1 21-22|0.0.0.0.0.0.0.1.2 20-21|0.0.0.0.0.0.0.1.2.0.1 19-20|0.0.0.0.0.0.0.1.2.0 17-18|0.0.0.0.0.0.0 15-17|0.0.0.0.0.0.1.1+0.0.0.0.0.0.1.0+0.0.0.0.0.0.1+0.0.0.0.0.0 14-15|0.0.0.0.0.0.2 12-13|0.0.0.0.1.1 11-12|0.0.0.0.0.1+0.0.0.0.0 10-11|0.0.0.0.0.0.0.1.0 8-9|0.0.0.0.2.0 5-6|0.0.0.0.0.0.0.1.2.0.0 3-4|0.0.0.0.1.0.1+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 2-3|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:19.979
(p2 / protein 
      :ARG0-of (e / extract-01 
            :ARG1 (t / thing 
                  :op1-of (a / and 
                        :ARG0-of (d / depend-01 
                              :ARG1 (t3 / thing 
                                    :ARG1-of (c / clone-01 
                                          :ARG0 24 
                                          :ARG1-of (t2 / treat-01 
                                                :ARG0 2 
                                                :ARG2 (a2 / adriamycin) 
                                                :op2-of (o / or 
                                                      :op1 (l / leave-11 
                                                            :ARG0 (r / right) 
                                                            :ARG1 (u / untreat))))) 
                                    :name (n / name 
                                          :op1 (g / GFP) 
                                          :op2 (e2 / ES)) 
                                    :op1-of (s / slash)) 
                              :polarity -) 
                        :ARG0-of (r2 / represent-01 
                              :ARG1 (w / world-region 
                                    :name (n2 / name 
                                          :op1 "West") 
                                    :wiki "Western_world") 
                              :ARG2 (p3 / p53) 
                              :op1-of 0.5) 
                        :ARG1-of (p / prepare-02 
                              :ARG0 (c2 / cell))))))

# ::snt p53GFP migrated at the expected size of 80 kDa and was expressed at unexpectedly high levels regardless of stress .
# ::tok p53GFP migrated at the expected size of 80 kDa and was expressed at unexpectedly high levels regardless of stress .
# ::alignments 18-19|0.1.0.0 16-17|0.1.0.2.1+0.1.0.2 15-16|0.1.0 14-15|0.1.0.1 13-14|0.1.0.1.0 11-12|0.1 9-10|0 8-9|0.0.1.1 7-8|0.1.0.2.0 5-6|0.0.1 4-5|0.0.1.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:20.108
(a / and 
      :op1 (m / migrate-01 
            :ARG0 (p / p53GFP) 
            :ARG1 (s2 / size 
                  :ARG1-of (e2 / expect-01) 
                  :poss (k / kDa))) 
      :op2 (e / express-01 
            :ARG1 (l / level 
                  :ARG1-of (s / stress-02) 
                  :ARG1-of (h / high-02 
                        :degree (u / unexpectedly)) 
                  :time (r / regard-01 
                        :ARG1 80 
                        :polarity -))))

# ::snt ( B ) RMCE with a p53PGFP plasmid .
# ::tok ( B ) RMCE with a p53PGFP plasmid .
# ::alignments 7-8|0.1 1-2|0.2+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:20.121
(l / location 
      :name (n / name 
            :op1 "B") 
      :part (p / plasmid) 
      :wiki -)

# ::snt The p53PGFP exchange construct ( which sequence was verified before use ) differed from the p53GFP construct only in that it contains a mutated exon 4 ( 4 * ) encoding a PRD deletion .
# ::tok The p53PGFP exchange construct ( which sequence was verified before use ) differed from the p53GFP construct only in that it contains a mutated exon 4 ( 4 * ) encoding a PRD deletion .
# ::alignments 33-34|0.0.0 32-33|0.0.1.0+0.0.1+0.0 30-31|0.0.0.0 27-28|0.2.0.1.1.1.0 25-26|0.2.0.1.0.0 24-25|0.2.0.1.1.0.0 23-24|0.2.0.1.1.0.0.0 21-22|0.2.0.1.1.0 17-18|0.1 16-17|0.2.0.1.1.1 12-13|0.2.0.1.1 10-11|0 9-10|0.2 8-9|0.2.0 6-7|0.2.0.0 3-4|0.2.0.1 2-3|0.2.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:20.697
(u / use-01 
      :ARG0 (o / organization 
            :mod-of (d / deletion 
                  :ARG1-of (e / encode-01)) 
            :name (n / name 
                  :op1 "PRD")) 
      :ARG1 (o2 / only) 
      :op1-of (b / before 
            :time-of (v / verify-01 
                  :ARG1 (s / sequence) 
                  :ARG2 (c3 / construct-01 
                        :ARG1 (e3 / exchange-01 
                              :ARG1 4) 
                        :ARG1-of (d2 / differ-01 
                              :ARG0 (c / contain-01 
                                    :ARG1 (e2 / exon 
                                          :ARG1-of (m / mutate-01))) 
                              :ARG2 (c2 / construct-01 
                                    :ARG1 4))))))

# ::snt RMCE was again very efficient , with 10/12 FIAU-resistant clones producing a 3 kb band by PCR with primers b and c .
# ::tok RMCE was again very efficient , with 10/12 FIAU-resistant clones producing a 3 kb band by PCR with primers b and c .
# ::alignments 21-22|0.0.0.0 20-21|0 19-20|0.0.0.1 18-19|0.0.3 14-15|0.0.1 13-14|0.0.2.0 12-13|0.0.1.0 10-11|0.0 9-10|0.0.0 4-5|0.0.2 3-4|0.0.2.1 2-3|0.0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:20.823
(a / and 
      :op1 (p2 / produce-01 
            :ARG0 (c2 / clone-01 
                  :ARG0 (c / c) 
                  :ARG1 (b / b)) 
            :ARG1 (b2 / band 
                  :quant 3) 
            :ARG1-of (e / efficient-01 
                  :ARG0 (k / kb) 
                  :degree (v / very) 
                  :mod (a2 / again)) 
            :manner (p / primer)))

# ::snt A western analysis of four FIAU-resistant clones is shown below ( with low/high exposures : Lo X/Hi X ) .
# ::tok A western analysis of four FIAU-resistant clones is shown below ( with low/high exposures : Lo X/Hi X ) .
# ::alignments 15-18|0.1.0.0.2+0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 13-14|0.0 9-10|0.3 8-9|0 6-7|0.1.1 4-5|0.2 2-3|0.1 1-2|0.1.2.1+0.1.2.0.0+0.1.2.0+0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:20.935
(s / show-01 
      :ARG0 (e / exposur) 
      :ARG1 (a / analyze-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "Lo" 
                        :op2 "X/Hi" 
                        :op3 "X")) 
            :ARG1 (c / clone-01) 
            :manner (w / world-region 
                  :name (n2 / name 
                        :op1 "West") 
                  :wiki "Western_world")) 
      :ARG3 4 
      :ARG4 (b / below))

# ::snt As expected , all except clone x expressed p53PGFP .
# ::tok As expected , all except clone x expressed p53PGFP .
# ::alignments 8-9|0.1 7-8|0 6-7|0.3.0 5-6|0.2.0 4-5|0.2 3-4|0.0 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:20.976
(e / express-01 
      :ARG0 (a / all) 
      :ARG1 (p / p53PGFP) 
      :condition-of (e2 / except-01 
            :ARG1 (c / clone)) 
      :time (e3 / expect-01 
            :ARG1 (x / x)))

# ::snt p53PGFP migrated at the expected size of 75 kDa and accumulated after stress , but at lower levels than p53WT .
# ::tok p53PGFP migrated at the expected size of 75 kDa and accumulated after stress , but at lower levels than p53WT .
# ::alignments 19-20|0.0.0.1.0.0 17-18|0.0.0.0.2.0 16-17|0.0.0.0.2 14-15|0 12-13|0.0.0.1.0 11-12|0.0.0.1 10-11|0.0 9-10|0.0.0 8-9|0.0.0.0.1.1 7-8|0.0.0.0.1.1.0 5-6|0.0.0.0.1 4-5|0.0.0.0.1.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:21.205
(c / contrast-01 
      :ARG1 (a2 / accumulate-01 
            :op2-of (a3 / and 
                  :op1 (m / migrate-01 
                        :ARG0 (p2 / p53PGFP) 
                        :ARG1 (s2 / size 
                              :ARG1-of (e / expect-01) 
                              :poss (k / kDa 
                                    :quant 75)) 
                        :purpose-of (l2 / low-04 
                              :ARG1 (l / level))) 
                  :time (a / after 
                        :op1 (s / stress-02 
                              :ARG1 (p / p53WT))))))

# ::snt ( C ) Germline transmission of the p53PGFP mutation .
# ::tok ( C ) Germline transmission of the p53PGFP mutation .
# ::alignments 8-9|0.0 4-5|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:21.217
(t / transmission 
      :poss (m / mutation 
            :domain (c / C)))

# ::snt DNA of seven littermates ( U42 -- U48 ) , obtained from mating a p53PGFP chimera with a WT mouse , was analyzed by PCR with primers d and e ( see B ) , with DNA from WT , p53 + / P and p53P/P MEFs ( 5 ) as controls .
# ::tok DNA of seven littermates ( U42 -- U48 ) , obtained from mating a p53PGFP chimera with a WT mouse , was analyzed by PCR with primers d and e ( see B ) , with DNA from WT , p53 + / P and p53P/P MEFs ( 5 ) as controls .
# ::alignments 51-52|0.5 48-49|0.5.0 46-47|0.4.2 44-45|0.4 43-44|0.4.1 42-43|0.4.1.0 40-41|0.4.1.0.0 36-37|0.4.0 32-33|0.1.2.0.1+0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 31-32|0.1.2 29-30|0.3 28-29|0 27-28|0.2 26-27|0.0.0 22-23|0.0 19-20|0.1.0.2 15-16|0.1.0.1 12-13|0.1.0 10-11|0.1 3-4|0.1.1 2-3|0.1.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:22.161
(a2 / and 
      :ARG1-of (a3 / analyze-01 
            :ARG2 (p3 / primer)) 
      :op1 (o / obtain-01 
            :ARG1 (m3 / mate-01 
                  :ARG0 (d3 / DNA) 
                  :ARG1 (c2 / chimera) 
                  :manner (m2 / mouse)) 
            :ARG2 (l2 / littermat 
                  :quant 7) 
            :ARG2-of (s2 / see-01 
                  :ARG1 (l / location 
                        :name (n / name 
                              :op1 "B") 
                        :wiki -))) 
      :op2 (d2 / d) 
      :op3 (e / e) 
      :op4 (a / and 
            :mod (d / DNA) 
            :op1 (p / P60 
                  :op2-of (s / slash 
                        :op1 (p2 / p53))) 
            :op2 (m / mef)) 
      :op5 (c / control-01 
            :ARG1 5))

# ::snt U45 , a p53 + / PGFP mouse , demonstrated transmission of the mutation .
# ::tok U45 , a p53 + / PGFP mouse , demonstrated transmission of the mutation .
# ::alignments 13-14|0.1.0 10-11|0.1 9-10|0 7-8|0.0 5-6|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:22.187
(d / demonstrate-01 
      :ARG0 (m2 / mouse 
            :op1-of (s / slash)) 
      :ARG1 (t / transmission 
            :poss (m / mutation)))

# ::snt Germline transmission of the p53 RMCE-ready locus .
# ::tok Germline transmission of the p53 RMCE-ready locus .
# ::alignments 6-7|0.0 5-6|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 4-5|0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:22.206
(t2 / transmission 
      :mod (l / locu 
            :mod (p / p53 
                  :mod-of (t / thing 
                        :name (n / name 
                              :op1 "RMCE-ready")))))

# ::snt p53RMCE / + ES cells were injected into blastocysts to generate chimeric mice .
# ::tok p53RMCE / + ES cells were injected into blastocysts to generate chimeric mice .
# ::alignments 12-13|0.1 11-12|0.1.0 10-11|0 8-9|0.0 6-7|0.2 4-5|0.2.0 3-4|0.2.0.0 1-2|0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:22.286
(g / generate-01 
      :ARG0 (b / blastocyst) 
      :ARG1 (m / mouse 
            :mod (c / chimeric)) 
      :ARG1-of (i / inject-01 
            :ARG2 (c2 / cell 
                  :mod (e / e) 
                  :op1-of (s / slash))))

# ::snt Chimeras ( > 80 % ) were then mated with p53 + /  mice ( Taconic ) and MEFs were prepared .
# ::tok Chimeras ( > 80 % ) were then mated with p53 + /  mice ( Taconic ) and MEFs were prepared .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:22.287
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt MEFs were first genotyped by PCR with primers a and b ( see Figure 2 ) to detect the PuroTK marker of the RMCE allele ( top ) .
# ::tok MEFs were first genotyped by PCR with primers a and b ( see Figure 2 ) to detect the PuroTK marker of the RMCE allele ( top ) .
# ::alignments 26-27|0.2.0 24-25|0.2.1 20-21|0.2 19-20|0.2.3.0.0+0.2.3.0+0.2.3 17-18|0.2.2 14-15|0.2.2.1 13-14|0.1 12-13|0 10-11|0.0 9-10|0.2.3.1 7-8|0.2.4 0-1|0.2.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:22.479
(s / see-01 
      :ARG0 (b / b) 
      :ARG1 (f / figure) 
      :purpose-of (m / mark-01 
            :ARG0 (t / top) 
            :ARG1 (a / allele) 
            :ARG1-of (d / detect-01 
                  :ARG0 (m2 / mef) 
                  :ARG2 2) 
            :ARG2 (t2 / thing 
                  :name (n / name 
                        :op1 "PuroTK") 
                  :op1-of (a2 / and)) 
            :op1-of (p / primer)))

# ::snt This revealed germline transmission of the p53 RMCE-ready locus in MEFs 1 , 2 and 6 .
# ::tok This revealed germline transmission of the p53 RMCE-ready locus in MEFs 1 , 2 and 6 .
# ::alignments 15-16|0.1.0.1 14-15|0.3 13-14|0.1.1.0.0.1 11-12|0.1.0.0 10-11|0.2 8-9|0.1.1 7-8|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 6-7|0.1.1.0 3-4|0.1 2-3|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:22.743
(r / reveal-01 
      :ARG0 (t3 / this) 
      :ARG1 (t2 / transmission 
            :mod (g / germline 
                  :mod-of 1 
                  :poss 6) 
            :mod (l / locu 
                  :mod (p / p53 
                        :mod-of (t / thing 
                              :name (n / name 
                                    :op1 "RMCE-ready") 
                              :quant 2)))) 
      :ARG2 (m / mef) 
      :location (a / and))

# ::snt Each of these three MEF clones was further analyzed ( bottom ) with primers f and g ( left lanes ) and h and i ( right lanes ) , routinely used to genotype p53 + /  mice ( sequences in Materials and Methods ) .
# ::tok Each of these three MEF clones was further analyzed ( bottom ) with primers f and g ( left lanes ) and h and i ( right lanes ) , routinely used to genotype p53 + /  mice ( sequences in Materials and Methods ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:22.747
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Primers f and g amplify a 320 bp product from a WT or RMCE allele , while primers h and i specifically amplify a 150 bp product from the Neo marker in the KO allele .
# ::tok Primers f and g amplify a 320 bp product from a WT or RMCE allele , while primers h and i specifically amplify a 150 bp product from the Neo marker in the KO allele .
# ::alignments 34-35|0.0.2.2.1 33-34|0.0.2.2.1.0 30-31|0.0.2.2 29-30|0.0.2.2.0.0.0+0.0.2.2.0.0+0.0.2.2.0 26-27|0.0.2.1 24-25|0.0.2.1.0 22-23|0.0.2 21-22|0.0.2.3 20-21|0.0.2.0.1 19-20|0.0.2.0 18-19|0.0.2.0.0 17-18|0.0.2.0.0.0 14-15|0.2 12-13|0.2.0 8-9|0.1 4-5|0 3-4|0.0.1 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:23.019
(a5 / amplify-01 
      :ARG0 (a6 / and 
            :op1 (f / f 
                  :mod (p4 / primer)) 
            :op2 (g / g) 
            :op3 (a2 / amplify-01 
                  :ARG0 (a3 / and 
                        :op1 (h / h 
                              :mod (p2 / primer)) 
                        :op2 (i / i)) 
                  :ARG1 (p / product 
                        :quant 150) 
                  :ARG2 (m / mark-01 
                        :ARG0 (t / thing 
                              :name (n / name 
                                    :op1 "Neo")) 
                        :location (a / allele 
                              :mod (k / ko))) 
                  :manner (s / specific-02))) 
      :ARG1 (p3 / product) 
      :ARG2 (a4 / allele 
            :op1-of (o / or)))

# ::snt MEF 1 are p53RMCE / + and MEFs 2 and 6 are p53RMCE /  cells .
# ::tok MEF 1 are p53RMCE / + and MEFs 2 and 6 are p53RMCE /  cells .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:23.021
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Performing RMCE in MEFs .
# ::tok Performing RMCE in MEFs .
# ::alignments 3-4|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:23.029
(m / mef 
      :ARG1-of (p / perform-01))

# ::snt ( A ) RMCE with the p53GFP plasmid leads to the transient observation of cells with intense nuclear fluorescence .
# ::tok ( A ) RMCE with the p53GFP plasmid leads to the transient observation of cells with intense nuclear fluorescence .
# ::alignments 18-19|0.2.0 17-18|0.2.0.0 16-17|0.2 14-15|0.1.0 12-13|0.1 11-12|0.1.1 8-9|0 7-8|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:23.079
(l / lead-03 
      :ARG1 (p / plasmid) 
      :ARG2 (o / observation 
            :domain (c / cell) 
            :mod (t / transient)) 
      :time (i / intense-02 
            :ARG1 (f / fluorescence 
                  :mod (n / nucleus))))

# ::snt p53RMCE /  MEFs , electroporated with a Cre expression plasmid and the p53GFP exchange plasmid , were analyzed 48 h later by fluorescence microscopy .
# ::tok p53RMCE /  MEFs , electroporated with a Cre expression plasmid and the p53GFP exchange plasmid , were analyzed 48 h later by fluorescence microscopy .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:23.080
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt A typical field ( left to right : fluorescence , phase contrast , merged ) with a fluorescent cell ( arrow ) is shown .
# ::tok A typical field ( left to right : fluorescence , phase contrast , merged ) with a fluorescent cell ( arrow ) is shown .
# ::alignments 23-24|0.2.1 20-21|0.2.2.0 18-19|0.2.2.1.0 17-18|0.2.2.1 13-14|0.1 11-12|0 10-11|0.0 8-9|0.1.0 6-7|0.2.2 4-5|0.2 2-3|0.2.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:23.235
(c2 / contrast-01 
      :ARG1 (p / phase) 
      :ARG1-of (m / merge-01 
            :ARG0 (f2 / fluorescence)) 
      :ARG2-of (l / leave-11 
            :ARG1 (f3 / field 
                  :ARG1-of (t / typical-02)) 
            :ARG1-of (s / show-01) 
            :beneficiary (r / right-05 
                  :ARG0 (a / arrow) 
                  :ARG1 (f / fluorescent 
                        :mod-of (c / cell)))))

# ::snt The fluorescent cell is enlarged ( extreme right ) .
# ::tok The fluorescent cell is enlarged ( extreme right ) .
# ::alignments 7-8|0.0.0 6-7|0.0 4-5|0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:23.269
(e2 / enlarge-01 
      :ARG0 (e / extreme 
            :mod (r / right)) 
      :ARG1 (c / cell 
            :mod (f / fluorescent)))

# ::snt ( B ) RMCE with the p53PGFP plasmid .
# ::tok ( B ) RMCE with the p53PGFP plasmid .
# ::alignments 7-8|0.1 1-2|0.2+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:23.283
(l / location 
      :name (n / name 
            :op1 "B") 
      :part (p / plasmid) 
      :wiki -)

# ::snt p53RMCE /  MEFs , electroporated with a Cre expression plasmid and the p53PGFP plasmid , were selected with ganciclovir .
# ::tok p53RMCE /  MEFs , electroporated with a Cre expression plasmid and the p53PGFP plasmid , were selected with ganciclovir .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:23.284
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt PCR with primers d and e ( Figure 3B ) indicated that 9/22 ganciclovir-resistant clones integrated the P mutation [ top row , a representative analysis of 10 clones ( Q -- Z ) is shown ] .
# ::tok PCR with primers d and e ( Figure 3B ) indicated that 9/22 ganciclovir-resistant clones integrated the P mutation [ top row , a representative analysis of 10 clones ( Q -- Z ) is shown ] .
# ::alignments 35-36|0 32-33|0.0.1.1.0 30-31|0.0.0 28-29|0.1.0 27-28|0.0.2 25-26|0.1 24-25|0.1.1 21-22|0.0.1.0 20-21|0.0.1.0.0 18-19|0.0.1.2.0 17-18|0.0.1.2 15-16|0.0.1 14-15|0.0 10-11|0.0.1.1 7-8|0.1.0.0 4-5|0.1.1.0 3-4|0.1.1.1 2-3|0.1.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:23.899
(s / show-01 
      :ARG0 (c2 / clone-01 
            :ARG0 (q / q) 
            :ARG0-of (i / integrate-01 
                  :ARG1 (r2 / row 
                        :mod (t / top)) 
                  :ARG1-of (i2 / indicate-01 
                        :ARG2 (z / z)) 
                  :manner (p / P60 
                        :mod-of (m / mutation))) 
            :ARG1 10) 
      :ARG1 (a / analyze-01 
            :ARG1 (c / clone-01 
                  :ARG1 (f / figure)) 
            :manner (r / represent-01 
                  :ARG0 (a2 / and) 
                  :ARG2 (d / d) 
                  :op1-of (p2 / primer))))

# ::snt PCR with primers b and c next verified that the detected PRD deletions resulted from RMCE at the p53 locus , not random integration ( middle row , as expected clones R , S , T and W are positive , but not Q ) .
# ::tok PCR with primers b and c next verified that the detected PRD deletions resulted from RMCE at the p53 locus , not random integration ( middle row , as expected clones R , S , T and W are positive , but not Q ) .
# ::alignments 43-44|0.1.1.2 42-43|0.1.1.2.0 41-42|0 39-40|0.1 37-38|0.1.0.2 36-37|0.1.0 35-36|0.1.0.1.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 33-34|0.1.2.0+0.1.2 31-32|0.1.1 30-31|0.1.1.0 29-30|0.1.1.1 26-27|0.0.0 25-26|0.0 23-24|0.1.0.0 22-23|0.2.0.0.0.0.0 21-22|0.1.0.0.1 19-20|0.2.0.0.2 18-19|0.2.0.0.2.0 13-14|0.2.0.0 12-13|0.2.0.0.0 11-12|0.2.0.0.0.1.0.0+0.2.0.0.0.1.0+0.2.0.0.0.1 10-11|0.2.0.0.0.0 7-8|0.2.0 6-7|0.2.0.1 5-6|0.1.1.1.0 4-5|0.2 3-4|0.1.0.0.0 2-3|0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:25.595
(c / contrast-01 
      :ARG0 (m / middle 
            :mod-of (r2 / row)) 
      :ARG1 (p / positive 
            :domain (a / and 
                  :ARG1-of (i / integrate-01 
                        :ARG0 (b / b) 
                        :polarity -) 
                  :op1 (a2 / aircraft-type 
                        :name (n / name 
                              :op1 "T50") 
                        :wiki "Sukhoi_PAK_FA") 
                  :op2 (w / w)) 
            :domain (r / r 
                  :ARG1-of (c2 / clone-01) 
                  :ARG1-of (e / expect-01 
                        :ARG0 (c3 / c)) 
                  :domain-of (q / q 
                        :polarity -)) 
            :domain (n2 / name 
                  :op1 "S-400")) 
      :ARG2 (a3 / and 
            :ARG0-of (v / verify-01 
                  :ARG1 (r4 / result-01 
                        :ARG0 (d / deletion 
                              :ARG1-of (d2 / detect-01 
                                    :ARG0 (r3 / random)) 
                              :mod (o / organization 
                                    :name (n3 / name 
                                          :op1 "PRD"))) 
                        :ARG1 (p3 / primer) 
                        :ARG2 (l / locu 
                              :mod (p2 / p53))) 
                  :manner (n4 / next))))

# ::snt Western analysis of positive clones ( bottom row ) showed that p53PGFP accumulated after ADR , but at lower levels than p53WT .
# ::tok Western analysis of positive clones ( bottom row ) showed that p53PGFP accumulated after ADR , but at lower levels than p53WT .
# ::alignments 21-22|0.0.1 19-20|0.0.2.0.1.0.0 18-19|0.0.2.0.1.0 16-17|0 13-14|0.0.3 12-13|0.0 11-12|0.0.0 9-10|0.0.2 7-8|0.0.2.0.0 6-7|0.0.2.0.0.0 4-5|0.0.2.0.1 3-4|0.0.2.0.1.1 1-2|0.0.2.0 0-1|0.0.2.0.2.1+0.0.2.0.2.0.0+0.0.2.0.2.0+0.0.2.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:25.803
(c / contrast-01 
      :ARG1 (a2 / accumulate-01 
            :ARG0 (p2 / p53PGFP) 
            :ARG1 (p / p53WT) 
            :ARG1-of (s / show-01 
                  :ARG0 (a3 / analyze-01 
                        :ARG0 (r / row 
                              :mod (b / bottom)) 
                        :ARG1 (c2 / clone-01 
                              :ARG1 (l2 / low-04 
                                    :ARG1 (l / level)) 
                              :mod (p3 / positive)) 
                        :mod (w / world-region 
                              :name (n / name 
                                    :op1 "West") 
                              :wiki "Western_world"))) 
            :time (a / after)))

# ::snt ( C ) Phenotypic assay of p53PGFP : loss of cell cycle control .
# ::tok ( C ) Phenotypic assay of p53PGFP : loss of cell cycle control .
# ::alignments 12-13|0.0.0 11-12|0.0 10-11|0.0.0.2 8-9|0.0.0.1 6-7|0.0.0.1.0 4-5|0.0.1 3-4|0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:26.094
(p2 / phenotypic 
      :ARG0-of (c2 / cycle-02 
            :ARG1-of (c / control-01 
                  :ARG0 (c4 / C) 
                  :beneficiary-of (l / loss 
                        :mod (p / p53PGFP)) 
                  :mod (c3 / cell)) 
            :ARG2 (a / assay)))

# ::snt Asynchronous p53RMCE /  and p53PGFP /  MEFs left untreated , or irradiated with doses of 6 or 12 Gy , were analyzed ( top shows a typical experiment ; bottom plots results from  4 independent experiments and  3 independent MEFs ) .
# ::tok Asynchronous p53RMCE /  and p53PGFP /  MEFs left untreated , or irradiated with doses of 6 or 12 Gy , were analyzed ( top shows a typical experiment ; bottom plots results from  4 independent experiments and  3 independent MEFs ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:26.095
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Note that the p53RMCE locus encodes a WT p53 .
# ::tok Note that the p53RMCE locus encodes a WT p53 .
# ::alignments 8-9|0.0.1 5-6|0.0 4-5|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:26.120
(n / note-01 
      :ARG1 (e / encode-01 
            :ARG0 (l / locu) 
            :ARG1 (p / p53)))

# ::snt Summary of targeting experiments .
# ::tok Summary of targeting experiments .
# ::alignments 3-4|0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:26.134
(t / target-01 
      :ARG1 (e / experiment-01))

# ::snt In ES cells , targeting p53PGFP or p53GFP by RMCE was  20 times more efficient than targeting Flox by homologous recombination .
# ::tok In ES cells , targeting p53PGFP or p53GFP by RMCE was  20 times more efficient than targeting Flox by homologous recombination .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:26.136
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt In MEFs , due to p53GFP toxicity , only the targeting efficiency of RMCE with p53PGFP could be evaluated .
# ::tok In MEFs , due to p53GFP toxicity , only the targeting efficiency of RMCE with p53PGFP could be evaluated .
# ::alignments 18-19|0.0 16-17|0 15-16|0.0.0.0 11-12|0.0.0 10-11|0.0.0.1 8-9|0.0.0.2 6-7|0.0.1 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:26.302
(p / possible-01 
      :ARG1 (e / evaluate-01 
            :ARG1 (e2 / efficient-01 
                  :ARG1 (p2 / p53PGFP) 
                  :ARG1-of (t / target-01 
                        :ARG0 (m / mef)) 
                  :mod (o / only)) 
            :ARG2 (t2 / toxicity)))

# ::snt Importantly , a phenotypic read-out of the p53PGFP mutation in MEFs , if it had been performed after targeting in fibroblasts by homologous recombination , would have required two rounds of inefficient targeting to target both p53 alleles .
# ::tok Importantly , a phenotypic read-out of the p53PGFP mutation in MEFs , if it had been performed after targeting in fibroblasts by homologous recombination , would have required two rounds of inefficient targeting to target both p53 alleles .
# ::alignments 37-38|0.0.1.0 36-37|0.0.1.0.0 35-36|0.0.1.0.1 34-35|0.0.1 32-33|0.0 31-32|0.0.2.1+0.0.2 29-30|0.1 28-29|0.1.0 27-28|0 23-24|0.0.0.0.0 22-23|0.0.0.0.1.0.2 20-21|0.0.0.0.1.0.0 18-19|0.0.0.0.1.0 17-18|0.0.0.0.1 16-17|0.0.0.0 10-11|0.0.0.0.1.0.1 8-9|0.0.0.2 4-5|0.0.0 3-4|0.0.0.1 0-1|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:46:27.349
(r2 / require-01 
      :ARG1 (t2 / target-01 
            :ARG0 (r4 / read-out 
                  :ARG1-of (p2 / perform-02 
                        :ARG0 (r3 / recombination) 
                        :time (a2 / after 
                              :op1 (t3 / target-01 
                                    :ARG0 (f / fibroblast) 
                                    :ARG1 (m / mef) 
                                    :time (h / homologou)))) 
                  :mod (p3 / phenotypic) 
                  :poss (m2 / mutation)) 
            :ARG1 (t / target-01 
                  :ARG1 (a / allel 
                        :mod (p / p53) 
                        :mod (b / both))) 
            :ARG1-of (e / efficient-01 
                  :ARG0 (i / importantly) 
                  :polarity -)) 
      :ARG2 (r / round 
            :quant 2))

